As of March 26, we're $27,100 in the red for the quarter. Donate here to support this vital work
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Psychedelic Medicine News Stories

Below are key excerpts of inspiring news articles on psychedelic medicine from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Explore our comprehensive news index on a wide variety of fascinating topics.
Explore the top 20 most revealing news media articles we've summarized.
Check out 10 useful approaches for making sense of the media landscape.

Sort articles by: Article Date | Date Posted on WantToKnow.info | Importance

Psychedelic drug MDMA moves closer to US approval following success in PTSD trial
2023-09-14, Nature
Posted: 2023-09-24 16:48:44
https://www.nature.com/articles/d41586-023-02886-x

The psychedelic drug MDMA, also known as ecstasy or molly, has passed another key hurdle on its way to regulatory approval as a treatment for mental illness. A second large clinical trial has found that the drug — in combination with psychotherapy — is effective at treating post-traumatic stress disorder (PTSD). In June, Australia became the first country to allow physicians to prescribe MDMA for treating psychiatric conditions. MDMA is illegal in the United States and other countries because of the potential for its misuse. But the Multidisciplinary Association for Psychedelic Studies (MAPS) ... has long been developing a proprietary protocol for using MDMA as a treatment for PTSD and other disorders. MAPS has been campaigning for its legalization. In 2021, researchers sponsored by MAPS reported the results of a study in which 90 people received a form of psychotherapy developed by the organization alongside either MDMA or a placebo. After three treatment sessions, 67% of those who received MDMA with therapy no longer qualified for a PTSD diagnosis, compared with 32% of those who received therapy and a placebo. The results of a second trial ... were similar: 71% of people who received MDMA alongside therapy lost their PTSD diagnosis. A MAPS spokesperson says that the organization plans to seek formal FDA approval before the end of this year, and that because the agency has already designated MDMA as a ‘breakthrough therapy’ ... it will be evaluated quickly.

Note: Read more about the healing potentials of mind-altering drugs. Explore more positive stories like this in our comprehensive inspiring news articles archive focused on solutions and bridging divides.


The History And Potential Of MDMA
2023-06-29, NPR
Posted: 2023-09-24 16:47:21
https://www.npr.org/2023/06/29/1185170371/the-history-and-potential-of-mdma

Stuck indoors during the peak of COVID lockdown, science journalist Rachel Nuwer found herself at a professional crossroads. She had already published a nonfiction book on the dark world of wildlife trafficking and was looking for her next subject. A moment of clarity came at a surprising time. She and her partner, at home with nothing much to do, ingested MDMA. MDMA, also known as ecstasy or molly, is illegal. It is listed as a Schedule 1 drug by the U.S. federal government (the same group as marijuana and psilocybin, or magic mushrooms). A growing body of academic research has suggested potential benefits of MDMA beyond the recreational ecstasy some partygoers are familiar with. One study found that MDMA-enhanced therapy dramatically reduced PTSD symptoms. Another showed that psychedelics like MDMA could reopen so-called critical periods of time when brains are especially impressionable and open to learning. A scientific case study profiled a former white supremacist who reformed his extremist views after taking MDMA. Nuwer experienced similar clarity while on the drug. Her new book, "I Feel Love: MDMA and the Quest for Connection in a Fractured World," is the result of her epiphany. She explores the history and potential of the so-called love drug.

Note: Read more about the healing potentials of mind-altering drugs. Explore more positive stories like this in our comprehensive inspiring news articles archive focused on solutions and bridging divides.


Psychedelics as Antidepressants
2021-01-30, Scientific American
Posted: 2023-08-15 13:05:45
https://www.scientificamerican.com/article/psychedelics-as-antidepressants/

As of 2018, nearly one in eight Americans use antidepressants. Unfortunately, more than a third of patients are resistant to the mood-improving benefits of medicine’s best antidepressant drugs. These people are not completely out of options. There are chemicals already out there that can restore their mood balance, and in some cases, even save their lives. Chemicals such as lysergic acid diethylamide (LSD), psilocybin (magic mushrooms) and dimethyltryptamine (DMT) are more accurately called “serotonergic psychedelics” among the neuroscience community. At the correct doses, psychedelics are well tolerated, producing only minor side effects such as transient fear, perception of illusions, nausea/vomiting or headaches. These fleeting side effects pale in comparison to the severity of commonly prescribed antidepressants, which include dangerous changes in heart rate and blood pressure, paradoxical increases in suicidality, and withdrawal symptoms. As far as outcomes go, psychedelics in combination with psychotherapy are remarkably efficient at treating depression. Compared to selective serotonin reuptake inhibitors, or SSRIs, the current gold standard in antidepressant medication, psychedelics have a faster effect on patients, sometimes effective with only a single therapy session. Psychedelics also have a longer-lasting effect than an SSRI regimen. A 2015 study ... demonstrated that past history of psychedelic use decreases the odds of suicidal thoughts or actions over the course of a lifetime.

Note: Read more about the healing potentials of psychedelic medicine. Explore more positive stories like this in our comprehensive inspiring news articles archive focused on solutions and bridging divides.


How a dose of MDMA transformed a white supremacist
2023-06-14, BBC News
Posted: 2023-07-03 15:31:29
https://www.bbc.com/future/article/20230614-how-a-dose-of-mdma-transformed-a-...

Harriet de Wit, a professor of psychiatry and behavioural science at the University of Chicago, was running an experiment on whether the drug MDMA increased the pleasantness of social touch in healthy volunteers. Mike Bremmer, de Wit's research assistant, appeared at her office door with a concerned look on his face. A man named Brendan had filled out a standard questionnaire at the end. Strangely, at the very bottom of the form, Brendan had written in bold letters: "This experience has helped me sort out a debilitating personal issue. Google my name. I now know what I need to do." Brendan had been the leader of ... a notorious white nationalist group. "Go ask him what he means by 'I now know what I need to do,'" [de Wit] instructed Bremmer. As he clarified to Bremmer, love is what he had just realised he had to do. "Love is the most important thing," he told the baffled research assistant. "I conceived of my relationships with other people not as distinct boundaries with distinct entities, but more as we-are-all-one. I realised I'd been fixated on stuff that doesn't really matter. There are moments when I have racist or antisemitic thoughts ... But now I can recognise that those kinds of thought patterns are harming me more than anyone else." While MDMA cannot fix societal-level drivers of prejudice and disconnection, on an individual basis it can make a difference. In certain cases, the drug may even be able to help people see through the fog of discrimination and fear that divides so many of us.

Note: A case study about Brendan was published in the journal Biological Psychiatry. Read more on the healing potentials of psychedelic medicine, including science journalist Rachel Nuwer's new book, I Feel Love: MDMA and the Quest for Connection in a Fractured World. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


New research illuminates how the human brain creates its own psychedelic drugs
2023-02-20, Salon
Posted: 2023-06-18 22:37:56
https://www.salon.com/2023/02/20/new-research-illuminates-how-the-human-brain...

The World Health Organization estimates that ... depression and anxiety rose by more than 25 percent in the first year of the COVID pandemic, adding to the nearly one billion people who were already living with a mental disorder. One of the principal ways mental health disorders are thought to manifest is through severed connections between neurons — the winding, spindly cells in our brain and throughout our body essential for interpreting info from the external environment. Certain antidepressant drugs seem to work by increasing serotonin levels, an important neurotransmitter that the brain uses to send signals between neurons. They can help regrow neuronal connections ... only the effect seems to be slower, less dramatic [and] can come with significant drawbacks. In contrast, psychedelics can promote this kind of regrowth in as little as 24 hours, often less. Many experts believe psychedelic drugs ... act like Miracle Grow for neurons, helping them flourish like a dense forest. Pretty much the only reason drugs have a psychoactive effect on us at all is because they closely resemble chemicals our body already produces. Most psychedelic drugs like LSD, DMT and psilocybin are structurally similar to serotonin, so they can act on serotonin receptors, but in a slightly different way. You can think of it like clumsily-made lockpicks that still work in a lock designed for a specific key. But even the slight differences can have profound effects, specifically, altered perception of time and space and intensified colors and sounds.

Note: Read more on the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psychedelic brew ayahuasca’s profound impact revealed in brain scans
2023-03-20, The Guardian (One of the UK's Leading Newspapers)
Posted: 2023-04-02 19:59:29
https://www.theguardian.com/science/2023/mar/20/psychedelic-brew-ayahuasca-pr...

The brew is so potent that practitioners report not only powerful hallucinations, but near-death experiences, contact with higher-dimensional beings, and life-transforming voyages through alternative realities. Often before throwing up, or having trouble at the other end. Now, scientists have gleaned deep insights of their own by monitoring the brain on DMT, or dimethyltryptamine, the psychedelic compound found in Psychotria viridis, the flowering shrub that is mashed up and boiled in the Amazonian drink, ayahuasca. The recordings reveal a profound impact across the brain, particularly in areas that are highly evolved in humans and instrumental in planning, language, memory, complex decision-making and imagination. The regions from which we conjure reality become hyperconnected, with communication more chaotic, fluid and flexible. “It is incredibly potent,” said Robin Carhart-Harris, a professor of neurology and psychiatry. “People describe leaving this world and breaking through into another that is incredibly immersive and richly complex, sometimes being populated by other beings that they feel might hold special power over them, like gods.” He added: “DMT breaks down the basic networks of the brain, causing them to become less distinct from each other. The major rhythms of the brain – that serve a largely inhibitory, constraining function – break down, and in concert, brain activity becomes more entropic or information-rich.”

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Australia becomes first country to recognise psychedelics as medicines
2023-02-03, Sydney Morning Herald
Posted: 2023-02-26 22:31:08
https://www.smh.com.au/politics/federal/australia-becomes-first-country-to-re...

Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people with certain mental health conditions. MDMA and psilocybin, the active ingredient in magic mushrooms, will be considered schedule 8 drugs - meaning they’re approved for controlled use when prescribed by a psychiatrist - from July this year after the TGA acknowledged there were few other options for patients with specific treatment-resistant mental illnesses. The changes will allow MDMA to be used to treat post-traumatic stress disorder, and psilocybin for treatment-resistant depression. They will still be considered prohibited substances ... for all other usages. “Prescribing will be limited to psychiatrists, given their specialised qualifications and expertise to diagnose and treat patients with serious mental health conditions,” a TGA statement published on Friday said. Associate Professor David Caldicott, an emergency department doctor who appeared at the Royal Commission into Defence and Veteran Suicide ... was pleasantly surprised by Friday’s decision. “The conditions for which these drugs might be used [post-traumatic stress disorder and treatment-resistant depression] are currently conditions for which you’re basically destined to a lifetime of drug use. Whereas the MDMA particularly is used to facilitate psychotherapy, only for a few doses,” [said Caldicott].

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms.
2022-11-09, Yahoo News
Posted: 2022-12-12 00:58:46
https://sports.yahoo.com/jim-harris-paralyzed-then-ate-103056289.html

Against all odds, Jim Harris was walking. There he was, at a music festival, getting around with the assistance of a walker, eight months out from a spinal-cord injury that left him paralyzed from the chest down. In November 2014, a snowkiting accident in Chile changed how the mountaineering instructor turned adventure photographer moved through the world. His days ... were now filled with rehabilitation exercises. A friend and former physical therapist invited him to the High Sierra Music Festival. "The disability made me feel like an outsider," he says. Then someone offered him magic mushrooms, which are packed with the psychoactive compound psilocybin. He commandeered an acquaintance's padded knee scooter so he could rest one leg at a time and still sway to the music. In the middle of a switch, he discovered that he could pick up his right foot and pull it back toward his butt. He tapped his right hamstring with a finger and the muscle contracted - a muscle that had been completely unresponsive since his injury, even in the low-gravity environment of a pool, despite eight months of physical therapy. With wonder and some degree of hesitation, he showed his physical-therapist friend. They marveled together at what had been impossible for Harris earlier that day. The next morning, Harris woke up afraid he'd imagined the whole thing, or that he'd lost his newfound ability while he slept, but his hamstring was still firing. The neuromuscular connection that had formed the night before wasn't going anywhere.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Colorado voters legalize psilocybin and psychedelic therapy
2022-11-08, Denver Post
Posted: 2022-11-29 01:24:38
https://www.denverpost.com/2022/11/08/colorado-results-prop-122-legalizing-ps...

Colorado is poised to become the second U.S. state to legalize medicinal psychedelics. Proposition 122, Access to Natural Psychedelic Substances, was supported by about 52% of the vote ... according to the Secretary of State’s Office. The measure legalizes psilocybin and psilocin, two compounds found in “magic mushrooms,” for use in therapeutic settings and paves the way for the establishment of “healing centers” where adults 21 years old and up can use the substances under the supervision of licensed professionals. Additionally, Proposition 122 decriminalizes the personal growing, use and sharing of psilocybin and psilocin, as well as ibogaine, mescaline and dimethyltryptamine, or DMT, for adults. Colorado follows Oregon, which legalized psilocybin in 2020. Natural Medicine Colorado lauded the results as a history-making win. “Colorado voters saw the benefit of regulated access to natural medicines, including psilocybin, so people with PTSD, terminal illness, depression, anxiety and other mental health issues can heal,” said the measure’s co-proponents, Kevin Matthews and Veronica Lightening Horse Perez, in a statement. Proposition 122 gives the Department of Regulatory Agencies (DORA) until January 2024 to develop licensing criteria for psychedelic treatment centers, facilitators, and ancillary businesses.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Key Articles From Years Past


Psychedelics And Mental Health: What Does The Science Say?
2022-09-02, Forbes
Posted: 2022-11-08 14:43:57
https://web.archive.org/web/20221021092440/https://www.forbes.com/health/mind...

Psychedelic therapy is the use of psychedelic substances, often alongside traditional talk therapy (psychotherapy), as a treatment for mental health issues such as anxiety, depression, suicidality and PTSD. Michael Mithoefer, M.D. ... at the Multidisciplinary Association for Psychedelic Studies (MAPS), likens psychedelic therapy to applying a cast to a broken bone. “[Psychedelic]-assisted therapy engages the mind’s innate power to heal itself—the participants’ ‘inner healing intelligence,’” claims Dr. Mithoefer, going on to explain that “the source of the healing process is the person themselves—the psychedelic and therapists are catalysts.” In the U.S., psychedelics continue to undergo medical trials, with some being granted a “breakthrough therapy” designation by the FDA, indicating that preliminary clinical evidence has shown the drug can demonstrate substantial improvement over currently available therapy. COMPASS Pathways, a mental health treatment company, received the designation for its psilocybin therapy for treatment-resistant depression in 2018. In 2019, Usona Institute ... received the designation to continue its testing of psilocybin as a treatment for major depressive disorder. Psilocybin-assisted therapy is also being tested as a treatment for various addictions ... as well as certain conditions such as anxiety, depression, post traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), cluster headaches, migraines and chronic pain.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


What Do Athletes Get From Ayahuasca, Mushrooms and Ecstasy?
2022-08-12, Sports Illustrated
Posted: 2022-11-08 14:42:24
https://www.si.com/more-sports/2022/08/12/psychedelics-sports-aaron-rodgers-d...

Aaron Rodgers and Kenny Stills are among the few who have spoken publicly about their use of psychedelics for mental health purposes. But a future where the treatment is more widespread across sports may not be so far away. “Some people still ... don’t recognize these as legitimate, life-saving medical medicines,” [NBA agent Daniel] Poneman says. “There are athletes that I know who have had life-changing experiences with these medicines, but only a few of them are brave enough to speak out for fear of being stigmatized.” There’s still stigma around taking medication of any kind for mental illness, but it’s slowly lessening. Aaron Rodgers said on a recent podcast that he has taken psychedelics to improve his mental health. The Packers’ quarterback said he does not identify as having a mental illness like depression or anxiety, but that his most recent psychedelic experience—with ayahuasca, in March 2020, in Peru—has helped increase his “self-love.” Before Rodgers spoke out, NFL free-agent wide receiver Kenny Stills was thought to be the only active professional athlete vocal about his psychedelic use. Stills, who last season played for the Saints, says his case of depression in 2016 felt like a “permanent cloud.” Last year he went to a clinic run by Field Trip Health, a for-profit that provides people with ketamine-assisted psychotherapy—meaning they have to take the medication under supervision of a licensed therapist and debrief with them afterward.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psilocybin as mental health therapy? Here’s what I found.
2022-09-05, Washington Post
Posted: 2022-10-02 22:04:26
https://www.washingtonpost.com/health/2022/09/05/psilocybin-mental-health-psy...

A few weeks ago, I mentioned to a friend that I was interested in learning more about psychedelics, especially how they might help me with depression and anxiety. That’s a broad category of plant medicines including psilocybin (“magic”) mushrooms, MDMA (ecstasy), DMT (Dimitri or the Businessman’s Trip), ketamine (“special K”) and some others. My friend told me he’d recently taken his first “trip,” which he described as life-changing. I asked him — a real estate developer living in Northern California, married with kids — why he decided to try a psychedelic substance. “My work felt increasingly stale and meaningless,” he explained to me over a beer. “Despite a massive amount of reflection and coaching around how to break the rut, I felt as though I was still off track.” When I confided my interest in psychedelics to a few other friends, several said they had tried the drugs and experienced several benefits: from easing anxiety to finding spiritual insights to combating depression and, among some with cancer, helping to reduce the fear of dying. They are hardly outliers. According to a new YouGovAmerica study, “one in four Americans say they’ve tried at least one psychedelic drug,” amounting to some 72 million U.S. adults. When I queried my psychiatrist about participating to help improve my mental health, he was supportive, with two caveats: Do it with a trained therapist or guide, and do your best to ensure that the substance is what it’s said to be.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Altering Perceptions on Psychedelics
2022-04-01, Harvard Medicine
Posted: 2022-08-21 18:03:59
https://hms.harvard.edu/magazine/viral-world/altering-perceptions-psychedelics

Growing evidence for the safety and efficacy of psychedelics could lead to better treatments for anxiety, depression, pain, and other often intractable conditions. Jerry Rosenbaum was intrigued when he first heard about the effect that psilocybin—the hallucinogenic compound found in certain species of mushrooms—was purported to have on the brain’s “resting state,” what neuroscientists call the default mode network. The default mode network encompasses any neural function that has some bearing on our autobiographical tendencies. When people take psilocybin at low doses, the default mode network becomes less active. That is, the drug appears to tame self-reflection and all but ruin rumination, that obsessive mental state characterized by excessive, repetitive thoughts. Rumination is a hallmark cognitive symptom of depression. Neuroscientists are observing that, when taken in a controlled setting, these substances are beneficial to the brain, especially for people who have certain psychiatric disorders. Landmark studies in 2014 and 2016 showed that LSD and psilocybin alleviated existential anxiety in patients with life-threatening illnesses for up to a year after beginning the treatment. Other studies have shown that ketamine may strengthen neurons against the damage from chronic stress by preventing synapses from being flooded with glutamate, an amino acid that, in excess, withers dendrites. And researchers continue to investigate whether psychedelics are useful as anti-inflammatory agents.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


MAPS Raises Nearly $1.6 Million in Christie's NFT Auction
2022-06-30, Yahoo News
Posted: 2022-08-21 18:02:19
https://www.yahoo.com/now/maps-raises-nearly-1-6-191900137.html

The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced that Cartography of the Mind: A Curated NFT Sale raised $1,569,960. Proceeds of the auction, presented by Christies in collaboration with Ryan Zurrer, founder of Dialectic and Vine Ventures, will benefit MAPS. Throughout the week, the physical exhibition at Christie's new gallery on 6th Avenue drew impressive crowds of enthusiastic visitors. With competitive bidding, the sale realized over $1.5 million. It was 100% sold, and 130% sold hammer over low estimate. Beeple, David Choe, Sarah Meyohas, Refik Anadol, Mad Dog Jones, IX Shells, and more donated art to support MAPS. The research, education, and advocacy organization ... remains the leading body at the vanguard of research into potentially life-saving psychedelic-assisted therapies. Psychedelic Healing is an artistic interpretation of the MAPS logo by renowned artist Alex Grey to celebrate MAPS' 35th anniversary in 2021. It was purchased by Ryan Zurrer and donated back to MAPS for additional fundraising. Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS is sponsoring the most advanced psychedelic therapy research in the world funded primarily by philanthropic donors and grantors who have given more than $130 million for research and education.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Biden Administration Plans for Legal Psychedelic Therapies Within Two Years
2022-07-26, The Intercept
Posted: 2022-08-15 21:17:49
https://theintercept.com/2022/07/26/mdma-psilocybin-fda-ptsd/

As twin mental health and drug misuse crises kill thousands of people per week, the potential of psychedelic-assisted therapies “must be explored,” urges a federal letter on behalf of the U.S. health secretary. President Joe Biden’s administration “anticipates” that regulators will approve MDMA and psilocybin within the next two years for designated breakthrough therapies for PTSD and depression, respectively. The administration is “exploring the prospect of establishing a federal task force to monitor” the emerging psychedelic treatment ecosystem, according to the letter sent by Assistant Secretary for Mental Health and Substance Use. The move followed [the] introduction of a bipartisan bill, co-sponsored by Sens. Cory Booker, D-N.J., and Rand Paul, R-Ky., to force the DEA to stop barring terminally ill patients from trying controlled drugs which have passed early trials. The right to try experimental therapies has been enshrined in federal law since 2018, but the DEA currently blocks its use among people with late-stage cancer who wish to be treated with psilocybin, a Schedule I controlled substance. “Studies have shown that psilocybin produces substantial and sustained decreases in depression and anxiety among patients with life-threatening cancer,” Booker wrote. “While typically terminally ill patients are allowed to access drugs that are in FDA clinical trials, they are barred from accessing Schedule I drugs, despite their therapeutic potential.”

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
2021-11-11, New York Times
Posted: 2022-07-04 12:59:31
https://www.nytimes.com/2021/11/11/health/veterans-psychedelics-ptsd-depressi...

Jose Martinez, a former Army gunner whose right arm and both legs were blown off by a roadside bomb in Afghanistan, has a new calling: He’s become one of the most effective lobbyists in a campaign to legalize the therapeutic use of psychedelic drugs across the country. On a Zoom call ... with Connie Leyva, a Democratic legislator in California who has long opposed relaxing drug laws, Mr. Martinez told her how psilocybin, the psychoactive ingredient in “magic” mushrooms, had helped to finally quell the physical pain and suicidal thoughts that had tormented him. Ms. Leyva says she changed her mind even before the call ended, and she later voted yes on the bill, which is expected to become law early next year. In the two years since Oregon, Washington, D.C., and a half-dozen municipalities decriminalized psilocybin, vets have become leading advocates in the drive to legalize psychedelic medicine, which they credit with helping ease the post-traumatic stress, anxiety and depression that are often tied to their experiences in the military. The campaign has been propelled by the epidemic of suicides among veterans ... but also by the national reckoning over the mass incarceration of people on drug charges. More than 30,000 service members have taken their own lives in the years since Sept. 11 — four times the number of those who died on the battlefield. “I will not be told no on something that prevents human beings from killing themselves,” Mr. Martinez said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Balm for Psyches Scarred by War
2022-05-29, New York Times
Posted: 2022-07-04 12:57:51
https://www.nytimes.com/2022/05/29/health/mdma-therapy-ptsd.html

Mr. McCourry, a former U.S. Marine, had been crippled by post-traumatic stress disorder ever since returning from Iraq in 2004. He could not sleep, pushed away friends and family and developed a drinking problem. The numbness he felt was broken only by bouts of rage and paranoia. He was contemplating suicide when his sister heard about a novel clinical trial using the psychedelic drug MDMA, paired with therapy, to treat PTSD. Desperate, he enrolled in 2012. PTSD is a major public health problem worldwide and is particularly associated with war. In the United States, an estimated 13 percent of combat veterans and up to 20 to 25 percent of those deployed to Iraq and Afghanistan are diagnosed with PTSD at some point in their lives, compared with seven percent of the general population. There is growing evidence that MDMA — the illegal drug known as Ecstasy or Molly — can significantly lessen or even eliminate symptoms of PTSD when the treatment is paired with talk therapy. Last year, scientists reported in Nature Medicine the most encouraging results to date. The 90 participants in the study had all suffered from severe PTSD for more than 14 years on average. Each received three therapy sessions with either MDMA or a placebo, spaced one month apart and overseen by a two-person therapist team. Two months after treatment, 67 percent of those who received MDMA no longer qualified for a PTSD diagnosis, compared with 32 percent who received the placebo. As in previous trials, MDMA caused no serious side effects.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Long, Strange Trip to the Mainstream for Psychedelics
2021-03-12, Boston Globe
Posted: 2022-05-23 20:39:03
https://www.bostonglobe.com/2021/03/12/opinion/long-strange-trip-mainstream-p...

Massachusetts General Hospital wouldn’t seem like a natural fit for a center devoted to mind-altering drugs. But this week, MGH launched the Center for the Neuroscience of Psychedelics to study the potential of psilocybin and other psychoactive drugs to treat conditions such as depression, addiction, trauma, and more. The new center at MGH signifies that the field of psychedelic therapy has arrived. Inspiration came from the search for ways to ease the misery of patients whose mental illness is resistant to traditional treatments. Psychedelics are known to facilitate “plasticity” in the brain, increasing its capacity for change, and [director Jerrold] Rosenbaum said his team wanted to understand how these agents “move the brain to change in a way that can address many of the most anguishing forms of human suffering.” The MGH center combines the disciplines of psychiatry, brain imaging, genomic medicine, and chemical biology. Some of the initial work involving patients will use psilocybin and be directed at rumination — the stuck, repetitive thought patterns that underlie several conditions, from addiction to obsessive-compulsive disorder. The future of the center’s research is boundless, since psychedelics’ role in neuroplasticity and neuritogenesis — the ability to build new synapses — may be useful in palliative care with terminally ill patients as well as in combatting neurodegenerative diseases such as Parkinson’s and Alzheimer’s.

Note: This article is also available on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Can magic mushrooms be used to treat racial trauma?
2022-03-28, The Guardian (One of the UK's leading newspapers)
Posted: 2022-05-02 23:08:52
https://www.theguardian.com/lifeandstyle/2022/mar/28/magic-mushrooms-racial-t...

Evan, a middle-class Black man, doesn’t come across as a psychedelic enthusiast. He’s a 23-year-old quantitative economics graduate student who takes pride in steaming his sweater vests to maintain a studious appearance. In 2015, Evan’s father was arrested for misdemeanor drug possession. A teenager at the time, he swore off drugs forever. But six years later, magic mushrooms have become Evan’s remedy to cope with racial trauma. Like most Americans, Evan followed the widespread media coverage of George Floyd and Breonna Taylor’s deaths in 2020. And like many Black Americans, he experienced traumatic-stress symptoms triggered by the constant exposure to cases of police brutality and racial discrimination. Debilitating panic attacks incapacitated him multiple times a day; insomnia drained his ... energy. After unsuccessfully trying three different anti-anxiety medications, he finally stumbled upon a study on psychedelics for racial trauma. He wondered: could psychedelic therapy be the solution? Psilocybin, the active compound in magic mushrooms, has been found to mitigate acute anxiety among patients with life-threatening cancer. A state-sponsored study in Texas is investigating psychedelics as a treatment for post-traumatic stress disorder in veterans. But one lesser-known benefit has been documented by researchers at the University of Ottawa: psychedelics may alleviate symptoms of race-based traumatic stress.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Can MDMA Save a Marriage?
2022-02-08, New York Times
Posted: 2022-03-14 17:25:35
https://www.nytimes.com/2022/02/08/well/mind/marriage-molly-mdma.html

After 10 years of marriage, Ree, 42, and her husband were ready to call it quits. Then a friend suggested that they try the illegal drug MDMA, popularly known as Ecstasy or Molly. For Ree ... the answer was an “immediate no.” Six months later, after reading “How to Change Your Mind,” the best-selling book by Michael Pollan that details his transformative experience with psychedelics, Ree reconsidered. And that’s how they found themselves in a secluded area of Utah at a large, rented house with a beautiful view of the mountains to trip on MDMA with five other couples. During their first trip on MDMA, Ree said she and her husband tearfully discussed things they had trouble speaking about for the last decade: How his emotional withdrawal had affected her self-esteem, and how sorry she was that she had continually pushed him to open up without understanding the pain he held inside. “My husband started sharing with me for the first time all these thoughts and emotions,” Ree said. “It was him without the walls,” she added. They also cuddled in bed for hours, skin to skin, describing all the things they loved about one another. “For a person who has always had body image issues, to allow him to touch me — touch my stomach, the part of me I don’t love, was incredibly healing,” she said. They continued using MDMA about twice a year to help them have difficult conversations. They both started seeing therapists. Now, about three years after they first tried MDMA ... they no longer need the drug to speak openly with one another.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma
2022-02-01, Scientific American
Posted: 2022-03-06 22:46:38
https://www.scientificamerican.com/article/a-psychedelic-may-soon-go-to-the-f...

Berra Yazar-Klosinski [is the] chief scientific officer at the Multidisciplinary Association for Psychedelic Studies (MAPS). I ... committed to working with her on the phase 3 program that would assess the efficacy and safety of MDMA—known recreationally as Molly or Ecstasy—for severe PTSD, or post-traumatic stress disorder. Although more than half a dozen phase 2 studies have demonstrated the effectiveness and safety of MDMA for PTSD, early trials often fail to accurately predict the outcome of the larger, multisite phase 3 trials that follow. In the case of MDMA, we have been lucky. At 15 study sites across three countries, working with more than 70 different therapists and with study participants with childhood trauma, depression and a treatment-resistant subtype of PTSD, we have obtained incredibly promising results. Phase 3 study participants receiving MDMA-assisted therapy showed a greater reduction in PTSD symptoms and functional impairment than participants receiving placebo plus therapy. In addition, their symptoms of depression plummeted. By the end of the study more than 67 percent of the participants in the MDMA group no longer met criteria for PTSD. An additional 21 percent had a clinically meaningful response—in other words, a lessening of anxiety, depression, vigilant mental states, and emotional flatness. MDMA-assisted therapy did not increase measures of suicidal thinking or behavior. MDMA also did not demonstrate any measurable misuse potential.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


It’s Been A Banner Year For MAPS Public Benefit Corporation And The Women Leading It
2021-12-29, Forbes
Posted: 2022-02-07 12:27:11
https://www.forbes.com/sites/amandasiebert/2021/12/29/its-been-a-banner-year-...

In May, a long-awaited randomized, double-blind, placebo-controlled, Phase 3 clinical trial testing MDMA-assisted therapy for the treatment of PTSD was published in Nature Medicine. The trial was conducted by MAPS Public Benefit Corporation, a for-profit subsidiary launched by the registered non-profit in 2014, with the goal of conducting the necessary research to make MDMA a legally available medicine. “We are a for-profit, but we’re wholly owned. We only have one shareholder, and it’s a non-profit,” says CEO Amy Emerson. While a non-profit is tax exempt and operates for charity, the PBC, like a traditional corporation, pays taxes, operates for profit, and has shareholders and stocks. The results of the Phase 3 clinical trial conducted by MAPS PBC revealed that after receiving a combination of talk therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 percent of participants who received the placebo. The trial was recently acknowledged as a “big win for the field” in Science Magazine’s annual Breakthrough of the Year awards. “In our three-session model, there’s no follow-up medication needed,” [MAPS CMO Dr. Corine de Boer] says. After pooling the data of six Phase 2 trials together, de Boer’s team found that 57 percent of participants no longer met the criteria for PTSD. At a one-year follow-up during which no MDMA was administered, that number increased to 67 percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Jurvetson’s Big Gift Shows How Psychedelics Capital Is Different
2021-12-06, Bloomberg
Posted: 2022-01-18 11:40:14
https://www.bloomberg.com/news/newsletters/2021-12-06/stephen-jurvetson-backs...

Psychedelics startups don’t just want to just reinvent mental health. They also want to reinvent capitalism. And judging by the news coming out of last week’s “Horizons: Perspectives on Psychedelics” conference in Manhattan, they’re having some early success. Stephen Jurvetson, co-founder of Future Ventures and a board member at SpaceX, told me ... that he’s a true believer in the industry’s mission to fix the state of mental-health care. He decided last week to carve up his own estate by giving around half of his net worth to fund psychedelic science. Organizations like the public-benefit corporation of Multidisciplinary Association for Psychedelics Studies, or MAPS, and the Psychedelic Science Funders Collaborative, a nonprofit organization, have both accepted charitable donations but fund research that could lead to blockbuster drugs. Psychedelics startups do need funding, and badly. Like biotech, it’s a high-risk industry with expensive clinical trials and regulatory uncertainty. And patents, a traditional financial engine for biotech, are harder to win for plants that have been around for centuries, or molecules that have already made the rounds as street drugs. MAPS also made a major announcement: The New York-based venture capital fund Vine Ventures has created a $70 million special purpose vehicle to fund its Phase 3 clinical trials on post-traumatic stress disorder and MDMA. The novel funding method ... will help keep MAPS a nonprofit while letting it retain control of its intellectual property.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Psychedelic Therapy Is Poised To Create A Revolution In Mental Health
2021-11-23, Forbes
Posted: 2022-01-18 11:38:39
https://www.forbes.com/sites/davidcarpenter/2021/11/23/psychedelic-therapy-is...

Legal psychedelic medicine is poised to soon disrupt the multibillion-dollar mental health field. Treatments being trialed today in clinical settings using substances like psilocybin-containing mushrooms will soon offer legal alternatives to the more than 50 percent of patients receiving therapy for major depressive disorder (MDD) who do not respond to approved depression medications. The creation of new effective therapies will likely put pressure on healthcare providers to examine the upside of psychedelic therapies and how such treatments will inevitably affect their bottom line. While these therapies will not be a cure-all for everyone, over the next three to five years an expanding number of psychedelic treatments will produce alternatives for the many patients who find no relief from FDA-approved, first-line therapeutics like selective serotonin reuptake inhibitors (SSRIs). Since legalizing the use of psilocybin-containing magic mushrooms in 2020 through a ballot measure, Oregon is now in the process of creating an intricate statewide system for qualified caregivers to deliver psilocybin treatments in therapeutic settings. Sessions using psilocybin can last over six hours, which does not include vital therapy before and after treatments. MDMA-assisted therapy for severe post-traumatic stress disorder (PTSD), which is very close to being an FDA-approved therapy, will likewise require significant clinician involvement before, during and after a session.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


The worldview-changing drugs poised to go mainstream
2021-09-06, BBC News
Posted: 2021-10-11 15:45:14
https://www.bbc.com/future/article/20210906-what-if-everyone-took-psychedelics

In the last 10 years, psychedelic drugs like LSD, magic mushrooms, DMT, a host of "plant medicines" – including ayahuasca, iboga, salvia, peyote – and related compounds like MDMA and ketamine have begun to lose much of their 1960s-driven stigma. Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction. The response from the psychiatric community ... has been largely open-armed. The drugs may well mark the field’s first paradigm shift since SSRIs in the 1980s. In 2017, for example, the US Food and Drug Administration designated MDMA a "breakthrough therapy", which meant it would be fast-tracked through to the second stage of Phase-3 trials. Psychedelics remain Schedule-1 drugs federally in the US and Class-A in the UK, but rules are relaxing. This wave of psychedelic enthusiasm in psychiatry isn’t the first. They were originally heralded as wonder drugs in the 1950s. Across some 6,000 studies on over 40,000 patients, psychedelics were tried as experimental treatments for an extraordinary range of conditions: alcoholism, depression, schizophrenia, criminal recidivism, childhood autism. And the results were promising. From as little as a single LSD session, studies suggested that the drug relieved problem drinking for 59% of alcoholic participants. Experimenting with lower, so-called "psycholytic" doses, many therapists were amazed by LSD’s power as an adjunct to talking therapy.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
2021-09-22, Newsweek
Posted: 2021-10-11 15:43:51
https://www.newsweek.com/2021/10/01/magic-mushrooms-may-biggest-advance-treat...

For most of his adult life, Aaron Presley, age 34, felt like a husk of a person, a piece of "garbage." Then, all at once, the soul-crushing, depressive fog started to lift, and the most meaningful experience of his life began. The turning point for Presley came as he lay on a psychiatrist's couch at Johns Hopkins University. He had consumed a large dose of psilocybin, the active ingredient in what's more commonly known as magic mushrooms, and entered a state that could best be described as lucid dreaming. Visions of family and childhood triggered overwhelming and long-lost feelings of love, he says. Presley was one of 24 volunteers taking part in a small study aimed at evaluating the effectiveness of a combination of psychotherapy and this powerful mind-altering drug to treat depression—an approach that, should it win approval, could be the biggest advance in mental health since Prozac in the 1990s. Depression ... affects 320 million people around the world. Roughly one-third of those who seek treatment won't respond to verbal or conventional drug therapies. Magic-mushroom therapy is offering some hope for these hopeless cases. In the Hopkins study, published last year in JAMA Psychiatry, the therapy was four times more effective than traditional antidepressants. Two-thirds of participants showed a more-than 50-percent reduction in depression symptoms after one week; a month later, more than half were considered in remission, meaning they no longer qualified as being depressed.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psychedelic trips could soon be part of therapy — here’s what those sessions will look like
2021-07-24, CNBC News
Posted: 2021-08-29 18:20:48
https://www.cnbc.com/2021/07/24/how-psychedelic-assisted-therapy-with-mdma-an...

Psychedelic drugs are substances that alter perception and mood and affect a number of cognitive processes. The classic psychedelics include MDMA aka “ecstasy” or “molly,” LSD, psilocybin or “mushrooms,” ayahuasca and ibogaine. Used in conjunction with therapists, research has shown that psychedelics can help treat historically difficult-to-treat conditions by essentially “reshaping” the way “parts of the brain talk to each other,” says Jennifer Mitchell, a neuroscientist. “Psychedelics allow for processing in a way that enables subjects to let go of things that had previously plagued them,” she says. As Mitchell explains it, when people are young, their brains go through critical periods of learning and development that then become closed off as they age. Researchers believe that psychedelics “open those closed critical periods for just a tiny window of time,” she says. “When that critical period is open again, you want to make the most of it, and make that potential change as positive as possible,” she says. With psilocybin, for instance, it is believed the drug boosts connectivity in the brain and increases “neuroplastic states,” which are the brain’s ability to reorganize and adapt, says Dr. Stephen Ross ... who has been conducting clinical trials on psilocybin-assisted therapy for the past 16 years. MDMA-assisted therapy could be approved by the FDA for medical use as early as 2023, while other psychedelics, notably psilocybin, are waiting in the wings for their turn to be evaluated for medical purposes.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Netflix documentary 'Fantastic Fungi' explores the many magical properties of mushrooms
2021-08-16, San Francisco Chronicle (San Francisco's leading newspaper)
Posted: 2021-08-29 18:19:22
https://www.sfgate.com/streaming/article/Netflix-documentary-Fantastic-Fungi-...

Fungi have been around for billions of years, setting the stage for humanity by supporting, carrying and converting life. But for complex political reasons, these organisms are still shrouded in mystery. One man, however, is determined to lift the veil on the magical world of mushrooms. Enter Stamets, a bespectacled author and researcher whose mission to decode nature’s hidden language and explore “altered states of consciousness" is chronicled in the documentary “Fantastic Fungi,” which was recently made available to stream on Netflix. While the film aims to destigmatize hallucinogenic mushrooms, it also demonstrates why we should legitimize the studies of all mushrooms. Contemporary experts in neurology, psychiatry and biology in the film show that fungal genomes can solve a host of mental, physical and environmental problems. From healing bacterial infections to cleaning petroleum spills, fungi possess unique, almost godlike properties that are otherwise unseen in nature. For instance, lion’s mane, an edible white mushroom that tastes like lobster, stimulates nerves in order to grow, suggesting that it could potentially cure degenerative diseases like Alzheimer’s. Ultimately, when Stamets discusses altered states of consciousness, it’s ... about accepting a different state of being. For some people — especially those who live in pain — the film posits that mushrooms can be the answer they’ve been looking for.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


How Should We Do Drugs Now?
2021-07-09, New York Times
Posted: 2021-08-01 17:51:06
https://www.nytimes.com/2021/07/09/opinion/sunday/drug-legalization-mdma-psil...

In the past two years, a new drug policy reform movement called Decriminalize Nature has persuaded local governments in a half dozen municipalities, including Washington, D.C., to decriminalize “plant medicines” such as psilocybin, ayahuasca, iboga and the cactuses that produce mescaline. Last month, the California State Senate passed a bill that would make legal the personal possession, use and “social sharing” of psychedelics, including LSD and MDMA, a.k.a. Ecstasy or Molly. Political opposition to all these measures has been notably thin. Neither party, it seems, has the stomach for persisting in a war that has achieved so little while doing so much damage, especially to communities of color and our civil liberties. But while we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively? In the case of psychedelics, decriminalizing these powerful compounds is only the first step in a process of figuring out how best to safely weave their use into our society. The main model we have for resocializing a formerly illicit drug is the legalization of cannabis, now the new normal in 18 states. The use of psychedelics by Indigenous peoples ... suggests a model we would do well to keep in mind as we figure out how best to handle these substances.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind altering drugs from reliable major media sources.


MDMA could help trauma survivors face painful memories
2021-05-13, BBC News
Posted: 2021-06-21 15:01:20
https://www.bbc.com/news/health-56997013

MDMA - most commonly known as a party drug - could be more effective than therapy alone at treating post-traumatic stress disorder (PTSD). The results of a keenly-awaited trial suggest two-thirds of people no longer qualified for a PTSD diagnosis after treatment. The study represents a significant step towards approval of the drug in the US. PTSD can be the result of a very distressing or frightening event, or longer-term series of experiences. That might include accidents, abuse, rape, combat or illness. And it can be very difficult to treat. This trial, run by US charity the Multidisciplinary Association for Psychedelic Studies (Maps), found 88% of people had a "meaningful reduction in symptoms" and 67% no longer qualified for a PTSD diagnosis at all after 18 weeks and three sessions of MDMA-assisted therapy. Talking therapy alone led to a significant improvement in 60%, and remission in 32% of people. The participants in the study, which was published in the journal Nature, had suffered from PTSD for an average of 14 years. MDMA appears to work in part by calming the amygdala. In people with PTSD and anxiety disorders, this part of the brain can overreact, sounding the alarm over seemingly small events. When we are babies, and again during adolescence, we experience periods where our brains are very pliable. The scientists involved in the study speculate that psychedelics and similar-acting drugs like MDMA might allow a "reopening" of this critical window of brain development.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Psychedelic Drug Passes a Big Test for PTSD Treatment
2021-05-03, New York Times
Posted: 2021-05-23 15:48:06
https://www.nytimes.com/2021/05/03/health/mdma-approval.html

In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy. Of the 90 people who took part in the new study, which is expected to be published later this month in Nature Medicine, those who received MDMA during therapy experienced a significantly greater reduction in the severity of their symptoms compared with those who received therapy and an inactive placebo. Two months after treatment, 67 percent of participants in the MDMA group no longer qualified for a diagnosis of PTSD, compared with 32 percent in the placebo group. MDMA produced no serious adverse side effects. Some participants temporarily experienced mild symptoms like nausea and loss of appetite. Unlike traditional pharmaceuticals, MDMA does not act as a band-aid that tries to blunt symptoms of PTSD. Instead, in people with PTSD, MDMA combined with therapy seems to allow the brain to process painful memories and heal itself. Scott Ostrom, who participated in the study, had suffered from PTSD since returning home from his second deployment in Iraq in 2007. For more than a decade, he experienced debilitating nightmares. Mr. Ostrom’s days were punctuated by panic attacks, and he dropped out of college. Therapy and medication did not help. But after participating in the trial, he no longer has nightmares. “Literally, I’m a different person,” he said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.
2021-05-09, New York Times
Posted: 2021-05-23 15:45:37
https://www.nytimes.com/2021/05/09/health/psychedelics-mdma-psilocybin-molly-...

It’s been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds. Dr. Doblin’s quest to win mainstream acceptance of psychedelics took a significant leap forward ... when the journal Nature Medicine published the results of his lab’s study on MDMA, the club drug popularly known as Ecstasy and Molly. The study, the first Phase 3 clinical trial conducted with psychedelic-assisted therapy, found that MDMA paired with counseling brought marked relief to patients with severe post-traumatic stress disorder. The results, coming weeks after a New England Journal of Medicine study that highlighted the benefits of treating depression with psilocybin, the psychoactive ingredient in magic mushrooms, have excited scientists, psychotherapists and entrepreneurs. They say it is only a matter of time before the Food and Drug Administration grants approval for psychoactive compounds to be used therapeutically — for MDMA as soon as 2023, followed by psilocybin a year or two later. Last year, Oregon became the first state to legalize the therapeutic use of psilocybin. Denver, Oakland, Calif., and Washington, D.C., have decriminalized the drug, and several states, including California, are mulling similar legislation. Though the drugs remain illegal under federal law, the Justice Department has so far taken a hands-off approach to enforcement.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Psychedelics for medical purposes: time to change your mind?
2021-03-21, The BMJ (Formerly British Medical Journal)
Posted: 2021-05-23 15:44:08
https://blogs.bmj.com/bmj/2021/03/21/psychedelics-for-medical-purposes-time-t...

There is clearly a psychedelic renaissance underway. These agents are now debated at medical conferences smirk-free, and my investment-obsessed friends predict a financial “‘shroom-boom”. During the 2020 US election ... Measure 109 asked voters in Oregon whether magic mushrooms should be allowed for medical purposes, and Initiative 81 asked Washingtonians about decriminalizing psychedelic plants and fungi. Research is also underway in institutions from Johns Hopkins to Imperial College London. Recently, Health Canada quietly ... allowed four terminally ill patients to take psilocybin under medical supervision. I have also been asked by several patients, at end-of-life, to prescribe a gram of mushrooms or a tablet of lysergic acid diethylamine (which my pharmacy cannot furnish), rather than a “bucket of fentanyl” (which the pharmacy readily can). The Default Mode Network (DMN) ... refers to interconnected brain regions that help us believe we are a distinct self, separate from others and the natural world. This drives self-reliance, but can make us feel isolated. Moreover, as it “matures,” we respond in more habitual, predictable, rigid ways. The theory is that DMN overactivity leads to excessive introspection, hypercriticism, obsession, depression, and anxiety. Psychedelics might decrease the tyranny of the DMN, thereby allowing unfamiliar parts of the brain to go on a play-date. We should not throw out the scientific method, but psychedelics could increase the colors in our crayon set.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Can Magic Mushrooms Heal Us?
2021-03-18, New York Times
Posted: 2021-05-10 17:36:06
https://www.nytimes.com/2021/03/18/opinion/oregon-psychedelic-therapy.html

Gov. Kate Brown of Oregon announced the members of the state’s newly formed Psilocybin Advisory Board this week. Oregon is about to become the first state in the country to try to build a support infrastructure through which psychedelic mushrooms can be woven into everyday life. This framework is different from what we’ve seen before: not legalization, not medicalization, but therapeutic use, in licensed facilities, under the guidance of professionals trained to guide psychedelic experiences. The ... pressing case for psilocybin comes from research out of Johns Hopkins, U.C.L.A., N.Y.U. and elsewhere that has shown it to be a potentially effective treatment for major depression, end-of-life anxiety and drug addiction. “One of the things I’ve come to is that addiction medicine in 2021 is in desperate need of transformative technologies,” Todd Korthuis, a ... member of Oregon’s Psilocybin Advisory Board, told me. Studies ... are “showing dramatic change in people’s lives — that’s what we need for cocaine use disorder, methamphetamine use disorder, even alcohol and tobacco.” A recent study on major depressive disorder, published in JAMA Psychiatry, found more than half of the subjects in remission four weeks later, after just two treatments alongside psychotherapy. A study on tobacco addiction, out of Johns Hopkins, found two-thirds of the subjects who received psilocybin in combination with cognitive behavioral therapy abstinent a year later.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


‘The ketamine blew my mind’: can psychedelics cure addiction and depression?
2021-03-13, The Guardian (One of the UK's leading newspapers)
Posted: 2021-04-06 02:05:24
https://www.theguardian.com/lifeandstyle/2021/mar/13/it-blew-my-mind-can-psyc...

In the summer of 1981, when he was 13, Grant crashed a trail motorbike. Grant hadn’t given this childhood memory much thought in the intervening years, but one hot August day ... he suddenly understood it as a clue to his dangerously unhealthy relationship with alcohol. The day before, a team of specialists at the Royal Devon and Exeter hospital had given him an intravenous infusion of ketamine, a dissociative hallucinogen, in common use as an anaesthetic since the 1970s, and more recently one of a group of psychedelic drugs being hailed as a silver bullet in the fight to save our ailing mental health. To date, more than 100 patients with conditions as diverse as depression, PTSD and addiction have been treated in research settings across the UK, using a radical new intervention that combines psychedelic drugs with talking therapy. What was once a fringe research interest has become the foundation of a new kind of healthcare, one that, for the first time in modern psychiatric history, purports to not only treat but actually cure mental ill health. Under its influence, Grant had an out-of-body experience he struggles to put into words. “It was like I was sinking deeper and deeper into myself,” he says. “Then I became white… and I left my body. I was up on the ceiling, looking at myself, but I was just this white entity. I felt very serene and humbled; I finally understood my place in the universe, just a white speck of light, I wasn’t the centre of everything and that was fine.”

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind altering drugs from reliable major media sources.


Job diary: I'm an LA doctor who runs a ketamine-infusion therapy program to help people overcome depression, anxiety, and trauma
2020-11-10, MSN News
Posted: 2020-11-29 19:42:45
https://www.msn.com/en-us/health/medical/job-diary-im-an-la-doctor-who-runs-a...

While I was in anesthesia residency at the University of Southern California Hospital's Department of Anesthesiology from 2006 to 2009, I learned how to put people under for surgery using an anesthetic called ketamine. Afterwards, as I began work as an anesthesiologist at a hospital, I began hearing interesting things about the anesthetic. Researchers had begun testing it as a treatment for mental health conditions like anxiety, depression, and PTSD — and with encouraging results. It also has psychedelic properties, so people can gain insight into their lives and even have mystical experiences on it. One study found that it reduced symptoms of depression and anxiety in patients with severe depression, both immediately after it was administered and as well as a month down the line. Another found that it even provided relief from chronic pain that lasted for up to two weeks after treatment. In 2014, inspired by findings like these and conversations with psychiatrists who were beginning to incorporate ketamine into their practices, I founded the Ketamine Healing Clinic of Los Angeles. Over time, I've seen people undergo big changes in their lives because of their work with ketamine, including a few who left abusive relationships, grew their businesses, or pursued totally new ventures. Overall ... people typically come out of their infusions with a newfound will to live and increased clarity about their future. Some patients who came in with suicidal thoughts no longer have them at all.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Oregon becomes first state to legalize magic mushrooms as more states ease drug laws in 'psychedelic renaissance'
2020-11-04, CNBC News
Posted: 2020-11-09 19:14:09
https://www.cnbc.com/2020/11/04/oregon-becomes-first-state-to-legalize-magic-...

Oregon on Wednesday became the first state to legalize the active ingredient in so-called magic mushrooms on an election night that saw more states ease restrictions on recreational drugs across the country. Oregon’s Measure 109 will give legal access to psilocybin, the main active ingredient in “magic mushrooms,” for mental health treatment in supervised settings. While some cities have moved to legalize and regulate access to the drug, Oregon will become the first state in the country to legalize it on a statewide basis. Supporters of the measure point to the medical benefits of the drug, which has been shown in some studies to benefit trauma survivors. Through Measure 110, which has captured more than 58% of the vote so far, Oregon would also decriminalize the possession of small amounts of some hard drugs, including heroin and LSD. Instead of criminal prosecution, people in possession would face a $100 fine, which can be waived if the person agrees to pursue treatment, according to the measure. Ronan Levy, the cofounder of Field Trip Health, a Toronto-based company that provides psychedelic-enhanced psychotherapy, said the ballot wins are “fantastic news” for what he called the psychedelic renaissance. Research is mounting that indicates the benefits of using psychedelic drugs to enhance therapy, Levy said, adding that ... the drug alone isn’t necessarily helpful; it needs to be taken under supervision of trained personnel.

Note: Recent studies suggest psilocybin can be used to treat addiction and anxiety. For more along these lines, see concise summaries of deeply revealing news articles on the healing potential of mind-altering drugs from reliable major media sources.


Silicon Valley and Wall Street Elites Pour Money Into Psychedelic Research
2020-08-20, Wall Street Journal
Posted: 2020-09-07 23:05:15
https://www.wsj.com/articles/silicon-valley-and-wall-street-elites-pour-money...

A group of Silicon Valley and Wall Street executives has raised $30 million to speed the development of a closely watched psychedelic-drug therapy. The Multidisciplinary Association for Psychedelic Studies, a nonprofit advocating for psychedelic research since the 1980s, is conducting its last phase of clinical trials to research the efficacy of using MDMA-assisted psychotherapy for post-traumatic stress disorder. PTSD afflicts about eight million adults a year. MDMA is more commonly known as the main component of Ecstasy. Armed with the new funding, MAPS is aiming to finish the trials and seek approval from the Food and Drug Administration to commercialize the MDMA-assisted psychotherapy as soon as 2022. In 2017, the FDA designated MDMA as a breakthrough therapy for PTSD, meaning it would expedite review of the drug. MAPS said a recent interim analysis of its Phase 3 clinical trials ... showed a very high likelihood the therapy will be effective for treating PTSD. In phase 2 clinical trials, individuals with post-traumatic stress disorder received psychotherapy, some with the psychedelic drug MDMA. More of those who received the drug no longer received a PTSD diagnosis in the months after treatment, compared with those who received a placebo. Business leaders said their donations came from a personal connection to mental-health conditions. Among them is billionaire Bob Parsons, founder of GoDaddy and ... a Marine Corps Vietnam War veteran, who said he has continued to battle PTSD.

Note: To read the entire article free of charge, see this webpage. Note that as big Pharma won't make big profits from these therapies, they are not funding any of the major studies, while the nonprofit MAPS has stepped in to make this happen. And not mentioned in this article is that the results of these studies has been dramatic, with over 2/3 of patients showing no signs of PTSD a year after treatment. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psychedelic Drugs Can Improve Quality Of Life - And Death - For Older Adults
2020-05-06, Forbes
Posted: 2020-09-07 22:57:37
https://www.forbes.com/sites/abbierosner/2020/05/06/psychedelic-drugs-can-imp...

Older Americans suffer disproportionately from chronic pain and its attendant ailments, anxiety, depression and insomnia. In the search for relief, they consume more pharmaceutical drugs than perhaps any comparable cohort on this planet. Psychedelic therapies to treat mental health conditions offer a radical departure from current pharmaceutical models. The psychedelic therapy modalities currently under investigation combine a limited number of treatment sessions with a psychedelic substance, sandwiched between intensive pre- and post-treatment therapy sessions. The ideal, and realistic, outcome from this course of treatment is not mere symptom control, but durable remission. Indeed, these studies are finding that, in clinically significant numbers, recipients of a single course of psychedelic therapy report the experience to be life-changing, and enduring over time. The positive preliminary outcomes of clinical studies by MAPS using MDMA to treat PTSD, and Compass Pathways for psilocybin therapy for treatment-resistant depression, have convinced the FDA to grant them Breakthrough Therapy Designation. In the 1960s researchers were interested in seeing if psychedelic drug treatment could alleviate existential distress in terminal cancer patients. This line of research was picked up 35 years later by Dr. Charles Grob, whose 2011 pilot study of psilocybin treatment for terminal cancer patients found significant enduring reductions in anxiety and improvement in mood at a six-month follow up.

Note: Read more on the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psychedelics: Can getting high improve your mental health?
2020-01-27, CNN News
Posted: 2020-06-29 00:56:26
https://www.cnn.com/2020/01/24/health/goop-psychedelics-wellness/index.html

Can the mind-blowing effects of psychedelics help heal our traumas? The scientific community [says] it's an increasingly hopeful thumbs up. Despite the fact that psychedelics are illegal, the last decade has seen an explosion of research, with results so intriguing that governments are greenlighting studies around the world. Scientists are busily exploring the role of hallucinogens on treatment-resistant depression, post traumatic stress disorder, cancer-related anxiety, addictions, and even anorexia. During the '40s and early '50s tens of thousands of patients took LSD and other psychotropics to study their effects on cancer anxiety, alcoholism, opioid use disorder, depression, and ... PTSD. Researchers began to see psychedelics as possible "new tools for shortening psychotherapy." In the 1950s UK psychiatrist Dr. Humphry Osmond began giving LSD to treatment-resistent alcoholics: 40% to 45% of those who took LSD were still sober after a year. [Then] in 1970, President Richard Nixon ... classified hallucinogenics as Schedule I drugs -- the most restrictive category. [Fast forward to today and] MAPS is in the final phase of a gold-standard study administering MDMA [Ecstasy] to 300 people with severe PTSD. Results of the second phase showed 68% of the people no longer met the criteria for PTSD at a 12-month follow-up; before the study they had suffered from treatment-resistant PTSD for an average of 17.8 years. The results are so positive that in January the FDA declared MDMA-assisted psychotherapy for PTSD a "Breakthrough Therapy." Perhaps one day soon a trip to the therapist will include a trip into your mind, and hopefully, a quicker path to healing.

Note: The full article at the link above gives a concise, yet thorough survey of the use of psychedelics for healing and growth over the years. For more along these lines, see concise summaries of deeply revealing news articles on the powerful healing potentials of some psychedelics from reliable major media sources.


Entrepreneurs At Davos This Week Portrayed Cannabis As A Gateway Drug But In A Good Way For Mental Health Treatment
2020-01-23, Forbes
Posted: 2020-03-03 01:54:43
https://www.forbes.com/sites/joanoleck/2020/01/23/entrepreneurs-at-davos-this...

At this weeks World Economic Forum (WEF) in Davos, Switzerland, where the cannabis industry enjoyed a whole pavilion of its own, the biggest takeaway was where cannabis is headed in terms of human health. Rick Doblin, executive director of MAPS, the Multidisciplinary Association for Psychedelic Studies ... has delivered a TED talk on the future of psychedelic-assisted psychotherapy. And at Davos there was strong interest in the plant-based psychedelic molecules Doblin works with, [pharmacist Saul] Kaye said. If you look at cannabis as an entryway into the market for botanical-based medicines, you can look at mushrooms, psilocybin, said Kaye. You can look at ibogaine, ayahuasca, which are new medicinal models that are breaking out in the world based on botanical medicine that has been illegal for the last 100 years. Cannabis has elevated access to all kinds of botanical-based medicines, which ultimately can change mental health, physical health; and its a fascinating area that we can ... elevate the conversation around. Other topics at the cannabis forum ... merited an elevated conversation of their own. A speaker from StemCell United, for example, addressed the fast expansion of CBD companies in Asia, building on what Kaye termed a global de-stigmaization across the Asian markets. The result, he said, has been to begin changing the traditional impression of cannabis from This is illicit, this is a drug, to, This a research drug that is much safer than alcohol and tobacco.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


After learning Whitey Bulger was unwitting subject of CIA experiment, juror regrets murder conviction
2020-02-18, Los Angeles Times
Posted: 2020-02-23 01:20:30
https://www.latimes.com/world-nation/story/2020-02-18/whitey-bulger-juror-say...

James Whitey Bulger terrorized Boston from the 1970s into the 1990s with a campaign of murder, extortion and drug trafficking. In 2013, Janet Uhlar was one of 12 jurors who found Bulger guilty in a massive racketeering case, including involvement in 11 murders. But now Uhlar says she regrets voting to convict Bulger on any of the murder charges. Her regret stems from a cache of more than 70 letters Bulger wrote to her from prison, some of which describe his unwitting participation in a secret CIA experiment with LSD. The agency dosed Bulger with the powerful hallucinogen more than 50 times when he was serving his first stretch in prison, in Atlanta. Uhlar has spoken publicly about her regret before but says her belief that the gangster was wrongly convicted on the murder charges was reinforced after reading a new book by Brown University professor Stephen Kinzer: Poisoner in Chief: Sidney Gottlieb and the CIA Search for Mind Control. Gottliebs secret program, known at MK-ULTRA, enlisted doctors and other subcontractors to administer LSD in large doses to prisoners, addicts and others unlikely to complain. Uhlar reviewed the 1977 hearings by the U.S. Senate Committee on Intelligence, which was looking into MK-ULTRA, and found testimony where CIA director Stansfield Turner acknowledged evidence showing that the agency had been searching for a drug that could prepare someone for debilitating an individual or even killing another person.

Note: Read more about the CIA's MK-ULTRA program. For more along these lines, see concise summaries of deeply revealing news articles on mind control from reliable major media sources.


The CIA's Secret Quest For Mind Control: Torture, LSD And A 'Poisoner In Chief'
2019-09-09, NPR
Posted: 2020-02-18 01:27:50
https://www.npr.org/2019/09/09/758989641/the-cias-secret-quest-for-mind-contr...

During the early period of the Cold War, the CIA became convinced that communists had discovered a drug or technique that would allow them to control human minds. In response, the CIA began its own secret program, called MK-ULTRA, to search for a mind control drug that could be weaponized against enemies. MK-ULTRA, which operated from the 1950s until the early '60s, was created and run by a chemist named Sidney Gottlieb. Some of Gottlieb's experiments were covertly funded at universities and research centers ... while others were conducted in American prisons and in detention centers in Japan, Germany and the Philippines. Many of his unwitting subjects endured psychological torture ranging from electroshock to high doses of LSD. In the early 1950s, he arranged for the CIA to pay $240,000 to buy the world's entire supply of LSD. He brought this to the United States, and he began spreading it around to hospitals, clinics, prisons and other institutions, asking them, through bogus foundations, to carry out research projects and find out what LSD was, how people reacted to it and how it might be able to be used as a tool for mind control. MK-ULTRA, was essentially a continuation of work that began in Japanese and Nazi concentration camps. Not only was it roughly based on those experiments, but the CIA actually hired the vivisectionists and the torturers who had worked in Japan and in Nazi concentration camps to come and explain what they had found out so that we could build on their research.

Note: Read more about the CIA's MK-ULTRA program. For more along these lines, see concise summaries of deeply revealing news articles on mind control from reliable major media sources.


MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
2019-08-04, NPR
Posted: 2020-01-13 16:39:29
https://www.npr.org/sections/health-shots/2019/08/14/746614170/mdma-aka-ecsta...

MDMA is the main ingredient in club drugs ecstasy or molly. But [Lori] Tipton wasn't taking pills sold on the street to get high at a party. She was trying to treat her post-traumatic stress disorder, with the help of licensed therapists. Two specially-trained psychotherapists ... sat next to Tipton as she recalled some of her deepest traumas, like discovering her mother's body after a murder-suicide. "I was able to find such empathy for myself. I realized how much I was thinking this was my fault," she says. The synthetic psychoactive chemical MDMA is emerging as a promising if unconventional treatment for PTSD. Scientists are testing how pharmaceutical-grade MDMA can be used in combination with psychotherapy to help patients who have a severe form of PTSD that has not responded to other treatments. It's not yet available as a treatment for PTSD outside of clinical trials, but the success of early trials has proponents hopeful that the therapy could be available to more people in coming years. They're aiming for approval by the The Food and Drug Administration, which granted breakthrough therapy status to MDMA-assisted psychotherapy in 2017. After the Phase 2 trials of MDMA-assisted treatments concluded in 2017, researchers found 54% of the patients who took MDMA had improved to the point that they no longer fit the diagnosis for PTSD (compared to 23% in the control group). A year later, the number who no longer had PTSD had risen to 68% percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psilocybin Sessions: Psychedelics could help people with addiction and anxiety
2019-12-29, CBS News
Posted: 2020-01-06 18:03:59
https://www.cbsnews.com/news/psychedelic-drugs-lsd-active-agent-in-magic-mush...

For most, psychedelic drugs conjure up images of the 1960's, hippies tripping out on LSD or magic mushrooms. But ... these powerful, mind-altering substances are now being studied seriously by scientists inside some of the country's foremost medical research centers. They're being used to treat depression, anxiety and addiction. The early results are impressive, as are the experiences of the studies' volunteers who go on a six-hour, sometimes terrifying, but often life-changing psychedelic journey. For nearly two decades now, [scientist Roland Griffiths] and his colleague Matthew Johnson have been giving what they call "heroic doses" of psilocybin to more than 350 volunteers, many struggling with addiction, depression and anxiety. Carine McLaughlin was a smoker for 46 years and said she tried everything to quit before being given psilocybin at Johns Hopkins last year. That was more than a year ago; she says she hasn't smoked since. The study she took part in is still ongoing, but in an earlier, small study of just 15 long-term smokers, 80% had quit six months after taking psilocybin. That's double the rate of any over-the-counter smoking cessation product. Jon Kostakopoulos was drinking a staggering 20 cocktails a night ... when he decided to enroll in another psilocybin trial at New York University. During one psilocybin session, he was flooded with powerful feelings and images from his past. He took psilocybin in 2016. He says he hasn't had a drink since.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Santa and Magic Mushrooms: Was the Christmas Icon Derived from Trippy Fungi?
2017-12-24, Newsweek
Posted: 2019-12-31 02:35:43
https://www.newsweek.com/santa-and-magic-mushrooms-was-christmas-icon-derived...

According to one theory, jolly old St. Nick might have been so jolly because he was derived from shamans who went from hut to hut handing out hallucinatory mushrooms in Siberia and the Arctic during the Winter Solstice, right around the same time as Christmas. "As the story goes, up until a few hundred years ago these practicing shamans or priests connected to the older traditions would collect Amanita muscaria (the Holy Mushroom), dry them, and then give them as gifts on the winter solstice," [said] anthropologist John Rush. The festive deep red and white mushrooms were eaten by the humans and reindeer who roamed the region, sending both of them on well ... a tinsel-turvy trip. "This idea [is] that reindeer go berserk because they're eating Amanita muscaria. Reindeers flying are they flying, or are your senses telling you they're flying because you're hallucinating?" Harvard biology professor Donald Pfister told NPR. Reindeer were also considered "spirit animals" and the Siberian shamans wore red deer pelts as tributes, according to scholars. Even more, shamans dressed up like the mushrooms, which explains Santa's cozy red and white suit. Another scholar told NBC that the idea of Rudolph's flashy red nose likely originated from the color of the mushrooms, noting how remarkable it was that the tripping beast was put in charge of directions. "It's amazing that a reindeer with a red-mushroom nose is at the head, leading the others," Boston College classics professor Carl Ruck mused.

Note: See a 7-minute New York Times video on this intriguing hypothesis. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Do Microdoses of LSD Change Your Mind?
2019-04-16, Scientific American
Posted: 2019-12-16 02:59:38
https://www.scientificamerican.com/article/do-microdoses-of-lsd-change-your-m...

Youve probably heard about microdosing, the productivity hack popular among Silicon Valley engineers and business leaders. Microdosers take regular small doses of LSD or magic mushrooms. At these doses, they dont experience mind-bending, hallucinatory trips, but they say they get a jolt in creativity and focus that can elevate work performance, help relationships, and generally improve a stressful and demanding daily life. Late last year, the first placebo-controlled microdose trial was published. The study concluded that microdoses of LSD appreciably altered subjects sense of time, allowing them to more accurately reproduce lapsed spans of time. Does a microdose change brain function? Theres a myriad of ways to test this, but [Devin] Terhune looked specifically at the way the subjects perceive time. When shown a blue dot on a screen for a specific length of time, the subjects were asked to recreate that length of time by pressing a key. Typically, with longer time intervals, people underrepresent time (i.e. hold the key down for a shorter period of time than reality). In the study, those who received microdoses held the key longer, better representing the actual time interval. Does this mean microdosing makes you smarter? Terhune and his co-authors were cautious in overinterpreting their finding. For one, its not clear that perceiving time more accurately is preferable. The brain seems to favor underrepresenting time for reasons that are unclear. The finding does show that microdoses changed brain function.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Taking Ayahuasca When Youre a Senior Citizen
2019-10-17, New York Times
Posted: 2019-12-09 22:42:27
https://www.nytimes.com/2019/10/17/style/ayahuasca-senior-citizen.html

At 74, the venture capitalist George Sarlo might not have seemed an obvious candidate for an ayahuasca experience. Mr. Sarlos close friend, a doctor, told him about ayahuasca, a psychedelic brew made from the Banisteriopsis caapi vine, native to the Amazon. Used for centuries in sacred healing traditions throughout Central and South America, ayahuasca is now gaining popularity around the world. [It] is mostly illegal in the United States. Notably, ayahuascas increasing popularity knows no age limits: many of those now showing interest are squarely in Mr. Sarlos own demographic. Mr. Sarlo himself was initially skeptical. Taking ayahuasca would entail a potentially distressing night of hallucinations, and excretions of all kind, especially vomiting. But he still decided to head to Yelapa, a small village in Mexico, and swallow down the bitter brew. Mr. Sarlo said that afterward, something shifted. It changed my life completely. He realized that his life had been absolutely full of miracles, he said. As Michael Pollan put it, psychedelics might be wasted on the young. Mr. Pollan, the author of the recent best seller How To Change Your Mind, a history of psychedelics and a chronicle of his own experiences trying them, said ... he was surprised by the number of people he encountered when writing his book in their 70s and 80s expressing interest in trying psychedelics. Though perhaps he shouldnt have been: as he himself has written, one of the reasons to come to psychedelics later in life is to tangle with ones own mortality.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Desperate Parents Of Autistic Children Trying Cannabis Despite Lack Of Studies
2015-06-10, Forbes
Posted: 2019-11-24 18:42:28
https://www.forbes.com/sites/debraborchardt/2015/06/10/desperate-parents-of-a...

Parents of severely autistic children are turning to medical marijuana for relief. There are very few studies linking cannabinoids as a treatment for autism, but that isn't holding these parents back. Most figure they don't have anything to lose. Some [autistic] children are able to function well with various treatments, while others suffer with the inability to speak and self-harming behaviors. According to the Center for Disease Control and Prevention, 1.5% of the children in the U.S. are diagnosed with autism as of 2014. They are using CBD or cannabidiol, which can be derived from marijuana and hemp plants. The stories of autistic children that are helped with CBD oil sound very familiar to the stories of the epileptic children that have responded to CBD. Recently, Kalel Santiago, a child with autism so severe he wasn't able to speak, started speaking his first words after simply spraying hemp oil in his mouth twice daily according to Dr. Giovanni Martinez, a clinical psychologist in Puerto Rico. Dr. Martinez said, He started using the product three weeks ago. He was a full non-verbal patient. He only made sounds. The only change in his treatments was the use of CBD. The parents pursued the treatment on their own. Dr. Martinez has also been doing his own research on CBD and shared it with the parents. I'm very impressed with the language he has acquired, said Dr. Martinez.

Note: Read more about the healing potential of CBD. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.


FDA approves ketamine-like nasal spray for depression
2019-03-06, CNN News
Posted: 2019-11-12 00:48:15
https://www.cnn.com/2019/03/05/health/esketamine-depression-nasal-spray-fda-b...

The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K. It will be sold as Spravato. It's for patients who have tried at least two other medications without success, and it should be taken with an oral antidepressant. "There has been a longstanding need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition," Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products at the FDA's Center for Drug Evaluation and Research, said. Spravato is a nasal spray administered by an approved health care provider in a doctor's office or a medical clinic. It may also be self-administered but only under the supervision of a care provider and cannot be taken home. Depending on the severity of the patient's depression, it is given either once a week or once every other week. The drug is rapidly acting, so it starts working faster than other antidepressants, according to Janssen. It works by restoring brain cells in patients with treatment-resistant depression. Currently available treatments for major depression are ineffective in 30% to 40% of patients. The drug was designated as a breakthrough therapy in 2013, a status intended to "expedite the development and review of drugs for serious or life-threatening conditions," the FDA said at the time.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Johns Hopkins Opens New Center for Psychedelic Research
2019-09-04, New York Times
Posted: 2019-10-06 17:34:24
https://www.nytimes.com/2019/09/04/science/psychedelic-drugs-hopkins-depressi...

Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, to study compounds like LSD and psilocybin for a range of mental health problems, including anorexia, addiction and depression. The center is the first of its kind in the country, established with $17 million in commitments from wealthy private donors and a foundation. The centers at Johns Hopkins and Imperial College give psychedelic medicine, as some call it, a long-sought foothold in the scientific establishment. Since the early 2000s, several scientists have been exploring the potential of psychedelics and other recreational drugs for psychiatric problems, and their early reports have been tantalizing. The emergence of depression treatment with the anesthetic and club drug ketamine and related compounds, which cause out-of-body sensations, also has piqued interest in mind-altering agents as aids to therapy. The ... funding will help clarify which drugs help which patients. Roland Griffiths, a neuroscientist at Johns Hopkins who will direct the new center ... said the new funds will cover six full-time faculty, five postdoctoral scientists and the costs of running trials. Among the first of those trials are a test of psilocybin for anorexia nervosa and of psilocybin for psychological distress and cognitive impairment in early Alzheimers disease. The one thats crying out to be done is for opiate-use disorder, and we also plan to look at that, Dr. Griffiths said.

Note: Learn about the fascinating man who is bankrolling a significant portion of this new center in this New York Times article. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


How a trip on magic mushrooms helped decriminalize psychedelic plants in a California city
2019-06-22, Los Angeles Times
Posted: 2019-07-28 18:15:50
https://www.latimes.com/local/lanow/la-me-ln-oakland-decriminalize-mushrooms-...

Carlos Plazola locked himself in a bedroom while his cousin stood guard. For five hours, he tripped on magic mushrooms. He ingested 5 grams - a heady amount that connoisseurs call the heroic dose. It was Plazolas first time using the mushrooms, which contain the naturally occurring hallucinogen psilocybin. He started having epiphanies, one right after the other, like lightning bolts. I was making connections that I had never made in terms of my understanding of what we are, what the cosmos are, why were here, where were going, Plazola said. That mushroom trip last October by Plazola, the well-connected onetime chief of staff of a former Oakland City Council president, helped make Oakland the first city in California and the second in the nation to effectively decriminalize magic mushrooms. In May, Denver became the first city in the nation to decriminalize psilocybin mushrooms. In Oakland ... the City Council on June 4 approved its ordinance unanimously, with little pushback. Oakland even went a step further by decriminalizing not just mushrooms but also a range of other psychoactive plants and compounds including peyote, iboga and ayahuasca. The measure ... does not actually legalize natural psychedelics, which remain illegal under state and federal law. Instead, it declares the arrest and investigation of adults for using, possessing, growing or distributing plant-based hallucinogens to be among the lowest priorities for local police and restricts the use of city funds to go after users.

Note: Forbes recently published an excellent article clearing up the hype about some aspects of this sensitive subject. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Magic mushrooms could replace antidepressants within five years, says new psychedelic research centre
2019-07-08, The Independent (One of the UK's leading newspapers)
Posted: 2019-07-28 18:14:02
https://www.independent.co.uk/news/health/magic-mushroom-depression-psychedel...

Hallucination-inducing drugs like magic mushrooms could be about to break big pharmas stranglehold on the hugely lucrative market for antidepressants, according to the head of the worlds first centre for psychedelic research. Antidepressant prescriptions have doubled in England in a decade with around seven million adults taking the drugs, and the global market is predicted to be worth $15.9bn (12.5bn) by 2023. At Imperial College London, Dr Robin Carhart-Harris is leading one of the first trials to test how therapy using psilocybin mushrooms, which are currently banned in the UK, compares to leading antidepressants. While he wont prejudge the results of the study, he says participants describe a cathartic emotional release with psilocybin therapy the polar opposite of antidepressants, which patients complain leave their emotions, whether positive or negative, blunted. It is the first of many studies planned under the banner of the new Centre for Psychedelic Research at Londons Imperial College. Dr James Rucker is another of those researching the potential benefits of psychedelics ... at Kings College London. The Kings team are launching two trials, one looking at whether psilocybin therapy can help people whose depression is resistant to treatment with conventional antidepressants. He says it was possible the drug could be licensed in five years.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psychedelics, long ignored by scientists, seeing resurgence in medical research
2019-06-01, San Francisco Chronicle (San Francisco's leading newspaper)
Posted: 2019-06-28 01:48:23
https://www.sfchronicle.com/bayarea/article/Psychedelics-long-ignored-by-scie...

UCSF psychiatrist Brian Anderson is studying an experimental therapy to help long-term AIDS survivors ... who are feeling sad and demoralized. In a clinic outfitted with a comfortable couch, soft lighting, throw pillows and blankets, the participants of his study are given psilocybin, the hallucinogenic compound found in magic mushrooms. The results were compelling enough that hes planning a second study. Andersons work is part of a resurgence in psychedelic study that has been ... fueling grassroots efforts around the country to decriminalize use of certain psychedelic drugs. Statewide measures are being discussed in California and Oregon. The decriminalization efforts are focused on natural psychedelics mushrooms, along with herbs, cacti and other plants from which hallucinogenic compounds can be extracted. Though several studies in the first half of the 20th century had shown promise in using psychedelics for treatment of mental health and neurological disorders, the drugs were broadly maligned in the 1960s and 70s. More recently, microdosing the practice taking small, carefully controlled amounts of a psychedelic has taken off among Silicon Valley techies and university students who believe it boosts productivity and creativity. Almost all studies at the moment rely on private donations for funding. Studies are still limited, but theyre happening at universities around the country. At Johns Hopkins, Johnson and his colleagues reported about an 80% success rate in using psilocybin to help people quit smoking in one small study. Research out of UCLA has found that psilocybin may help cancer patients with depression and anxiety.

Note: For more along these lines, see concise summaries of deeply revealing news articles on studies of psychedelics from reliable major media sources.


FDA designates MDMA as 'breakthrough therapy' for PTSD
2017-08-31, CBS News
Posted: 2019-06-17 19:08:44
https://www.cbsnews.com/news/fda-designates-mdma-as-breakthrough-therapy-for-...

After years of lobbying and experimental research, the FDA has granted "breakthrough therapy" status for the drug MDMA as a potential treatment for post-traumatic stress disorder. The designation does not mean the drug is FDA-approved, but it does ease the way for clinical trials to test its safety and effectiveness in patients with PTSD. The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), which has been advocating and fundraising for MDMA research for three decades, announced the FDA's designation. More commonly known as its street names ecstasy or Molly, MDMA (methylenedioxymethamphetamine) is a psychoactive drug that produces feelings of energy and euphoria, often followed by an emotional crash. In recent years, some in the scientific community have suggested it could have medical benefits, as well. In previous phases of clinical trials, the drug was shown to offer significant relief to sufferers of PTSD, a mental health disorder characterized by nightmares or flashbacks and heightened anxiety or depression after experiencing or witnessing a terrifying event. In phase 2 clinical trials sponsored by MAPS, 61 percent of the 107 participants with chronic, treatment-resistant PTSD no longer had the disorder after two months of MDMA-assisted psychotherapy treatment. At a 12-month follow up, 68 percent no longer had PTSD. The organization expects to begin phase 3 trials with a larger group of participants next year.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Investors are starting to bet big on psychedelic medicine
2019-03-23, CNBC News
Posted: 2019-04-29 16:12:01
https://www.cnbc.com/2019/03/27/psychedelic-medicine-start-ups-vet-ketamine-p...

Psychedelic medicine is having a moment. Just weeks after the U.S. Food and Drug Administration approved Johnson & Johnsons ketamine-like nasal spray for depression, a group of European technology investors ... got together for the largest-ever private financing round for a psychedelic medicine biotech company, ATAI. Psychedelic medicine involves research and investigations into mind-altering substances to treat mental illnesses including addiction, depression and post-traumatic stress disorder. After recreational use of psychedelics became popular in the 1960s, the U.S. government classified most of them drugs of abuse with no real medical value. However, recent clinical studies show mounting evidence that some psychedelics can help patients with certain mental illnesses, either in combination with traditional therapies or in cases where nothing else has worked. Now health and technology investors are paying attention. German company ATAI Life Sciences announced on Tuesday that it has raised more than $40 million in new financing. The round valued the company at $240 million, according to a person familiar, making it both the biggest round and the most valuable company in the young space. ATAI is currently funding clinical trials for what it refers to as formerly stigmatized compounds, including psilocybin, the active compound in psychedelic mushrooms, and arketamine, a different variant of ketamine from the one Johnson & Johnson researched, as potential treatments for depression.

Note: Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Study: Patients Find More Relief In Marijuana's Psychoactive Compound THC Than In CBD
2019-02-27, Forbes
Posted: 2019-03-11 18:02:48
https://www.forbes.com/sites/javierhasse/2019/02/27/study-patients-find-more-...

CBD, the non-psychoactive compound found in cannabis, hemp and hops, has been getting a lot of attention from the media recently. On the other hand, THC, the psychoactive compound in cannabis that makes people feel high or stoned, is often overlooked (and sometimes even looked down on) when discussing marijuanas medical potential. However, a new study ... published on the Scientific Reports journal on Tuesday, revealed that THC exhibited the strongest correlation with therapeutic relief, compared to the more socially acceptable chemical found in cannabis, CBD (cannabinol). Cannabinoid content, and especially THC content, came out as the main factor for optimizing symptom relief, when tested for a wide variety of health conditions. [Study co-author Jacob Miguel] Vigil explained the results derived from the observation of real-time data from Releaf App, which he qualified as the largest database of its kind in our country. Using the app, patients reported the results and effects of their actual cannabis use. The researchers discovered cannabis is more effective for the treatment of mental symptoms like agitation, irritability, anxiety, depression, excessive appetite, insomnia, loss of appetite, nausea, gastrointestinal pain, stress and tremors, than it is in the treatment of physical ailments. Despite the conventional wisdom ... that only CBD has medical benefits while THC merely makes one high, our results suggest that THC may be more important than CBD in generating therapeutic benefits.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the healing potentials of mind-altering drugs.


MDMA to be Used in Trauma Treatment in Israel and U.S. May Not be Far Behind
2019-02-11, Newsweek
Posted: 2019-03-04 13:51:43
https://www.newsweek.com/mdma-be-used-trauma-treatment-israel-and-us-may-not-...

MDMA, the principal ingredient in the party drug ecstasy, is about to give a lifeline to some of the worst sufferers of post-traumatic stress disorder (PTSD) in Israel. The U.S. could be just years behind in launching similar clinical treatments using the substance. Israels Ministry of Health has approved the use of MDMA, a psychoactive drug, for use on dozens of patients. While the drug is still on the countrys law books as dangerous for recreational use, it is now being administered as treatment for compassionate use. In compassionate cases the drug will be made available to patients outside of clinical trials if they have not responded sufficiently to other medications or treatments. MDMA makes people feel euphoric, a sensation that made its use synonymous with rave culture and EDM (Electronic Dance Music), because it floods the body with serotonin. Serotonin is produced by nerve cells. When levels are low it can lead to depression and disrupt other physiological processes. The launching of the new Israeli initiative is a direct result of groundbreaking research in the U.S. The Middle Eastern nation approved the program after sending a representative to the California-based Multidisciplinary Association for Psychedelic Studies (MAPS) for training. MDMA has been illegal in the U.S. since 1985 but the findings of clinical trials, ongoing with Food and Drug Administration (FDA) approval since 2001, have shown that the drug enhances the treatment of PTSD in a clinical setting.

Note: Read also a CBC article titled "How psychedelic drugs are changing lives and transforming psychiatry." For more along these lines, see concise summaries of deeply revealing mind altering drugs news articles from reliable major media sources.


It can rewire peoples brains: how traumatised veterans turned to underground MDMA therapy
2018-11-17, The Guardian (One of the UK's leading newspapers)
Posted: 2018-11-26 07:19:05
https://www.theguardian.com/film/2018/nov/18/it-can-rewire-peoples-brains-how...

Dead Dog on the Left isnt just a documentary about the use of ecstasy in treating PTSD, its a story of the lengths one former marine will go to for friendship. [Tyler] McCourry and [Nigel] Flanigan are the subjects of [the] mini-documentary taken from a forthcoming feature film, MDMA the Movie, which explores the history of the so-called party drug more popularly known as ecstasy, its use in therapy, and harm reduction. Both films are directed by Emanuel Sferios. His protagonists may have survived the Iraq war, but only barely. Suicidal thoughts have stalked them both. In May 2012 McCourry did his first [MDMA-assisted psychotherapy] session ... lying in bed, flanked by two therapists. At the beginning of the session he was given a 75mg dose of MDMA. During those eight hours youre addressing the most challenging situations in your life, he says. It feels very exhausting, like it was some of the most work youve ever done in one day. McCourry calls those trials, now completed, a transformation of the psyche. MDMA-assisted psychotherapy has breakthrough therapy designation by the FDA. Since the MDMA therapy Im able to recognise when something comes up that I need to talk about, [McCourry] says. McCourry hopes that the therapy will be adopted by the Veterans Administration and Department of Defense. If you can cure PTSD after three sessions of MDMA therapy then you dont have to provide a veteran with medications for the rest of their life and talk therapy once a month.

Note: A touching 26-documentary on this case is available at the above link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


MDMA helps people cooperate and rebuild trust, study shows
2018-11-19, The Independent (One of the UK's leading newspapers)
Posted: 2018-11-26 07:16:21
https://www.independent.co.uk/news/health/mdma-ecstasy-drug-ptsd-mental-healt...

MDMA, the active ingredient of ecstasy pills, makes people more inclined to cooperate on tasks and quicker to rebuild trust, according to researchers investigating its use in treating psychological disorders. Scans reveal it increases activity in parts of the brain linked to empathy and social behaviour that helps interpret other peoples beliefs and intentions, researchers from Kings College London said. This could make it a useful addition to psychotherapy sessions and the drug is currently undergoing medical trials to assess its use in supporting treatment of post-traumatic stress disorder (PTSD). Understanding the brain activity underlying social behaviour could help identify what goes wrong in psychiatric conditions, said Professor Mitul Mehta from the Kings Institute of Psychiatry, Psychology & Neuroscience (IoPPN). While it is possible that making users more helpful and collaborative could lead to them being exploited, Professor Mehta and his team found the drug did not make users gullible. During the study ... participants on MDMA were less likely to cheat their partners than those on the placebo. Where they had previously been cheated ... subjects on MDMA were as likely to act selfishly as those on a placebo, however they were quicker to trust these partners again after a run of cooperation. This was backed up with patterns of brain activity.

Note: The study referenced by this article is available here. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Magic mushrooms for depression? FDA gives treatment breakthrough status
2018-11-05, Atlanta Journal-Constitution (Atlanta's leading newspaper)
Posted: 2018-11-13 05:01:02
https://www.ajc.com/news/health-med-fit-science/magic-mushrooms-for-depressio...

This week, life sciences company COMPASS Pathways announced that it has received Breakthrough Therapy designation from the United States Food and Drug Administration for its psilocybin therapy aimed at individuals with treatment-resistant depression. Psilocybin, the main active ingredient in psychedelic mushrooms ... can alter ones perception, thoughts and feelings or cause hallucinations. Researchers from Switzerland, the United Kingdom and the U.S. have been studying the therapy for many years. In fact, a study published in January found that the psychoactive compound helped revive emotional responsiveness in patients with treatment-resistant depression. Another showed that patients mental benefits after two psilocybin treatments lasted for weeks. COMPASS Pathways will begin running the first large-scale psilocybin clinical trial for treatment-resistant depression in Europe and North America within the next two years. "This is great news for patients, COMPASS executive chairman George Goldsmith said. We are excited to be taking this work forward with our clinical trial. The FDA will be working closely with us to expedite the development process and increase the chances of getting this treatment to people suffering with depression as quickly as possible. While treatments such as antidepressants and psychotherapy exist, those with severe, treatment-resistant depression ... have trouble finding help. Approximately 100 million around the globe are affected by such treatment-resistant depression.

Note: In 2017, the psychoactive drug MDMA similarly received a "Breakthrough Therapy" designation from the FDA for the promise it shows in treating PTSD. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


MDMA, the main ingredient in ecstasy, could be key in helping veterans with PTSD
2018-09-18,
Posted: 2018-10-08 04:14:10
https://www.cbsnews.com/news/mdma-the-main-ingredient-in-ecstasy-could-be-key...

It's the little things that Jon Lubecky appreciates now, like playing a board game with his family. But it wasn't always that way for the former Army sniper, who came home in 2006 after nearly a year in Iraq with a traumatic brain injury from a mortar attack and a nasty case of post-traumatic stress disorder (PTSD). Traditional treatments, including the use of antidepressants like Zoloft, were useless. Over three sessions, Lubecky spent six to eight hours under the influence of MDMA, the active ingredient in ecstasy. Finally, Lubecky was able to talk about his trauma and thus make progress dealing with it. Rick Doblin runs the Multidisciplinary Association for Psychedelic Studies, or MAPS, a non-profit advocating for MDMA-assisted psychotherapy. "It starts by reducing activity in the amygdala, which is the fear-processing part of the brain, so that people's fearful emotions linked to trauma can be more easily recalled and processed," Doblin said. Once the drug produces feelings of safety, veterans can then access memories which had been crippling before. While one in three veterans found pills like Zoloft and Paxil effective in treating their PTSD, a study including 24 veterans showed PTSD was eliminated in 68 percent of vets treated with MDMA-assisted therapy and significantly reduced in the other 32 percent. MDMA-assisted therapy is now about to begin its third phase of FDA testing. If all goes well, MDMA will be available by prescription as early as 2021.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs.


Psychedelic Mushrooms Are Closer to Medicinal Use
2018-10-03, New York Times
Posted: 2018-10-08 04:12:35
https://www.nytimes.com/2018/10/03/science/magic-mushrooms-psilocybin-schedul...

Researchers from Johns Hopkins University have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medical use, potentially paving the way for the psychedelic drug to one day treat depression and anxiety. The suggestion to reclassify psilocybin from a Schedule I drug, with no known medical benefit, to a Schedule IV drug, which is akin to prescription sleeping pills, was part of a review to assess the safety and abuse of medically administered psilocybin. Before the Food and Drug Administration can be petitioned to reclassify the drug, though, it has to clear extensive study and trials, which can take more than five years, the researchers wrote. The study comes as many Americans shift their attitudes toward the use of some illegal drugs. The widespread legalization of marijuana has helped demystify drug use, with many people now recognizing the medicinal benefits for those with anxiety, arthritis and other physical ailments. Psychedelics, like LSD and psilocybin, are illegal and not approved for medical or recreational use. But in recent years scientists and consumers have begun rethinking their use to combat depression and anxiety. Researchers who conducted the new study included Roland R. Griffiths, a professor ... at the Johns Hopkins University School of Medicine, who is one of the most prominent researchers on the behavioral and subjective effects of mood-altering drugs.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs.


Octopuses Get Strangely Cuddly On The Mood Drug Ecstasy
2018-09-20, NPR
Posted: 2018-09-30 21:54:33
https://www.npr.org/sections/health-shots/2018/09/20/648788149/octopuses-get-...

The psychoactive drug known as ecstasy can make people feel extra loving toward others. A study published Thursday suggests it has the same effect on octopuses. Octopuses are almost entirely antisocial, except when they're mating. Scientists who study them have to house them separately so they don't kill or eat each other. However, octopuses given the drug known as MDMA (or ecstasy, E, Molly or a number of other slang terms) wanted to spend more time close to other octopuses and even hugged them. Octopuses' ... brains have a host of strange structures that evolved on a completely different trajectory from the human path. "They have this huge complex brain that ... has absolutely no business acting like ours does but here they show that it does," says [neuroscientist Judit] Pungor. "This ... gentle, cuddly behavior is really pretty fascinating." The idea to test the drug's effect in octopuses came from Gul Dolen, a neuroscientist at Johns Hopkins University. "My lab has been studying MDMA for a long time, she says, "and we have worked out a lot of neural mechanisms that enable MDMA to have ... pro-social effects." Dolen got interested in octopuses a few years ago, when scientists sequenced the full genetic code of a ... California two-spot octopus. It turns out that octopuses and people have almost identical genes for a protein that binds the signaling molecule serotonin to brain cells. This protein is also the target of MDMA, so Dolen wondered how the drug would affect this usually unfriendly animal.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Ending America's War on Drugs Would Finally Unleash the Therapeutic Potential of Psychedelics
2018-05-30, Time
Posted: 2018-07-09 00:11:35
http://time.com/5295544/war-on-drugs-ptsd-mdma-rick-doblin/

It was only after U.S. veteran Jonathan Lubecky pulled the trigger on a loaded gun aimed at his head and it misfired that he finally decided to seek help. He had tried to commit suicide five times after struggling with post-traumatic stress disorder (PTSD). The only two drugs approved by the Food and Drug Administration for PTSD, Zoloft and Paxil ... didnt work for combat-related PTSD. Out of desperation, he volunteered as a subject in an experimental study of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. The study was sponsored by the ... Multidisciplinary Association for Psychedelic Studies (MAPS), and funded entirely by private donations. After his treatment with MDMA-assisted psychotherapy, Lubecky managed to heal from his PTSD to the point that he became National Veterans Director for Senator Rand Pauls 2016 presidential primary campaign. His recovery is not unusual. The Lancet Psychiatry published a scientific paper about the study Lubecky volunteered for; it reported that two-thirds of the 26 veterans, firefighters and police officers treated no longer qualified for a diagnosis of PTSD one month after their second MDMA session, with their reduction of PTSD symptoms lasting over time. Drug prohibition has for decades delayed medical research into the healing properties of Schedule 1 drugs. Now that this research is finally being conducted, were learning that enormous suffering and many suicides could have been prevented over these decades.

Note: The above was written by MAPS founder Rick Doblin. Read more about how MDMA, also known as 'ecstasy,' has been found to be effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Canada becomes second nation in the world to legalize marijuana
2018-06-20, CNN News
Posted: 2018-06-25 23:26:58
https://www.cnn.com/2018/06/20/health/canada-legalizes-marijuana/index.html

Recreational marijuana use will soon be legal in Canada after the Senate passed a "historic" bill. Canada is only the second country in the world - and the first G7 nation - to implement legislation to permit a nationwide marijuana market. In the neighboring US, nine states and the District of Columbia now allow for recreational marijuana use, and 30 allow for medical use. The Cannabis Act, stems from a campaign pledge of Prime Minister Justin Trudeau to keep marijuana away from underage users and reduce related crime. Uruguay was the first country to legalize marijuana's production, sale and consumption in December 2013. The justice minister, Jody Wilson-Raybould, ... applauded the vote. "This is an historic milestone for progressive policy in Canada," she tweeted. "This legislation will help protect our youth from the risks of cannabis while keeping profits out of the hands of criminals and organized crime." Once the bill is formally approved, adults will be able to carry and share up to 30 grams of legal marijuana in public. They also will be allowed to cultivate up to four plants in their households. However, stringent rules will still govern the purchase and use of marijuana. Consumers are expected to purchase marijuana from [regulated] retailers. Marijuana will also not be sold in the same location as alcohol or tobacco. The Canadian government has also implemented changes to their impaired driving laws, to address repercussions for driving under the influence of cannabis.

Note: In the US, more people are arrested for marijuana use than for all violent crimes combined.


A Strait-Laced Writer Explores Psychedelics, and Leaves the Door of Perception Ajar
2018-05-14, New York Times
Posted: 2018-05-21 19:31:19
https://mobile.nytimes.com/2018/05/14/books/review-how-to-change-your-mind-ps...

To microdose is to take small amounts of LSD, which generate subperceptual effects that can improve mood, productivity and creativity. Michael Pollans new book, How to Change Your Mind, is not about that. Its about taking enough LSD or psilocybin (mushrooms) to feel the colors and smell the sounds. If Pollans wide-ranging account has a central thesis, its that were still doing the hard work of rescuing the science of psychedelics from the countercultural baggage of the 1960s. In the mid-60s the exuberance surrounding these new drugs gave way to moral panic, and ... the whole project of psychedelic science had collapsed. Before collapsing, though, that project discovered in psychedelics the same potential that scientists are exploring as they reclaim it today: possible help in treating addiction, anxiety and depression, and existential distress common in people confronting a terminal diagnosis, which of course, broadly speaking, is all of us. Pollan doesnt give a lot of prime real estate to psychedelics naysayers. But given that those on LSD can appear to be losing their minds, and that the drug leaves one feeling emotionally undefended (a potential benefit as well as a profound risk), he does strongly recommend having an experienced guide in a proper setting when you trip. With those safeguards in place, he believes usage could be on the verge of more widespread acceptance.

Note: A recent clinical trial found psilocybin to be an extremely effective treatment for anxiety and depression. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.


The New Science of Psychedelics
2018-05-03, Wall Street Journal
Posted: 2018-05-15 06:48:34
https://www.wsj.com/articles/the-new-science-of-psychedelics-1525360091

Recent trials of psilocybin, a close pharmacological cousin to LSD, have demonstrated that a single guided psychedelic session can alleviate depression when drugs like Prozac have failed; can help alcoholics and smokers to break the grip of a lifelong habit; and can help cancer patients deal with their existential distress at the prospect of dying. At the same time, studies imaging the brains of people on psychedelics have opened a new window onto the study of consciousness, as well as the nature of the self and spiritual experience. Perhaps the most significant new evidence for the therapeutic value of psychedelics arrived in a pair of phase 2 trials (conducted at Johns Hopkins and NYU and published in the Journal of Psychopharmacology in 2016) in which a single high dose of psilocybin was administered to cancer patients struggling with depression, anxiety and the fear of death or recurrence. Eighty percent of the Hopkins cancer patients who received psilocybin showed clinically significant reductions in standard measures of anxiety and depression, an effect that endured for at least six months after their session. Results at NYU were similar. Curiously, the degree to which symptoms decreased in both trials correlated with the intensity of the mystical experience that volunteers reported, a common occurrence during a high-dose psychedelic session. Few if any psychiatric interventions for anxiety and depression have ever demonstrated such dramatic and sustained results.

Note: This entire article by best-selling author Michael Pollan is filled with the results of excellent studies in this exciting new field. If the above link fails, here is an alternative link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Active ingredient in ecstasy may help veterans with PTSD, study finds
2018-05-01, CNN News
Posted: 2018-05-08 00:42:32
https://www.cnn.com/2018/05/01/health/mdma-psychotherapy-ptsd-study/

MDMA - the active ingredient in the banned street drug ecstasy - is safe and enhances the treatment of post-traumatic stress disorder when administered during psychotherapy, according to a new clinical trial. The US Food and Drug Administration-approved ... study included just 26 patients, all of them veterans, firefighters and police officers who developed PTSD as a result of trauma in the line of duty. PTSD ... affects about 8 million American in any given year. Continuing symptoms, including flashbacks and frightening thoughts, may lead to substance abuse, unemployment, family disruption and even suicide. Up to 72% of veterans who receive psychotherapy retain their PTSD diagnosis and frequently drop out of their treatment programs. "We only included people who had received prior treatment but still had clinically significant PTSD," [Dr. Michael C. Mithoefer, lead author of the study] said. Participants received ... about 13 hours of non-drug psychotherapy plus two eight-hour sessions of MDMA-assisted psychotherapy. Participants were randomly assigned to receive MDMA (orally) in one dose of either 30, 75 or 125 milligrams for each of the two MDMA-assisted psychotherapy sessions. One month after the second MDMA session, 68% of patients in the two higher-dose groups no longer qualified for a diagnosis of PTSD. One year later, 67% of all participants no longer qualified for a diagnosis of PTSD. Those participants who still met the criteria for PTSD experienced a reduction in symptoms, the researchers noted.

Note: Watch an engaging interview with one of the participants of the study at the link above. Read more about how MDMA has been found to be effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Anxiety Relief Without The High? New Studies On CBD, A Cannabis Extract
2018-04-23, NPR
Posted: 2018-04-29 20:15:05
https://www.npr.org/sections/health-shots/2018/04/23/604307015/anxiety-relief...

As more states legalize marijuana, there's growing interest in a cannabis extract cannabidiol, also known as CBD. It's marketed as a compound that can help relieve anxiety - and, perhaps, help ease aches and pains, too. CBD doesn't have the same mind-altering effects as marijuana, since it does not contain THC, the psychoactive component of the plant. "There's good evidence to suggest that CBD could be an effective treatment of anxiety and addiction" and other disorders, says Dr. Esther Blessing, a psychiatrist and researcher at New York University. "But we need clinical trials." Small, short-term human studies ... suggest CBD exhibits anti-inflammatory and anti-anxiety properties. These preliminary findings piqued Blessing's interest. For instance, she points to a 2011 study of a few dozen people, some of whom had social anxiety disorder, who were asked to speak in front of a large audience. Researchers compared anxiety levels in people after they took CBD, compared to those who got the placebo or nothing at all. "People who took CBD reported significantly less anxiety" compared to those who got the placebo, Blessing says. Though CBD supplements are widely available for sale, a legal murkiness surrounds marijuana extracts. Even if you live in a state where marijuana use is legal, the federal Drug Enforcement Administration still classifies the CBD extract as a Schedule 1 substance the DEA's most restricted category.

Note: Read more about the use of CBD to treat epilepsy and other serious conditions. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.


Why Psychedelic Psychotherapy Works
2018-03-01, Optimist Daily
Posted: 2018-03-18 17:08:59
https://www.optimistdaily.com/2018/03/why-psychedelic-psychotherapy-works/

In recent years, rigorous research has been conducted on entheogens, such as ayahuasca, LSD, mescaline and psilocybin, and on the empathogen Ecstasy. The goal is to evaluate their effects on addiction, cluster headaches, depression, trauma, cancer, epilepsy, death and dying, as well as to explore their value in the study of consciousness. Psilocybin - or magic mushrooms - have been used in traditional healing rituals for thousands of years. However, for more than 40 years it has been illegal in the U.S. But recent findings are tearing down the barriers surrounding psychedelic research, as it has been clinically shown that they have the ability to ease depression and soothe anxiety in patients dealing with serious illness and impending death. Two separate studies discovered that a single, moderate-to-large dose of psilocybin was able to help alleviate profound distress among cancer patients. Researchers know how, but they do not know why, psilocybin has worked in these settings. One theory is that psilocybin interrupts the circuitry of self-absorbed thinking that is so pronounced in depressed people, making way for a mystical experience. Neuro-imaging studies ... suggest that the positive effects of psychedelic-assisted psychotherapy are explained by changes in something in the brain called the default mode network. It turns out that this network is hyperactive in depression. Interestingly, in both meditation and also with psilocybin this network becomes quiescent.

Note: See an article in the UK's Independent showing remarkable results from these studies. Learn more about the healing potentials of mind-altering drugs now being explored by the scientific community.


Medical marijuana has no public health risks should not be withheld from patients
2017-12-19, The Guardian (One of the UK's leading newspapers)
Posted: 2017-12-24 21:24:36
https://guardian.ng/features/health/medical-marijuana-has-no-public-health-ri...

After months of deliberation and investigation, the WHO has concluded that cannabidiol (CBD) is a useful treatment for epilepsy and palliative care, and does not carry any addiction risks. The organization is set to run a fuller review of cannabis next year. The report ... also recommended imposing the strong restrictions available on fentanyl, a synthetic opioid which has killed thousands of people in Americas drug addiction epidemic. There is increased interest from Member States in the use of cannabis for medical indications including for palliative care, the report said. Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components. In conclusion, the authors wrote: Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions. They added that current information does not justify scheduling of cannabidiol, and declared that taking medical marijuana will not lead to addiction to THC, the psychoactive property of cannabis that induces a high.

Note: More people are arrested in the US for marijuana use than for all violent crimes combined and the US federal government continues to regard non-psychoactive CBD as a dangerous drug. The UK government recently announced it will regulate CBD as medicine. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.


Portugals radical drugs policy is working. Why hasnt the world copied it?
2017-12-05, The Guardian (One of the UK's leading newspapers)
Posted: 2017-12-11 04:08:23
https://www.theguardian.com/news/2017/dec/05/portugals-radical-drugs-policy-i...

When the drugs came, they hit all at once. It was the 80s, and by the time one in 10 people had slipped into the depths of heroin use - bankers, university students, carpenters, socialites, miners - Portugal was in a state of panic. In 2001 ... Portugal became the first country to decriminalise the possession and consumption of all illicit substances. Rather than being arrested, those caught with a personal supply might be given a warning, a small fine, or told to appear before a local commission a doctor, a lawyer and a social worker about treatment, harm reduction, and the support services that were available to them. The opioid crisis soon stabilised, and the ensuing years saw dramatic drops in problematic drug use, HIV and hepatitis infection rates, overdose deaths, drug-related crime and incarceration rates. HIV infection plummeted from an all-time high in 2000 of 104.2 new cases per million to 4.2 cases per million in 2015. Portugals remarkable recovery ... could not have happened without an enormous cultural shift, and a change in how the country viewed drugs. Portugals policy rests on three pillars: one, that theres no such thing as a soft or hard drug, only healthy and unhealthy relationships with drugs; two, that an individuals unhealthy relationship with drugs often conceals frayed relationships with loved ones, with the world around them, and with themselves; and three, that the eradication of all drugs is an impossible goal. In spite of Portugals tangible results, other countries have been reluctant to follow.

Note: Portugal's successful policy has contributed to public health outcomes that starkly contrast US trends.


Veterans, grappling with PTSD, are helping to boost public support for medical marijuana
2017-11-26, CNBC News/Associated Press
Posted: 2017-12-11 04:03:30
https://www.cnbc.com/2017/11/26/veterans-grappling-with-ptsd-are-helping-to-b...

Against the backdrop of the nation's largest Veterans Day parade, Democratic Gov. Andrew Cuomo announced this month he'd sign legislation making New York the latest in a fast-rising tide of states to OK therapeutic pot as a PTSD treatment, though it's illegal under federal law. Twenty-eight states plus the District of Columbia now include PTSD in their medical marijuana programs, a tally that has more than doubled in the last two years. The increase has come amid increasingly visible advocacy from veterans' groups. Retired Marine staff sergeant Mark DiPasquale says the drug freed him from the 17 opioids, anti-anxiety pills and other medications that were prescribed to him for migraines, post-traumatic stress and other injuries from service that included a hard helicopter landing in Iraq in 2005. In a sign of how much the issue has taken hold among veterans, the 2.2-million-member American Legion began pressing the federal government this summer to let Department of Veterans Affairs doctors recommend medical marijuana where it's legal. The Legion started advocating last year for easing federal constraints on medical pot research, a departure into drug policy for the nearly century-old organization. "People ask, `Aren't you the law-and-order group?' Why, yes, we are," Executive Director Verna Jones said at a Legion-arranged news conference early this month at the U.S. Capitol. But "when veterans come to us and say a particular treatment is working for them, we owe it to them to listen and to do scientific research required."

Note: This Associated Press article no longer appears on CNBC's website. Here's an alternate link for the complete article. The illegal drug MDMA was recently fast tracked for FDA approval after preliminary studies found it to be effective for treating PTSD in a therapeutic context. While police in the US arrest more people for marijuana use than for all violent crimes combined, articles like these suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.


In Brazil, Some Inmates Get Therapy With Hallucinogenic Tea
2015-03-28, New York Times
Posted: 2017-12-04 03:17:28
https://www.nytimes.com/2015/03/29/world/americas/a-hallucinogenic-tea-time-f...

Dozens of adults and children, all clad in white, stood in a line. A holy man handed each a cup of ayahuasca, a muddy-looking hallucinogenic brew. Among those imbibing from the holy mans decanter were prison inmates, convicted of crimes such as murder, kidnapping and rape. Im finally realizing I was on the wrong path in this life, said Celmiro de Almeida, 36, who is serving a sentence for homicide. Each experience helps me communicate with my victim to beg for forgiveness, said Mr. de Almeida. The provision of a hallucinogen to inmates ... reflects a continuing quest for ways to ease pressure on Brazils prison system. The countrys inmate population has doubled since the start of the century ... straining underfunded prisons rife with human rights violations. Around [2002], Acuda, a pioneering prisoners rights group in Porto Velho, began offering inmates therapy sessions in yoga, meditation and Reiki. Two years ago, the volunteer therapists at Acuda had a new idea: Why not give the inmates ayahuasca as well? Acuda had trouble finding a place where the inmates could drink ayahuasca, but they were finally accepted by an offshoot here of Santo Daime, a Brazilian religion founded in the 1930s. Many people in Brazil believe that inmates must suffer, said Euza Beloti, 40, a psychologist with Acuda. This thinking bolsters a system where prisoners return to society more violent than when they entered prison. At Acuda, she said, we simply see inmates as human beings with the capacity to change.

Note: Read more about emerging research into ayahuasca in Brazil. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.


The Promise of Ecstasy for PTSD
2017-11-03, New York Times
Posted: 2017-11-27 01:30:41
https://www.nytimes.com/2017/11/03/opinion/ecstasy-ptsd.html

In July, the Food and Drug Administration took the important step of approving two final-phase clinical trials to determine whether a party drug that has long been on the Drug Enforcement Administrations Schedule I list of banned substances could be used to treat a psychiatric condition that afflicts millions. The drug is MDMA, a psychedelic commonly known as Ecstasy. The trials aim to determine whether the drug is, as earlier trials have suggested, a safe and effective treatment for post-traumatic stress disorder. The F.D.A. approval is a beacon of hope for the roughly eight million Americans believed to suffer from PTSD, a group that includes victims of abuse, refugees and combat veterans. The shortcomings in the way we have typically treated PTSD mean that many are condemned to suffer from the condition for years, even decades, with little relief. Less than 20 percent of patients are estimated to get effective treatment through prescription psychiatric drugs ... which, along with psychotherapy, have been the global standard of mental health care since the 1990s. This could change with the F.D.A.s decision, which has given MDMA-assisted psychotherapy for the treatment of PTSD the status of a potential breakthrough therapy. This designation permits the fast-tracking of trials in hopes of proving the drug, which has psychedelic and stimulant effects, to be safe and capable of doing what no other drug on the market can.

Note: Read more about how MDMA has been found to be highly effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


How MDMA Went From Club Drug to Breakthrough Therapy
2017-10-18, Wall Street Journal
Posted: 2017-10-31 11:37:28
https://www.wsj.com/articles/how-mdma-went-from-club-drug-to-breakthrough-the...

Stephen Ross spends most of his time helping people quit drugs. But early next year, he will begin administering MDMA in his ... medical research lab. MDMA, aka ecstasy, will still be an illegal drug. But its emerging as one of the most promising treatments for intractable post-traumatic stress disorder. Rick Doblin ... encountered MDMA for the first time [in 1982]. Two years later, he watched a patient suffering from PTSD undergo MDMA-assisted therapy. That completely persuaded me of its therapeutic potential, Doblin says. In 1985, Doblin learned that the DEA was moving to ban the drug ... and founded a nonprofit - the Multidisciplinary Association for Psychedelic Studies - to fight the prohibition. In 2000 [Doblin] met Michael Mithoefer, a therapist specializing in PTSD. Mithoefer had grown frustrated by the available treatments. Mithoefer and his wife and co-therapist, Annie, conducted the first MAPS-funded Phase II trial in 2004, which used MDMA to treat PTSD in victims of rape and childhood sexual abuse. These were patients with chronic cases that had proved resistant to other treatment methods. A second group, made up of veterans, firefighters and police officers, followed. Therapists refer to MDMA as an empathogen - something that enables patients to feel empathy not just for others but also for themselves. Of the 90 people who completed the 12-month follow-up after Phase II, 68% of them did not meet PTSD criteria, according to the study results MAPS submitted to the FDA. Of the remaining third, many had some reduction in symptoms.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Lucy in the sky with doctors
2017-10-14, Boston Globe
Posted: 2017-10-31 11:35:50
http://www.bostonglobe.com/ideas/2017/10/14/lucy-sky-with-doctors/On92CQWm0YC...

A nascent movement of activists working to reframe psilocybin as both a medicine and as a tool for personal or spiritual growth [thinks] researchers and policy makers should be able to discuss, in a dispassionate way, the medical or recreational use of hallucinogenic drugs a subject that not long ago was unthinkable. The Boston Entheogenic Network (BEN) ... formed last year. Instead of the more familiar, more polarizing adjective psychedelic, BEN uses the term entheogenic - meaning generating the divine within - to describe multiple methods of achieving altered states of consciousness. Proof of medical usefulness was the first step toward marijuanas legalization. Could it be the same for hallucinogens? In fact, medical applications for psilocybin abound. Recent studies have found that MDMA seems to be a remarkably useful tool in treating post-traumatic stress disorder, when combined with psychotherapy. In August, the FDA designated the drug as a breakthrough therapy, meaning that it may have substantial advantages over existing PTSD treatments. Other studies suggest psilocybin has promise as a treatment for anxiety and depression. Meanwhile, microdosing - the regular use of tiny amounts of LSD or other psychedelics not to hallucinate but to improve creativity and mood - has become a Silicon Valley trend. Advocates for psychedelics have come a long way from Learys indiscriminate call for young people to turn on, tune in, and drop out, but many still believe these drugs could change the world.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Will Psychedelic Therapy Transform Mental Health Care?
2017-10-06, NBC News
Posted: 2017-10-09 02:02:43
https://www.nbcnews.com/mach/science/will-psychedelic-therapy-transform-menta...

In the mid-1950s, LSD and other psychedelic drugs took the medical world by storm. Studies at the time suggested that the hallucinogens were effective against a variety of difficult-to-treat mental health problems. The research stalled in the early 1970s ... but [it] is picking up again. If the drugs prove to be as safe and effective as recent research suggests, we may be on the brink of what some are calling a revolution in mental health care. People with mood disorders, including those who are unresponsive to conventional therapies, might be able to ditch their antidepressants and antianxiety medications. Those with terminal illness could enjoy their remaining days without the fear of death looming over them, while people with PTSD could return to a normal life unobstructed by paralyzing flashbacks. Were not at this point yet. But such is the promise of psychedelic medicine. What makes psychedelic therapy so powerful? Experts say it may be because the drugs work on a deep emotional as well as biological level, with patients experiencing a transformative sense of positivity, benevolence, and unity. "Unlike almost all other psychiatric medications ... these drugs seem to work through biology to open up a psychological opportunity," says Matthew Johnson, a Johns Hopkins University psychiatrist. And the drugs benefits may go beyond simply treating specific disorders. In 2011, Johnson and his colleagues showed that a single psilocybin session can give people a more "open" personality, as well as a greater appreciation of new experiences.

Note: Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Ecstasy could be breakthrough therapy for soldiers, others suffering from PTSD
2017-08-26, Washington Post
Posted: 2017-09-04 23:35:03
https://www.washingtonpost.com/national/health-science/ecstasy-could-be-break...

For Jon Lubecky, the scars on his wrists are a reminder of the years he spent in mental purgatory. He returned from an Army deployment in Iraq a broken man. He got every treatment offered by Veterans Affairs for post-traumatic stress disorder. But they didnt stop him from trying to kill himself - five times. Finally, he signed up for an experimental therapy and was given a little green capsule. The anguish stopped. Inside that pill was the compound MDMA, better known ... as ecstasy. That street drug is emerging as the most promising tool in years for the militarys escalating PTSD epidemic. The MDMA program was created by a small group of psychedelic researchers who had toiled for years in the face of ridicule, funding shortages and skepticism. But the results have been so positive that this month the Food and Drug Administration deemed it a breakthrough therapy - setting it on a fast track for review and potential approval. Only two drugs are approved for treating PTSD: Zoloft and Paxil. Both have proved largely ineffective. By giving doses of MDMA at the beginning of three, eight-hour therapy sessions, researchers say they have helped chronic PTSD patients process and move past their traumas. In clinical trials with 107 patients closely monitored by the FDA, 61 percent reported major reductions in symptoms - to the point where they no longer fit the criteria for PTSD. Follow-up studies a year later found 67 percent no longer had PTSD.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Can Psychedelics Be Therapy? Allow Research to Find Out
2017-07-17, New York Times
Posted: 2017-08-06 16:24:29
https://www.nytimes.com/2017/07/17/upshot/can-psychedelics-be-therapy-allow-r...

In the last few years, calls for marijuana to be researched as a medical therapy have increased. It may be time for us to consider the same for psychedelic drugs. Two general classes of such drugs exist, and they include LSD, psilocybin, mescaline and ecstasy (MDMA). All are illegal in the United States, [and can] cause harm. The best-known adverse event is persistent flashbacks, though these are believed to be rare. More common are symptoms like increased heart rate and blood pressure, anxiety and panic. Some people have pointed to ... positive effects. People with life-threatening illnesses can also suffer from anxiety, which is hard to treat. In 2014, a small randomized controlled trial was published that examined if LSD could be used to improve this anxiety. Anxiety was significantly reduced in the intervention group for up to a year. More common are studies of the use of psychedelics to treat abuse or addiction to other substances. [One study] exploring LSDs potential to treat alcoholism [found that] alcohol use and misuse were significantly reduced in the LSD group for six months. Similar studies using psilocybin have also shown promising results. Researchers [have also] examined the potential for MDMA in the treatment of chronic and treatment-resistant post-traumatic stress disorder. At two months after therapy, more than 80 percent of those in the treatment group saw a clinical improvement versus only 25 percent of those in the placebo group. The beneficial effects lasted for at least four years, even with no further treatment.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are beginning to gain mainstream scientific credibility.


Religious leaders get high on magic mushrooms ingredient for science
2017-07-08, The Guardian (One of the UK's leading newspapers)
Posted: 2017-07-17 09:33:47
https://www.theguardian.com/science/2017/jul/08/religious-leaders-get-high-on...

Scientists at Johns Hopkins University in Baltimore have enlisted two dozen religious leaders from a wide range of denominations, to participate in a study in which they will be given two powerful doses of psilocybin, the active ingredient in magic mushrooms. Dr William Richards ... who is involved in the work, said: With psilocybin these profound mystical experiences are quite common. It seemed like a no-brainer that they might be of interest, if not valuable, to clergy. The experiment, which is currently under way, aims to assess whether a transcendental experience makes the leaders more effective and confident in their work and how it alters their religious thinking. Despite most organised religions frowning on the use of illicit substances, Catholic, Orthodox and Presbyterian priests, a Zen Buddhist and several rabbis were recruited. The team has yet to persuade a Muslim imam or Hindu priest to take part, but just about all the other bases are covered, according to Richards. The participants have been given two powerful doses of psilocybin in two sessions, one month apart. Their instruction is to go within and collect experiences, Richards said. So far everyone incredibly values their experience. No one has been confused or upset or regrets doing it. A full analysis of the outcomes will take place after a one-year follow-up with the participants, whose identities are being kept anonymous. It is too early to talk about results, but generally people seem to be getting a deeper appreciation of their own religious heritage, he said.

Note: In 1962, a similar experiment was conducted called the "Good Friday Experiment." Almost all of the members of the experimental group reported experiencing profound religious experiences. In 2002, a similar experiment at Johns Hopkins University yielded similar results. Learn about both of these in this Wikipedia article. Read more about the potentials of mind altering drugs now being explored by the scientific community.


Marijuana may be a miracle treatment for children with autism
2017-04-25, USA Today
Posted: 2017-04-30 23:28:51
https://www.usatoday.com/story/news/world/2017/04/25/marijuana-pot-treatment-...

When Noa Shulman came home from school, her mother, Yael, sat her down to eat, then spoon-fed her mashed sweet potatoes - mixed with cannabis oil. Noa is part of the first clinical trial in the world to test the benefits of medicinal marijuana for young people with autism, a potential breakthrough. There is anecdotal evidence that marijuanas main non-psychoactive compound - cannabidiol or CBD - helps children in ways no other medication has. Now this first-of-its-kind scientific study is trying to determine if the link is real. Israel is ...one of just three countries with a government-sponsored medical cannabis program, along with Canada and the Netherlands. Conducting cannabis research is also less expensive here and easier under Israeli laws, particularly compared to the United States. Autism is one of the fastest-growing developmental disorders, affecting 1 in 68 children in the United States. Only two medications have been approved in the United States by the Food and Drug Administration to treat the symptoms of autism. Both are antipsychotic drugs that are not always effective and carry serious side effects. Adi Aran, the pediatric neurologist leading the study, said nearly all the participants previously took antipsychotics and nearly half responded negatively. Anecdotal reports of autistic children who benefited from cannabis ... led Aran to pursue more scientific testing. After seeing positive results in 70 of his autistic patients in an observational study, Aran said, OK we need to do a clinical trial."

Note: Dozens of studies have found evidence that CBD can treat epilepsy as well as a range of other illnesses. While more people are arrested in the US for marijuana use than for all violent crimes combined and the US federal government continues to regard non-psychoactive CBD as a dangerous drug, the UK government recently announced it will regulate CBD as medicine. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.


The definitive guide to what experts know about the effects of marijuana use
2017-01-13, Washington Post
Posted: 2017-01-16 13:47:26
https://www.washingtonpost.com/news/wonk/wp/2017/01/13/the-definitive-guide-t...

As eight states plus the District of Columbia have moved to fully legalize recreational marijuana, debates on the merits of legalization have focused on the effects of marijuana use on individuals and society. The National Academies of Sciences, Medicine and Engineering have brought a great deal of clarity to the situation with an encyclopedic report summarizing pretty much everything researchers know (and don't know) about the health effects of marijuana use. For the 395-page report, a team of dozens of drug policy experts at some of the nation's most prestigious universities analyzed 24,000 scientific papers to arrive at more than 100 conclusions regarding the effects of marijuana use. The committee found strong evidence showing marijuana is effective at treating chronic pain in adults. Given the current public health crisis involving tens of thousands of deaths annually because of painkiller overdoses, this is a potentially significant finding. The report also turned up strong evidence that marijuana is effective at treating nausea and vomiting, [as well as] muscle spasticity. The literature shows limited evidence that marijuana use is linked to the use of other substances. The report does not address the implications of these findings for current legalization debates. The researchers do, however, state emphatically that the current designation of marijuana as a Schedule 1 controlled substance ... is one of the chief barriers to conducting more badly needed research.

Note: Big Pharma has been caught systematically bribing doctors to over-prescribe deadly painkillers, and an ex-DEA official has publicly accused Congress of helping drug makers avoid responsibility for their role in the US opioid epidemic. Meanwhile, more people are arrested in the US for marijuana use than for all violent crimes combined. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.


A powerful new form of medical marijuana, without the high
2016-12-31, Washington Post
Posted: 2017-01-08 22:50:00
https://www.washingtonpost.com/national/health-science/a-powerful-new-form-of...

Jackson Leyden had always been a healthy kid. But in 2011, a few months after his eighth birthday, he began having seizures several times a day. His parents took him to more than 20 doctors. He tried more than a dozen medications. Nothing worked. Two years ago, the Leydens ... decided to see whether marijuana might help. Within a few days, he was having hardly any seizures, says his mother, Lisa. I was shocked. Over the next few months, he stopped taking other medications. Not only did the medicine help, it did so without making him high. The strain of marijuana that Jackson takes is unusual: It contains high levels of cannabidiol, or CBD, one of the two main molecules in marijuana; the other is tetrahydrocannabinol, or THC. While THC is famously mind-altering, CBD is not. Over decades, researchers have found that THC may help treat pain, nausea, loss of appetite and other problems, while CBD was thought to be biologically inactive. But in the past 10 years ... dozens of studies have found evidence that the compound can treat epilepsy as well as a range of other illnesses, including anxiety, schizophrenia, heart disease and cancer. Now 13, Jackson ... continues to use marijuana every day. He still has seizures, but they are less severe and they occur once every week or two, down from around 200 a month before he started using cannabis. Although it doesnt make users high, CBD ... is classified by the federal government as a Schedule 1 drug [with] no accepted medical use.

Note: While more people are arrested in the US for marijuana use than for all violent crimes combined and the US federal government continues to regard non-psychoactive CBD as a dangerous drug, the UK government recently announced it will regulate CBD as medicine. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.


A Dose of a Hallucinogen From a Magic Mushroom, and Then Lasting Peace
2016-12-01, New York Times
Posted: 2016-12-12 04:18:01
http://www.nytimes.com/2016/12/01/health/hallucinogenic-mushrooms-psilocybin-...

On a summer morning in 2013, Octavian Mihai entered a softly lit room. He swallowed a capsule of psilocybin, an ingredient found in hallucinogenic mushrooms. Then he put on an eye mask and headphones and lay down on a couch. Mr. Mihai, who had just finished treatment for Stage 3 Hodgkins lymphoma, was participating in a study looking at whether the drug can reduce anxiety and depression in cancer patients. Throughout that eight-hour session, a psychiatrist and a social worker ... stayed by his side. The results from that study, and a similar small, controlled trial, were striking. About 80 percent of cancer patients showed clinically significant reductions in both psychological disorders, a response sustained some seven months after the single dose. Side effects were minimal. In both trials, the intensity of the mystical experience described by patients correlated with the degree to which their depression and anxiety decreased. Although cancer patients will not have access to therapeutically administered psilocybin anytime soon, the findings add vigor to applications to expand research in a multicenter trial with hundreds of participants. Psilocybin trials are underway in the United States and Europe for alcoholism, tobacco addiction and treatment-resistant depression. Other hallucinogens are also being studied for clinical application. This week, the Food and Drug Administration approved a large-scale trial investigating MDMA, the illegal party drug better known as Ecstasy, for post-traumatic stress disorder.

Note: See another article in the UK's Independent showing remarkable results from these studies. Learn more about the healing potentials of mind-altering drugs now being explored by the scientific community.


F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients
2016-11-29, New York Times
Posted: 2016-12-06 10:55:45
http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html?_r=0

After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world. He had tried almost all the accepted treatments for post-traumatic stress disorder. Nothing worked for me, said Mr. Hardin. Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. It changed my life, he said. It allowed me to see my trauma without fear or hesitation and finally process things and move forward. Based on promising results like Mr. Hardins, the Food and Drug Administration gave permission Tuesday for large-scale, Phase 3 clinical trials of the drug - a final step before the possible approval of Ecstasy as a prescription drug. The Multidisciplinary Association for Psychedelic Studies, a small nonprofit created in 1985 ... sponsored six Phase 2 studies treating a total of 130 PTSD patients. Two trials ... focused on treating combat veterans, sexual assault victims, and police and firefighters with PTSD who had not responded to traditional prescription drugs or psychotherapy. Patients had, on average, struggled with symptoms for 17 years. After three doses of MDMA administered under a psychiatrists guidance, the patients reported a 56 percent decrease of severity of symptoms on average, one study found. By the end of the study, two-thirds no longer met the criteria for having PTSD. Follow-up examinations found that improvements lasted more than a year after therapy.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. This FDA approval to begin Phase 3 clinical trials of MDMA suggests that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Can Ecstasy Help Relieve Social Anxiety Epidemic Among Autistic People?
2016-10-29, NPR
Posted: 2016-11-14 18:07:08
https://ww2.kqed.org/futureofyou/2016/10/24/ecstasy-party-drug-offers-hope-fo...

For a long time, Daniel Au Valencia got the message that she was wrong, wrong, wrong. Theres a lot of shame around autism, she says. Last year Valencia heard about an unusual experimental study ... exploring a treatment specifically for social anxiety in autistic adults. Many traditional therapies dont work for autistic people, says Nick Walker, [a] consultant on the new study, because they reinforce stigma around autism. He sees this new research as a uniquely culturally appropriate approach to addressing the epidemic of social anxiety in autistic adults. The treatment is MDMA, known more commonly as Ecstacy or Molly. Early studies ... show it can ease or erase symptoms of post-traumatic stress disorder. In one study, 83 percent of study participants treated with MDMA and psychotherapy were cured of their PTSD. Psychologist Alicia Danforth [is] conducting the social anxiety study at UCLAs Los Angeles Biomedical Research Institute, along with psychiatrist Charles Grob. Valencia is one of just 12 autistic adults participating in the pilot study. Its impossible to draw a direct line between the treatment and how Valencia is doing right now, but she says shes doing great. Shes got a steady full-time job, her own apartment, and she just got married. She says her biggest takeaway ... is more about emotions than social anxiety. She says shes learned that theres no such thing as good emotions or bad emotions. All emotions deserve to exist, she says.

Note: Learn more about the healing potentials of mind-altering drugs now being explored by the scientific community.


My therapist gave me a pill: can MDMA help cure trauma?
2016-09-26, The Guardian (One of the UK's leading newspapers)
Posted: 2016-10-10 15:23:44
https://www.theguardian.com/society/2016/sep/16/mdma-ptsd-therapy-trauma-maps...

For as long as Alice, now 32, can remember, her father, a major drug dealer with freezers full of cocaine, was physically abusive towards her and her mother. Alices post-traumatic stress disorder (PTSD) ... went misdiagnosed for many years. She tried [many therapies]. Nothing worked. Then, two and a half years ago, Alice enrolled in a clinical trial for a treatment combining psychotherapy with MDMA. Her trips were accompanied by eight-hour therapy sessions. During the session[s], her psychiatrist guided the conversation according to goals she had set with Alice beforehand. Alices recovery was astonishing. The clinician-administered PTSD scale, or Caps ... uses a lengthy questionnaire to determine the severity of a patients symptoms. Any score over 60 is severe. Alices score went from 106 to two. Its now at zero. In other words, her PTSD is gone. Alice is one of 136 patients who have undergone MDMA-assisted psychotherapy in trials run by the not-for-profit Multidisciplinary Association for Psychedelic Studies (Maps), based in Santa Cruz, California. [In] one South Carolina study ... 83% of those given the MDMA no longer met the criteria for PTSD following treatment, compared with 25% of those who were not given the drug. Best of all? The results have held for several years. MDMA is not a silver bullet: treatment is heavily reliant on the accompanying therapy, and there is a lot of therapy: three monthly sessions with the drug, lasting eight hours each, punctuated by nine weekly 90-minute sessions without it.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are beginning to gain mainstream scientific credibility.


High Hitler: how Nazi drug abuse steered the course of history
2016-09-25, The Guardian (One of the UK's leading newspapers)
Posted: 2016-10-02 14:50:32
https://www.theguardian.com/books/2016/sep/25/blitzed-norman-ohler-adolf-hitl...

The German writer Norman Ohler['s] book ... "The Total Rush" or, to use its superior English title, "Blitzed" reveals the astonishing and hitherto largely untold story of the Third Reichs relationship with drugs, including cocaine, heroin, morphine and, above all, methamphetamines (aka crystal meth). The story Ohler tells begins in the days of the Weimar Republic, when ... Hitlers inner circle established an image of him as an unassailable figure who was willing to work tirelessly on behalf of his country, and who would permit no toxins not even coffee to enter his body. When the Nazis seized power in 1933, seductive poisons were immediately outlawed. Some drugs, however, had their uses. A substance that could integrate shirkers, malingerers, defeatists and whiners into the labour market might even be sanctioned. Ohler describes [the methyl-amphetamine Pervitin] as National Socialism in pill form. In 1940, as plans were made to invade France through the Ardennes mountains, a stimulant decree was sent out to army doctors, recommending that soldiers take [Pervitin]. The invasion of France was made possible by the drugs. In Berlin, Hitler was [prescribed injections of] a designer opiate. He would combine it with twice daily doses of the high grade cocaine. The effect of the drugs could appear to onlookers to be little short of miraculous. One minute the Fhrer was so frail he could barely stand up. The next, he would be ranting unstoppably at Mussolini.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and the manipulation of public perception.


One striking chart shows why pharma companies are fighting legal marijuana
2016-07-13, Washington Post
Posted: 2016-07-24 22:49:36
https://www.washingtonpost.com/news/wonk/wp/2016/07/13/one-striking-chart-sho...

Painkiller abuse and overdose are lower in states with medical marijuana laws. When medical marijuana is available, pain patients are increasingly choosing pot over powerful and deadly prescription narcotics. Now a new study [provides] clear evidence of a missing link in the causal chain running from medical marijuana to falling overdoses. Researchers at the University of Georgia scoured the database of all prescription drugs paid for under Medicare Part D from 2010 to 2013. In the 17 states with a medical-marijuana law in place by 2013, prescriptions for painkillers and other classes of drugs fell sharply compared with states that did not have a medical-marijuana law. They found that, in medical-marijuana states, the average doctor prescribed 265 fewer doses of antidepressants each year, 486 fewer doses of seizure medication, 541 fewer anti-nausea doses and 562 fewer doses of anti-anxiety medication. But most strikingly, the typical physician in a medical-marijuana state prescribed 1,826 fewer doses of painkillers in a given year. Estimating the cost savings to Medicare from the decreased prescribing, [the study] found that about $165 million was saved in the 17 medical marijuana states in 2013. The estimated annual Medicare prescription savings would be nearly half a billion dollars if all 50 states were to implement similar programs.

Note: The war on drugs has been called a "trillion dollar failure", and an increasing number of deaths are caused by prescription opioid overdose in the US each year. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.


LSD-Like Drugs Are Out of the Haze and Back in the Labs
2016-05-15, New York Times
Posted: 2016-05-23 18:13:30
http://www.nytimes.com/2016/05/16/us/lsd-like-drugs-are-out-of-the-haze-and-b...

In recent years, researchers have sought to rescue hallucinogens from exile by examining their efficacy in treating certain disorders of the mind. Psychoactive substances, often derived from mushrooms, have been part of human cultures ... for thousands of years. In the 1950s and 60s, researchers assiduously explored LSD as a tool for treating mental illness and various addictions. The Central Intelligence Agency tested the drugs possibilities as a truth serum or perhaps a vehicle for mind control. Prohibitions against LSD and brethren hallucinogens, like psilocybin and mescaline, were codified in the Controlled Substances Act of 1970. Soon enough, serious scientific exploration of psychedelics dried up. In recent years, though, mind-bending drugs have begun tiptoeing back into the research mainstream. Modern scientists are ... studying hallucinogens potential to help smokers kick the habit, to undo addictions to drugs and alcohol, to cope with cluster headaches and depression, and to deal with obsessive-compulsive and post-traumatic stress disorders. Institutions where such work is underway include New York University; Johns Hopkins University; the University of California, Los Angeles; Psychiatric University Hospital in Zurich; and Imperial College in London. Hallucinogens, while not addictive, remain officially taboo everywhere. Nonetheless ... if carefully administered, [some researchers] say, hallucinogens can reorient patients perceptions of their place in the universe and pull them out of ruts of negative thinking.

Note: Watch a 13-minute New York Times video on the return of psychedelics as a powerful healing modality. While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD could make you smarter, happier and healthier.
2016-04-01, Washington Post
Posted: 2016-05-23 18:11:16
https://www.washingtonpost.com/posteverything/wp/2016/04/01/lsd-could-make-yo...

In 1970, Congress dropped psychedelics into the war on drugs. The federal government declared that the drugs had no medical use - and high potential for abuse. Over the past decade, some scientists have begun to challenge that conclusion. Far from being harmful, they found, hallucinogens can help sick people: They helped alcoholics drink less; terminal patients eased more gently into death. And its not just the infirm who are helped by the drugs. They can help us solve problems more creatively and make us more open-minded and generous. Scientists think [that] when someone takes a psychedelic, there is a decrease in blood flow and electrical activity in the brains default mode network, [which] is primarily responsible for our ego or sense of self. When we trip, our default mode network slows down. With the ego out of commission, the boundaries between self and world, subject and object dissolve. Robin Carhart-Harris, a neuroscientist with Imperial College London, notes that the default mode network is responsible for a lot of our rigid, habitual thinking and obsessions. Psychedelics help relax the part of the brain that leads us to obsess. And they can help loosen if not break the entrenched physical circuits responsible for addictive behavior. Steve Jobs famously said that taking LSD was one of the most important things in my life. The entrepreneur Tim Ferriss said that the billionaires I know, almost without exception, use hallucinogens on a regular basis.

Note: While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


Ecstasy and Acid in Your Medicine Cabinet? Doctors Explore Psychedelics
2014-10-14, Newsweek
Posted: 2016-05-23 18:08:39
http://www.newsweek.com/2014/11/07/thats-trip-scientists-discuss-merits-psych...

Psychedelics, the drugs of choice for many in the 1960s counterculture movement, may be making a comeback. Scientists, doctors and scholars who have researched the health potential of drugs such as LSD, magic mushrooms and ecstasy, gathered at the Horizons conference ... to discuss innovations in the field. Psychedelics ... went out of favor with the law in the 1960s and 1970s, [which] slammed the lid on research. Those prohibitions seem to be loosening somewhat, with some governments allowing a small amount of research with psychedelic drugs, results of which show they may carry promise for treating a wide variety of ailments, from anxiety to addiction. Some of the most significant civilizations have given an honored place to psychedelics, scholar and writer Graham Hancock told conference attendees. Hancock said hallucinogenic mushrooms played a part in cultures such as the Mayan Civilization and were depicted in European and African cave paintings as far back as 9,000 years ago. A recently completed project at New York University found that psilocybin appears to reduce anxiety and depression in terminal cancer patients. It appeared that psilocybin led many of the study participants, who were all in various stages of life-threatening cancer, to have mystical experiences that gave them great insights, improved their anxiety and generally made them more positive and loving, they and their loved ones reported. To date there have been no adverse reactions to psilocybin in any study.

Note: While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


How LSD Makes Your Brain One With The Universe
2016-04-13, NPR
Posted: 2016-04-24 23:07:34
http://www.npr.org/sections/health-shots/2016/04/13/474071268/how-lsd-makes-y...

Some users of LSD say one of the most profound parts of the experience is a deep oneness with the universe. The sensation ... correlates to changes in brain connectivity while on LSD, according to a study published Wednesday in Current Biology. An MRI scanner [showed that] the brains of people on acid looked markedly different than those on the placebo. Their sensory cortices, which process sensations like sight and touch, became far more connected than usual to the frontal parietal network, which is involved with our sense of self. "The stronger that communication, the stronger the experience of the dissolution (of self)," says Enzo Tagliazucchi, the [study's] lead author. Researchers also measured the volunteers' brain electrical activity with another device. Our brains normally generate a regular rhythm of electrical activity called the alpha rhythm, which links to our brain's ability to suppress irrelevant activity. But in a different paper published on Monday in the Proceedings of the National Academy of Sciences, he and several co-authors show that LSD weakens the alpha rhythm. He thinks this weakening could make the hallucinations seem more real. The idea is intriguing ... says Dr. Charles Grob, a psychiatrist at the Harbor-UCLA Medical Center. "They may genuinely be on to something. This should really further our understanding of the brain and consciousness." And, he says, the work highlights hallucinogens' powerful therapeutic potential.

Note: While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD's impact on the brain revealed in groundbreaking images
2016-04-11, The Guardian (One of the UK's leading newspapers)
Posted: 2016-04-18 08:29:32
https://www.theguardian.com/science/2016/apr/11/lsd-impact-brain-revealed-gro...

The profound impact of LSD on the brain has been laid bare by the first modern scans of people high on the drug. The images, taken from volunteers ... revealed that trippers experienced images through information drawn from many parts of their brains. Under the drug, regions once segregated spoke to one another. Further images showed that other brain regions that usually form a network became more separated in a change that accompanied users feelings of oneness with the world, a loss of personal identity called ego dissolution. David Nutt, the governments former drugs advisor ... and senior researcher on the study, said, This is to neuroscience what the Higgs boson was to particle physics. [Study co-author Robin] Carhart-Harris said, We saw many more areas of the brain than normal were contributing to visual processing under LSD, even though volunteers eyes were closed. The more prominent the effect, the more intense people rated their dreamlike visions. Under the influence, brain networks that deal with vision, attention, movement and hearing became far more connected. But at the same time, other networks broke down. The drug can be seen as reversing the more restricted thinking we develop from infancy to adulthood. The study could pave the way for LSD or related chemicals to be used to treat psychiatric disorders. Nutt said the drug could pull the brain out of thought patterns seen in depression and addiction through its effects on brain networks.

Note: For more, see an NPR article titled "How LSD Makes Your Brain One With The Universe". This ground-breaking study appears in the journal Proceedings of the National Academy of Sciences. While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


Top medical experts say we should decriminalize all drugs and maybe go even further
2016-03-24, Washington Post
Posted: 2016-03-27 20:38:50
https://www.washingtonpost.com/news/wonk/wp/2016/03/24/top-medical-experts-sa...

A group of 22 medical experts convened by Johns Hopkins University and The Lancet have called today for the decriminalization of all nonviolent drug use and possession. The experts further encourage countries and U.S. states to "move gradually toward regulated drug markets and apply the scientific method to their assessment." Their report comes ahead of a special UN General Assembly Session on drugs to be held next month. In a lengthy review of the state of global drug policy, the Hopkins-Lancet experts conclude that the prohibitionist anti-drug policies of the past 50 years "directly and indirectly contribute to lethal violence, disease, discrimination, forced displacement, injustice and the undermining of peoples right to health. "The goal of prohibiting all use, possession, production and trafficking of illicit drugs is the basis of many of our national drug laws, but these policies are based on ideas about drug use and drug dependence that are not scientifically grounded," said Commissioner Dr. Chris Beyrer. "The idea that all drug use is necessarily 'abuse' means that immediate and complete abstinence has been seen as the only acceptable approach," commissioner Adeeba Kamarulzaman ... said. But, she added, "continued criminalization of drug use fuels HIV, hepatitis C and tuberculosis transmission within prisons and the community at large. There is another way. Programmes and policies aimed at reducing harm should be central to future drug policies."

Note: While the war on drugs has been called a "trillion dollar failure", and the healing potentials of mind altering drugs are starting to be investigated more openly, there remains powerful evidence that the CIA and US military are directly involved in the drug trade.


War on drugs harmed public health: report
2016-03-24, CBC (Canada's public broadcasting system)
Posted: 2016-03-27 20:37:05
http://www.cbc.ca/news/health/drug-war-public-health-1.3504843

The war on drugs has failed, fuelling higher rates of infection and harming public health and human rights to such a degree that it's time to decriminalize non-violent minor drug offences, according to a new global report. The authors of the Johns Hopkins-Lancet Commission on Public Health and International Drug Policy call for minor use, possession and petty use to be decriminalized following measurably worsened human health. "We've had three decades of the war on drugs, we've had decades of zero-tolerance policy," said Dr. Chris Beyrer, a professor of infectious disease epidemiology at Johns Hopkins Bloomberg School of Public Health in Baltimore and the senior author of the report published Thursday in The Lancet. "It has had no measurable impact on supply or use, and so as a policy to control substance use it has arguably failed. It has evidently failed." Given that the goal of prohibiting all use, possession, production and trafficking of illicit drugs was to protect societies, the researchers evaluated the health effects and found they were overwhelmingly negative. For a role model, the authors point to Portugal, which decriminalized not only cannabis but also possession of heroin, cocaine and methamphetamine. HIV transmission, hepatitis C and incarcerations all decreased, Beyrer said, and there was about a 15 per cent decline in substance use by young people in Portugal.

Note: While the war on drugs has been called a "trillion dollar failure", and the healing potentials of mind altering drugs are starting to be investigated more openly, there remains powerful evidence that the CIA and US military are directly involved in the drug trade.


Patients Legally Take Ecstasy While Receiving Therapy In Marin County
2016-02-26, KPIX TV (CBS San Francisco affiliate)
Posted: 2016-03-14 19:16:32
http://sanfrancisco.cbslocal.com/2016/02/26/patients-legally-take-ecstasy-whi...

Decades after the U.S. Federal Government banned the drug ecstasy which in turn went underground, gaining notoriety as a party drug a Bay Area medical team got special permission to study its therapeutic use. The goal of the trial is to see whether a pure dose of the compound MDMA, also known as ecstasy, can be pure medicine: could it ease the crippling anxiety, fear, or depression felt by those suffering from a life-threatening disease? The lead investigator for this study is psychiatrist Phil Wolfson. The medical doctor has permission from the U.S. FDA to conduct the study, and legally administer the drug. The FDA approved so the DEA had to follow suit, explained Wolfson. Before the DEA declared MDMA illegal in 1985, Doctor Wolfson used it medicinally in his own practice and saw a tremendous benefit for patients. In the study, MDMA is not used alone. The use of the compound is combined with psychotherapy sessions that can last five hours or longer. Its not this 50 minutes in and out, its these extended periods of real interactive exchange, explained [study participant Andy] Gold. With the MDMA, everything opened up, recalled [study participant Wendy] Donner. You start seeing things very, very clearly and at a nice slow pace, truths in your life are bubbling up. And revealed to you piece by piece, explained [study participant John] Saul. The participants all say theyve changed and are better able to face the future. Wolfson hopes the drug may one day be available to other patients as a legally accepted remedy.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.


Mind-Altering Drugs Could Cure PTSD
2015-12-22, Popular Science
Posted: 2016-01-17 15:44:27
http://www.popsci.com/mind-altering-drugs-can-cure-ptsd

About 8 percent of Americans experience PTSD; for veterans, that number is 30 percent. Treatment is notoriously difficult, but people could find relief in an unusual form: psychedelic drugs. MDMA - found in molly and ecstasy - earned a bad rap in the 1990s as ravers drug of choice. But psychotherapists are coming to value the way it increases empathy while decreasing fear and defensiveness. MDMA gives people the ability to revisit an event thats still painful without being overwhelmed, says psychiatrist Michael Mithoefer. Following a recent MDMA trial, 83 percent of his treatment-resistant participants no longer showed symptoms of PTSD. In one study, Mithoefer worked with a New York City firefighter post-9/11. The subject had tried treatment before. While undergoing a popular method that uses eye movement to reprocess a trauma, hed been so overcome that he ripped a sink off the wall. MDMA, however, worked. It wasnt easy for him, Mithoefer says. But our sink is still attached. MDMA isnt a one-trick pony either; it can treat end-of-life anxiety and alcoholism, and its not addictive. Were talking about the rise of a whole field of medicine, says Rick Doblin, founder of the nonprofit Multidisciplinary Association for Psychedelic Studies, which is running a handful of MDMA trials, including Mithoefers. Doblin thinks the FDA will greenlight the drug for mainstream use by 2021.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.


Psychedelic drugs may be ready for a medical comeback
2015-09-08, Los Angeles Times
Posted: 2015-09-27 18:31:13
http://www.latimes.com/science/sciencenow/la-sci-sn-psychedelic-drugs-medical...

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal. For several decades, the North American medical establishment has classified psychedelic drugs – including LSD, psilocybin and [MDMA, better known as ecstasy] – as drugs of abuse with little to no medical purpose or means of safe use. That, four researchers argue, is changing. In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness. Clinical investigators are demonstrating that such research "can conform to the rigorous scientific, ethical and safety standards expected of contemporary medical research," the authors write in the new analysis, titled "Psychedelic medicine: a re-emerging therapeutic paradigm." And the body of research they are generating is demonstrating that such drugs as MDMA, LSD and psilocybin can be effective in treating well-chosen patients. Two other factors - cost and time - also appear to be opening minds about the potential therapeutic uses of psychedelic drugs.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Psychedelics Promise a Paradigm Shift in Treating Mental Illness
2015-09-08, Newsweek
Posted: 2015-09-27 18:29:36
http://www.newsweek.com/psychedelics-promise-paradigm-shift-treating-mental-i...

In the 1950s through the early 70s, research began to show that psychedelics like LSD and psilocybin, the active ingredient in magic mushrooms, could be quite effective at treating mental health disorders like addiction. Then ... the so-called war on drugs began. For nearly a generation, science on these substances shut down. But thats changing. In the past 20 years or so, a small amount of research has once again begun to focus on these chemicals, showing that they have promise for treating a range of conditions, from addiction to depression and anxiety, says Evan Wood, a psychiatric researcher at the University of British Columbia. In 2006, researchers at the University of Arizona published a study showing obsessive-compulsive patients who ingested psilocybin had immediate and lasting reductions in problematic symptoms. The same year, Johns Hopkins University physician and researcher Roland Griffiths showed that in healthy volunteers, psilocybin produced lasting benefits like improved mood and peacefulness six months after ingestion. Similar work has shown psilocybin can help treat anxiety associated with cancer, at UCLA and New York University. And a study in late 2014 found that LSD permanently reduced anxiety in a small number of patients. Wood says hes most excited about research into using psychedelics to treat addiction. He published a review on September 8 in the Canadian Medical Association Journal covering recent work in this field.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Congress quietly ends federal government's ban on medical marijuana
2014-12-16, Los Angeles Times
Posted: 2015-08-23 20:48:36
http://www.latimes.com/nation/la-na-medical-pot-20141216-story.html

Tucked deep inside the 1,603-page federal spending measure is a provision that effectively ends the federal government's prohibition on medical marijuana and signals a major shift in drug policy. The bill's passage ... marks the first time Congress has approved nationally significant legislation backed by legalization advocates. It brings almost to a close two decades of tension between the states and Washington over medical use of marijuana. Under the provision, states where medical pot is legal would no longer need to worry about federal drug agents raiding retail operations. Agents would be prohibited from doing so. Congress for years had resisted calls to allow states to chart their own path on pot. The marijuana measure, which forbids the federal government from using any of its resources to impede state medical marijuana laws, was previously rejected half a dozen times. Even as Congress has shifted ground on medical marijuana, lawmakers remain uneasy about full legalization. Marijuana proponents nonetheless said they felt more confident than ever that Congress was drifting toward their point of view. Approval of the pot measure comes after the Obama administration directed federal prosecutors last year to stop enforcing drug laws that contradict state marijuana policies.

Note: The war on drugs has been called a "trillion dollar failure". The healing potentials of mind altering drugs are starting to be openly investigated.


Could Pot Help Veterans With PTSD?
2015-08-02, Newsweek
Posted: 2015-08-16 23:31:01
http://www.newsweek.com/pot-and-ptsd-358139

Marijuana and the Veterans Affairs Hospital systems relationship is complicated. On the one hand, 23 states plus the District of Columbia say marijuana is legal for sanctioned medical use, and veterans are clamoring for it for their post-combat symptoms. On the other, marijuana is classified a Schedule I drug. Veterans [have] been stuck in the middle. As many as 20 percent of veterans from Iraq and Afghanistan suffer from post-traumatic stress disorder. Antidepressants like Zoloft and Paxil, along with other heavy-duty pills, have been the traditional mainstays in VA doctors arsenals. Non-FDA approved options, marijuana among them, havent been options at all. But that has started to change. The Veterans Equal Access Act ... aims to open the entire VA system to judicious prescription of medical cannabis. Prior to its introduction, VA doctors couldnt even discuss cannabis with their patients, much less prescribe it. Arizona psychiatrist Sue Sisley [has] spent two decades treating patients with PTSD. All we have now is Zoloft and Paxil. And if you know much about those meds, you know there are many side effects, and they often dont work. If they are effective, then patients are dealing with these side effects, Sisley adds. Vets come home from service, and they just want to reintegrate into their family. And we make them fat and impotent and mired in a bunch of disabling side effects. When asked why marijuana might be better than other options, Sisleys quick to answer: A single plant can provide monotherapy for this whole constellation of symptoms.

Note: The war on drugs has been called a "trillion dollar failure". The healing potentials of mind altering drugs are starting to be openly investigated.


The Likely Cause of Addiction Has Been Discovered, and It Is Not What You Think
2015-01-20, Huffington Post
Posted: 2015-07-26 17:05:12
http://www.huffingtonpost.com/johann-hari/the-real-cause-of-addicti_b_6506936...

It is now one hundred years since drugs were first banned. Through this long century of waging war on drugs, we have been told a story about addiction by our teachers and by our governments. Almost everything we have been told about addiction is wrong. Nearly fifteen years ago, Portugal had one of the worst drug problems in Europe, with 1 percent of the population addicted to heroin. They had tried a drug war, and the problem just kept getting worse. So they decided to do something radically different. They resolved to decriminalize all drugs, and transfer all the money they used to spend on arresting and jailing drug addicts, and spend it instead on reconnecting them - to their own feelings, and to the wider society ... so they have a purpose in life, and something to get out of bed for. They are helped, in warm and welcoming clinics, to learn how to reconnect with their feelings, after years of trauma and stunning them into silence with drugs. The results of all this are now in. An independent study by the British Journal of Criminology found that since total decriminalization, addiction has fallen, and injecting drug use is down by 50 percent. For too long, we have talked exclusively about individual recovery from addiction. We need now to talk about social recovery - how we all recover, together, from the sickness of isolation. But this new evidence isn't just a challenge to us politically. It doesn't just force us to change our minds. It forces us to change our hearts.

Note: The above was written by Johann Hari, bestselling author of Chasing The Scream: The First and Last Days of the War on Drugs. Read more about Portugal's stunning success in curbing drug addiction by ending its drug war and cultivating human connection. For more, read about how the science behind the bonding theory of addiction has been suppressed since the 1970's by drug war profiteers.


How Medical Marijuanas Chemicals May Protect Cells
2015-01-20, Scientific American
Posted: 2015-07-26 17:02:28
http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-m...

Edward Maa did not plan to become a marijuana researcher. But a few years ago, when the neurologist and epilepsy specialist surveyed his patients about their use of alternative medicines, he discovered that more than a third had turned to marijuana to try to control their seizures. According to the Epilepsy Foundation of Colorado, the widely reported case of Charlotte Figi, a child whose nearly constant seizures were dramatically curtailed with cannabidiol, a marijuana ingredient, has helped trigger an influx of families from around the U.S. [into Colorado] seeking similar treatment for their children with seizure disorders. Maa wants to move beyond anecdote and into data. He is monitoring 150 epilepsy patients who all take a product derived from the same strain of marijuana that Figi used, provided by the same source. Although the federal government still lists marijuana as a Schedule I drug, a class with no currently accepted medical use, a body of recent research suggests that cannabinoids, which are the active ingredients in marijuana, may have medicinal uses even beyond the approved ones. They might protect the brain from the effects of trauma, ease the spasms of multiple sclerosis and reduce epileptic seizures. Further preliminary work indicates that the chemicals may slow the growth of tumors and reduce brain damage in Alzheimer's disease. Before World War II, marijuana was listed as a medicine in the country's encyclopedia of drugs, the United States Pharmacopeia.

Note: Read a summary of a CNN News story that describes how marijuana helped stem the seizures of 6 year old Jayden. Colorado has become the first U.S. state to directly fund medical marijuana research.


The War on Drugs: 'A Trillion-Dollar Failure'
2015-06-25, Rolling Stone
Posted: 2015-07-03 22:33:53
http://www.rollingstone.com/culture/features/the-war-on-drugs-a-trillion-doll...

Don Winslow['s book] The Cartel, a sequel to 2005's The Power of the Dog [is] a sort of Game of Thrones of the Mexican drug wars, a multipart, intricately plotted, blood-soaked epic that tells the story of how America's unquenchable appetite for illegal drugs has brought chaos to our southern neighbors and darkened our own political and criminal culture. Dog ... traces the rise of the narcotraficantes who split Mexico into territories and smuggled cocaine across the U.S. border by the ton. The violence ... spills out into Mexican society, turning cities like Juarez into Fallujah-like battle zones. But the most shocking thing about these books is that almost all the horror stories Winslow tells ... are largely true – from the narcotrafficker who threw children off a bridge to ... countless murders, kidnappings and tortures. The War on Drugs is a trillion-dollar failure. We spend billions of dollars pursuing drugs and billions imprisoning people that probably shouldn't be in prison. This war has killed a hundred thousand people in Mexico. These ISIS beheadings that we're seeing [are] a direct copy of what the cartels were doing in 2007 and 2008. The Zetas had imported Special Forces veterans from the Guatemalan army – and one of their things was to cut off heads. [There's] a direct line between events in Ferguson and Baltimore and Cleveland to the War on Drugs. The fruits that we're reaping now are seeds that were planted back in 1971, when Nixon declared war on drugs. The War on Drugs is more of a problem to the United States than drugs are.

Note: For more along these lines, see concise summaries of deeply revealing news articles on drugs from reliable major media sources on little-known facts about mind-altering drugs. Then explore the excellent, reliable resources provided in our War Information Center.


Ayahuasca Psychedelic Tested for Depression
2015-04-08, Scientific American
Posted: 2015-04-12 19:43:02
http://www.scientificamerican.com/article/ayahuasca-psychedelic-tested-for-de...

A psychedelic drink used for centuries in healing ceremonies is now attracting the attention of biomedical scientists as a possible treatment for depression. Researchers from Brazil last month published results from the first clinical test of a potential therapeutic benefit for ayahuasca, a South American plant-based brew. The work forms part of a renaissance in studying the potential therapeutic benefits of psychedelic or recreational drugs research that was largely banned or restricted worldwide half a century ago. Ketamine, which is used medically as an anaesthetic, has shown promise as a fast-acting antidepressant; psilocybin, a hallucinogen found in magic mushrooms, can help to alleviate anxiety in patients with advanced-stage cancer; MDMA (ecstasy) can alleviate post-traumatic stress disorder; and patients who experience debilitating cluster headaches have reported that LSD eases their symptoms. Ayahuasca, a sacramental drink traditionally brewed from the bark of a jungle vine (Banisteriopsis caapi) and the leaves of a shrub (Psychotria viridis) ... has been studied by anthropologists, social scientists and theologians, but clinical research on ayahuasca has been limited to observation of its effects in mice and rats, and in healthy human volunteers, including brain-imaging studies and retrospective surveys of past use. Further trials are under way.

Note: Are the healing potentials of mind altering drugs finally starting to receive honest mainstream attention?


This is your brain on LSD? Scientists want to find out
2015-03-06, CBS News
Posted: 2015-03-23 15:53:55
http://www.cbsnews.com/news/lsd-scientists-crowdfunding-research-on-psychedel...

A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) needed to complete the first scientific study ever to image the brains of people "tripping" on the psychedelic drug LSD. Led by neuroscientists at Imperial College London, the study seeks to use MRI and MEG imaging to show how LSD affects brain processes. It is part of a research project that the scientists say could revolutionize the understanding of the human brain. Researchers hope the images will begin to reveal the way the drug could work to heal many debilitating conditions such as obsessive compulsive disorder, alcohol addiction, depression and anxiety. The public's response to the crowdfunding appeal was overwhelming. Within the first 24 hours after its request was posted online, the Beckley Foundation/Imperial College [exceeded] its goal. "We went into it tenuously and have been delighted by the response," said [Beckley Foundation Psychedelic Research Foundation director Amanda] Fielding. "It's an incredibly important area. LSD is something that can expand certain areas of the human personality: openness, spirituality, and creativity. Fielding's team is working hard to provide substantial scientific research to help eliminate the taboo of LSD and other hallucinogenic substances and loosen regulations on scientific testing. "There are many millions of people who have experienced the benefits of psychedelics, and there are millions of people who are suffering with illnesses that want to see if these drugs can help," said Fielding.

Note: It took just 24 hours for the public to fund this study directly. Are the healing potentials of mind altering drugs finally starting to receive honest mainstream attention?


The '60s Are Gone, But Psychedelic Research Trip Continues
2014-03-09, NPR
Posted: 2015-03-02 11:32:55
http://www.npr.org/2014/03/09/288285764/the-60s-are-gone-but-psychedelic-rese...

Psychedelic drug research is coming back. But the research still faces stigma, and funding is hard to get. Stanislav Grof was one of the leading researchers on the therapeutic applications of LSD in the 1950s and '60s. He studied the effect of hallucinogens on mental disorders, including addiction. Grof tells NPR's Arun Rath, "This was a tremendous deepening and acceleration of the psychotherapeutic process. Compared with the therapy in general, which mostly focuses on suppression of symptoms, here we had something that could actually get to the core of the problems." The Schedule 1 classification of LSD and other hallucinogenic substances in 1970 was a huge blow to research. But by the '90s, attitudes had begun to change. By the 2000s, a small but growing research community was picking up where Grof and others had left off. One area that showed promise was using hallucinogens to ease anxiety and depression in patients with cancer, like Erica Rex. "I was diagnosed with breast cancer, stage 2, in 2009," Rex says. "I went through the treatment, and then there are some drugs that have terrible side effects." She says she became obsessed with the possibility of her death, and it was crippling. Then Rex [was approved] for a study on the experimental drug psilocybin, an active compound in psychedelic mushrooms. In the end, she says, it helped her depression.

Note: Food justice champion Michael Pollan recently wrote a fascinating article prominently featured in the venerable magazine The New Yorker about the amazing power of psilocybin mushrooms to create profound healing in carefully controlled environments. It is subtitled "Research into psychedelics, shut down for decades, is now yielding exciting results." Are the healing potentials of mind altering drugs finally starting to receive honest mainstream attention?


When Silicon Valley takes LSD
2015-01-25, CNN
Posted: 2015-02-23 15:27:03
http://money.cnn.com/2015/01/25/technology/lsd-psychedelics-silicon-valley

In Silicon Valley, there is a premium on creativity, and tools thought to induce or enhance it are avidly sought. Some view psychedelics as ... a way to approach problems differently. There's no definitive scientific evidence that LSD or other hallucinogens improve creativity, and the DEA classifies LSD as a highly addictive, Schedule I drug. But the belief that they might work as a creative tool is enough to fuel some technologists' hope for professional epiphanies. Tim Ferriss, a Silicon Valley investor and author of "The 4-Hour Workweek," says he knows many successful entrepreneurs who dabble in psychedelics. "The billionaires I know, almost without exception, use hallucinogens on a regular basis," Ferriss said. "[They're] trying to be very disruptive and look at the problems in the world ... and ask completely new questions." The phenomenon was satirized on HBO's Silicon Valley when psychedelic mushrooms guide one of the show's main characters in the hunt for a new name for their startup. A recent study at Imperial College London provides a possible explanation. Twenty participants ingested LSD and then had their brain activity monitored in an fMRI machine. The drug [allowed] new patterns of communication to form. "Psychedelics dismantle 'well-worn' networks, and this allows novel communication patterns to occur. Modules that don't usually talk to each other are talking to each other more," explained Dr. Robin Carhart-Harris, the researcher who conducted the study.

Note: Food justice champion Michael Pollan recently wrote a fascinating article prominently featured in the venerable magazine The New Yorker about the amazing power of psilocybin mushrooms to create profound healing in carefully controlled environments. It is subtitled "Research into psychedelics, shut down for decades, is now yielding exciting results." Are the healing potentials of mind altering drugs finally starting to receive honest mainstream attention?


Special K, a Hallucinogen, Raises Hopes and Concerns as a Treatment for Depression
2014-12-09, New York Times
Posted: 2015-01-04 21:46:37
http://www.nytimes.com/2014/12/10/business/special-k-a-hallucinogen-raises-ho...

While [Ketamine] has been used as an anesthetic for decades, small studies at prestigious medical centers like Yale, Mount Sinai and the National Institute of Mental Health suggest it can relieve depression in many people who are not helped by widely used conventional antidepressants like Prozac or Lexapro. And the depression seems to melt away within hours, rather than the weeks typically required for a conventional antidepressant. Pharmaceutical companies hope to [develop] drugs that work like ketamine but without the side effects, which are often described as out-of-body experiences. Some doctors and patients are not waiting for the pharmaceutical industry. Because ketamine has long been approved for anesthesia, doctors are allowed to use it off-label to treat depression. There is clearly a need for new drugs. Almost half of depressed patients are not being treated adequately by existing drugs, said Dr. Sheldon H. Preskorn, a professor of psychiatry at the University of Kansas School of Medicine-Wichita. That, he said, is because virtually all the antidepressants used in the last 60 years work essentially the same way. Ketamine would represent a new mechanism of action. Synaptic connections that help us to cope seem to grow back, said Dr. John H. Krystal, chairman of psychiatry at Yale and a pioneer in the study of ketamine for depression.

Note: A 2012 NPR story provides more detail about the ketamine research done at Yale to treat depression. Could this put a stop to the thousands of horror stories involving conventional antidepressants?


Colorado Funds Medical Marijuana Research, a First
2014-12-17, New York Times
Posted: 2015-01-04 21:44:13
http://www.nytimes.com/aponline/2014/12/17/us/ap-us-marijuana-research.html?_r=0

Colorado will spend more than $8 million researching marijuana's medical potential. The grants awarded by the Colorado Board of Health will go to studies on whether marijuana helps treat epilepsy, brain tumors, Parkinson's disease and post-traumatic stress disorder. Some of the studies still need federal approval. Though the awards are relatively small, researchers say they're a big step forward. While several other federal studies currently in the works look at marijuana's health effects, all the Colorado studies are focused on whether marijuana actually helps. "This is the first time we've had government money to look at the efficacy of marijuana, not the harms of marijuana," said Dr. Suzanne Sisley, a Scottsdale, Arizona, psychiatrist who will help run a study on marijuana for veterans with PTSD. Federal approval to study marijuana's medical potential requires permission of the Food and Drug Administration, the Drug Enforcement Administration, and either the National Institutes of Health or the Department of Health and Human Services. Twenty-three states and Washington, D.C., allow marijuana use by people with various medical conditions. But under federal law, pot is considered a drug with no medical use and doctors cannot prescribe it. Dr. Larry Wolk, Colorado's Chief Medical Officer, says the lack of research on marijuana's medical value leaves sick people guessing about how pot may help them and what doses to take.

Note: For more on the proven benefits from many mind-altering drugs, see these deeply revealing reports from reliable major media sources.


How 'magic mushroom' chemical could free the mind of depression, addictions
2014-09-17, CNN
Posted: 2014-12-07 23:04:25
http://www.cnn.com/2014/09/17/health/magic-mushroom-chemical-depression

"People try and run away from things and to forget, but with psychedelic drugs they're forced to confront and really look at themselves," explains Dr Robin Carhart-Harris, from Imperial College London. The drugs Carhart-Harris is referring to are hallucinogens such as magic mushrooms -- specifically the active chemical inside them, psilocybin. Carhart-Harris scanned the brains of 30 healthy volunteers after they had been injected with psilocybin and found the more primitive regions of the brain associated with emotional thinking became more active and the brain's "default mode network," associated with high-level thinking, self-consciousness and introspection, was disjointed and less active. "We know that a number of mental illnesses, such as OCD and depression, are associated with excessive connectivity of the brain, and the default mode network becomes over-connected," says David Nutt, professor of neuropsychopharmacology, who leads the Imperial College team. The over-connectivity Nutt describes causes depressed people to become locked into rumination and concentrate excessively on negative thoughts about themselves. Depression is estimated to affect more than 350 million people around the world. The current pharmaceutical approach to treatment is with selective serotonin re-uptake inhibitors (SSRIs), such as Prozac. But SSRIs ... are generally prescribed for long periods of time to maintain their effect. Nutt thinks psilocybin could be a game-changer, used as part of a therapeutic package ... to treat people within just one or two doses of treatment.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Could this be the next medicinal marijuana?
2014-10-31, CNN News
Posted: 2014-11-16 21:33:42
http://www.cnn.com/2014/10/22/health/ayahuasca-medicine-six-things

Imagine discovering a plant that has the potential to help alleviate post-traumatic stress disorder, suicidal thoughts and paralyzing anxiety. That's what some believe ayahuasca can do, and this psychedelic drink is attracting more and more tourists to the Amazon. War vets are seeking it for PTSD. Former Marine Lance Cpl. Ryan LeCompte organizes trips to Peru for war veterans, like himself, who are seeking ayahuasca as a possible treatment for PTSD and other emotional and mental trauma suffered after multiple combat deployments. "Ayahuasca is a way to give relief to those who are suffering," says LeCompte, who says many veterans are not satisfied with the PTSD treatment they receive when they return from combat. Libby ... is one of the veterans who accompanied LeCompte to Peru to try ayahuasca for her PTSD diagnosis, which includes sexual trauma while on active duty. She says antidepressants made her more suicidal. "I would like to wish not to die all the time," she said, when asked why she was seeking ayahuasca. "I want that to go away." Those of have tried ayahuasca say that any benefits - like with other drugs or medicine - must be combined with therapy. There are efforts to study the medicinal benefits of ayahuasca, explains Rick Doblin, executive director of the Multidisciplinary Association of Psychedelic Studies. "At a time when drug policy is being reevaluated ... how ayahuasca should be handled in a regulatory context is really up in the air," Doblin said.

Note: Watch the full CNN documentary on an ayahuasca ceremony in Peru. For more along these lines, see these concise summaries of deeply revealing news articles about mind altering drugs from reliable sources.


Controversial Drugs Get Another Look
2014-09-14, CNN
Posted: 2014-10-27 20:46:50
http://transcripts.cnn.com/TRANSCRIPTS/1409/13/hcsg.01.html

Dr Sanjay Gupta: There's a group of outlawed drugs out there that are generating new interest among a growing number of doctors. Some of these drugs include things like MDMA also known as ecstasy, also LSD. Psychiatrists have (long) been fascinated by the properties of psychedelics. The U.S. military's efforts in the 1950s ... tested LSD as a potential weapon. But the interests in these drugs didn't stay in the lab. They trickled on to the black market and were soon outlawed. The pattern repeated itself with MDMA. Therapists tried it with patients. Millions tried it on their own. And in 1985, it was banned under federal law. Over the last decade, a small band of researchers wrangled permission to try again. This time giving MDMA during therapy sessions with patients who were suffering post-traumatic stress. DR. MICHAEL MITHOEFER, TESTING MDMA AS TREATMENT FOR PTSD PATIENTS: It was revisiting the trauma that was painful. The MDMA seemed to make it possible for them to do it effectively. GUPTA: Dr. Mithoefer has treated nearly 50 patients. He's currently working with veterans. RICK DOBLIN, MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES: People are able to look at traumatic memories, the fear is reduced, and then they're able to separate out it was happening then and not now. GUPTA: So, if they're going through counselling, for example, it could make that counselling more effective, they're not as paralyzed if you will by the memories that are being brought up? DOBLIN: We're saying that MDMA itself is not the medicine, it's MDMA assisted psychotherapy.

Note: Watch this CNN news clip and decide for yourself. For more about how the CIA secretly experimented on people with LSD and other drugs, read this deeply revealing information about a project called MK ULTRA. For more about the legitimate therapeutic uses of these drugs, and how investigation into these is suppressed, see these concise summaries of deeply revealing news articles from reliable sources.


'Absurd' drug laws 'hinder research' - Prof David Nutt
2013-04-06, BBC News
Posted: 2014-10-08 20:43:23
http://www.bbc.com/news/health-22042994

'Absurd' laws dealing with magic mushrooms, ecstasy and cannabis are hindering medical research, according to a former government drugs adviser. Prof David Nutt says he has funding to research the use of the chemical psilocybin - found in fungi known as "magic mushrooms" to treat depression. But he says "insane" regulations mean he cannot get hold of the drug. The Home Office said there was "no evidence" that regulations were a barrier to research. It is not the first time Prof Nutt has been at odds with government policy. He was sacked as an adviser over views that ecstasy and LSD were less harmful than alcohol. Earlier research at Imperial College London showed that injections of psilocybin could calm a region of the brain which is overactive in depression. The UK's Medical Research Council has given the lab a 550,000 grant to test the idea - in 30 patients who have not responded to at least two other therapies. They have also been given ethical approval. However, there are more stringent regulations for testing the drug as a treatment than in earlier experiments. As a potential medicine it must meet Good Manufacturing Practice requirements set out by the EU. "It hasn't started yet because the big problem is getting hold of the drug," said Prof Nutt. He said finding a company to provide a clinical-grade psilocybin had "yet proved impossible" as none was prepared to "go through the regulatory hoops". He told the BBC: "We have regulations which are 50 years old, have never been reviewed and they are holding us back, they're stopping us doing the science and I think it's a disgrace actually."

Note: Watch an informative three-minute BBC news clip of an interview with Prof. Nutt. Another good five-minute BBC interview is available here. For more on this, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources. See also the website of MAPS, and excellent organization supporting scientific study of the healing powers of these drugs.


A brief history of psychedelic psychiatry
2014-09-02, The Guardian (One of the UK's leading newspapers)
Posted: 2014-09-23 19:25:53
http://www.theguardian.com/science/neurophilosophy/2014/sep/02/psychedelic-ps...

On 5th May, 1953, the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley took the drug in his California home under the direct supervision of psychiatrist Humphry Osmond, to whom Huxley had volunteered himself as a willing and eager guinea pig. Osmond was one of a small group of psychiatrists who pioneered the use of LSD as a treatment for alcoholism and various mental disorders in the early 1950s. He coined the term psychedelic, meaning mind manifesting and although his research into the therapeutic potential of LSD produced promising initial results, it was halted during the 1960s for social and political reasons. While at St. Georges [Hospital after WWII], Osmond and his colleague John Smythies learned about Albert Hoffmans discovery of LSD at the Sandoz Pharmaceutical Company in Bazel, Switzerland. Osmond and Smythies started their own investigation into the properties of hallucinogens. Osmond tried LSD himself and concluded that the drug could produce profound changes in consciousness. Osmond and [Abram] Hoffer also recruited volunteers to take LSD and theorised that the drug was capable of inducing a new level of self-awareness which may have enormous therapeutic potential. In 1953, they began giving LSD to their patients, starting with some of those diagnosed with alcoholism. Their first study involved two alcoholic patients, each of whom was given a single 200-microgram dose of the drug. One of them stopped drinking immediately after the experiment. The other stopped 6 months later. Osmond and Hoffer were encouraged, and continued to administer the drug to alcoholics. Their studies seemed to show that a single, large dose of LSD could be an effective treatment for alcoholism, and reported that between 40 and 45% of their patients given the drug had not experienced a relapse after a year.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


Book review: Acid Test, on psychedelic drug therapy for PTSD
2014-09-11, Washington Post
Posted: 2014-09-23 19:24:03
http://www.washingtonpost.com/opinions/book-review-acid-test-on-lsd-as-therap...

LSD, ecstasy (MDMA) and other psychedelics are powerful, mind-altering drugs that, as described by former Washington Post Magazine editor Tom Shroder, intrinsically [challenge] the rationalist, materialist underpinnings of Western culture. For most of a century, our society has struggled to come to grips with these profoundly threatening drugs, largely without success. Theyve all been made illegal. For decades, the Food and Drug Administration and the Drug Enforcement Administration have strictly banned scientific investigations into their potential benefits which is unfortunate, since these psychoactive drugs also seem able to do incredible good, particularly in the treatment of post-traumatic stress disorder (PTSD). Every year, as many as 5 million Americans suffer from its effects. Frequent consequences include depression, drug and alcohol abuse, and a host of associated health problems. In both humanitarian and economic terms, the costs are staggering. And PTSD stubbornly resists treatment. Psychoactive drugs such as LSD and MDMA seem to bring powerful healing energies to bear on the underlying issues. But despite a growing mountain of evidence supporting the therapeutic benefits delivered by these drugs, government authorities have blocked scientific and therapeutic explorations of their potential. Fortunately, the governments prohibitions may be loosening, thanks to a cadre of psychedelic advocates who have steadfastly refused to surrender to the taboos. The story of those people and their efforts to win scientific and therapeutic approval for psychedelic drugs is the central thrust of Shroders strangely wonderful new book, Acid Test: LSD, Ecstasy, and the Power to Heal.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


Prescription painkiller deaths fall in medical marijuana states
2014-08-25, Chicago Tribune/Reuters
Posted: 2014-09-15 07:04:08
http://www.chicagotribune.com/sns-rt-us-medical-marijuana-deaths-20140825-sto...

Researchers aren't sure why, but in the 23 U.S. states where medical marijuana has been legalized, deaths from opioid overdoses have decreased by almost 25 percent, according to a new analysis. "Most of the discussion on medical marijuana has been about its effect on individuals in terms of reducing pain or other symptoms," said lead author Dr. Marcus Bachhuber. "The unique contribution of our study is the finding that medical marijuana laws and policies may have a broader impact on public health." California, Oregon and Washington first legalized medical marijuana before 1999, with 10 more following suit between then and 2010, the time period of the analysis. Another 10 states and Washington, D.C. adopted similar laws since 2010. For the study, Bachhuber, of the Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania, and his colleagues used state-level death certificate data for all 50 states between 1999 and 2010. In states with a medical marijuana law, overdose deaths from opioids like morphine, oxycodone and heroin decreased by an average of 20 percent after one year, 25 percent by two years and up to 33 percent by years five and six compared to what would have been expected, according to results in JAMA Internal Medicine. Meanwhile, opioid overdose deaths across the country increased dramatically, from 4,030 in 1999 to 16,651 in 2010, according to the Centers for Disease Control and Prevention (CDC). Three of every four of those deaths involved prescription pain medications.

Note: For more on this, see concise summaries of deeply revealing mind-altering drug news articles from reliable major media sources.


Dr Robin Carhart-Harris is the first scientist in over 40 years to test LSD on humans
2014-08-17, The Independent (One of the UK's leading newspapers)
Posted: 2014-08-25 07:48:08
http://www.independent.co.uk/news/people/dr-robin-carhartharris-is-the-first-...

Dr Robin Carhart-Harris, a research associate in the Centre for Neuropsychopharma-cology at Imperial College, is ... the first person in the UK to have legally administered doses of lysergic acid diethylamide (LSD) to human volunteers since the Misuse of Drugs Act of 1971. Born in Durham 33 years ago and raised in Bournemouth, he ... is a careful and articulate speaker, but his enthusiasm for his work is evident. "We're at an early, but certainly promising, stage. It's really exciting," he says. The potential scientific benefits of psychedelics ... fall broadly into two categories. They look like being medicinally or therapeutically useful, and they offer an unconventional view of the workings of the human mind, such that the age-old, so-called "hard problem of consciousness" might be made a little easier. Uniquely potent in minute doses, and with what Carhart-Harris calls "a very favourable physiological safety profile" which is to say, it is non-toxic this newly synthesised psychedelic drug opened new doors, in more ways than one. "You could say the birth of the science of psychedelics occurred with the discovery of LSD," says Carhart-Harris. "It was only then that we started to study them systematically." Cary Grant famously used it during his therapy, as did the Alcoholics Anonymous co-founder Bill Wilson. Between the 1950s and 1965, when Sandoz withdrew the drug, there were more than 1,000 clinical papers discussing 40,000 patients. A 2012 meta-analysis of six controlled trials from the era found its clinical efficiency for the treatment of alcohol addiction to be as effective as any treatment developed since.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Medical Marijuana Research Hits Wall of U.S. Law
2014-08-10, New York Times
Posted: 2014-08-18 07:33:17
http://www.nytimes.com/2014/08/10/us/politics/medical-marijuana-research-hits...

[There are many] obstacles and frustrations scientists face in trying to study the medical uses of marijuana. Dating back to 1999, the Department of Health and Human Services has indicated it does not see much potential for developing marijuana in smoked form into an approved prescription drug. In guidelines issued that year for research on medical marijuana, the agency quoted from an accompanying report that stated, If there is any future for marijuana as a medicine, it lies in its isolated components, the cannabinoids and their synthetic derivatives. Scientists say this position has had a chilling effect on marijuana research. Though more than one million people are thought to use the drug to treat ailments ranging from cancer to seizures to hepatitis C and chronic pain, there are few rigorous studies showing whether the drug is a fruitful treatment for those or any other conditions. A major reason is this: The federal government categorizes marijuana as a Schedule 1 drug, the most restrictive of five groups established by the Controlled Substances Act of 1970. Drugs in this category including heroin, LSD, peyote and Ecstasy are considered to have no accepted medical use in the United States and a high potential for abuse, and are subject to tight restrictions on scientific study. In the case of marijuana, those restrictions are even greater than for other controlled substances. Marijuana remains illegal under federal law, though nearly half the states and the District of Columbia allow its medical use and two, Colorado and Washington, have legalized its recreational use.

Note: For more on this, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.


Psychedelic mushrooms put your brain in a waking dream, study finds
2014-07-03, Washington Post
Posted: 2014-07-07 08:13:21
http://www.washingtonpost.com/news/to-your-health/wp/2014/07/03/psychedelic-d...

Psychedelic mushrooms can do more than make you see the world in kaleidoscope. Research suggests they may have permanent, positive effects on the human brain. In fact, a mind-altering compound found in some 200 species of mushroom is already being explored as a potential treatment for depression and anxiety. People who consume these mushrooms, after trips that can be a bit scary and unpleasant, report feeling more optimistic, less self-centered, and even happier for months after the fact. But why do these trips change the way people see the world? According to a study published today in Human Brain Mapping, the mushroom compounds could be unlocking brain states usually only experienced when we dream, changes in activity that could help unlock permanent shifts in perspective. The study examined brain activity in those whod received injections of psilocybin, which gives shrooms their psychedelic punch. After injections, the 15 participants were found to have increased brain function in areas associated with emotion and memory. The effect was strikingly similar to a brain in dream sleep, according to Dr. Robin Carhart-Harris, a post-doctoral researcher in neuropsychopharmacology at Imperial College London and co-author of the study. Administration of the drug just before or during sleep seemed to promote higher activity levels during Rapid Eye Movement sleep, when dreams occur. An intriguing finding, Carhart-Harris says, given that people tend to describe their experience on psychedelic drugs as being like a waking dream.

Note: For more on this, see concise summaries of deeply revealing mind altering drugs news articles from reliable major media sources.


The Other Cannabis War?: The Battle Over Hemp
2014-06-03, Rolling Stone
Posted: 2014-06-09 08:20:37
http://www.rollingstone.com/politics/news/the-other-cannabis-war-20140603

Buried in Februarys $956 billion farm bill is an amendment ... that legally distinguishes industrial hemp from marijuana, after decades of conflation [of the two]. It defines hemp as an agricultural crop rather than a drug and effectively frees American farmers to grow it for the first time in almost 60 years. For 20 years, legislators, farmers, hippies, activists, agency heads and agronomists have worked to recast hemp as a game-changer, an American cash crop that could jump-start the country's next economic revival. Colorado, Vermont and Kentucky wasted no time launching their industrial hemp research and the pilot programs provided for in the farm bill. In an obscure notice dated April 16th, the USDA alerted state and county officials that farmers in states that [approved] hemp production (15 so far) could now include hemp acreage in their crop reports. The floodgates have opened. The current American hemp market is estimated at nearly half a billion dollars, with hemps oil, seed and fiber used in food, carbon-negative building materials, and automobile composites that are already inside millions of cars. Hemp cultivation is ... as old as the country itself. George Washington and Thomas Jefferson grew it, hemp was once legal tender, and several drafts of the Declaration of Independence were written on hemp paper. During WWII, American farmers were paid to grow it, cultivating more than 150 million pounds of industrial hemp to support the American war effort.

Note: Hemp is derived from the cannabis sativa plant, which also produces marijuana. For news on mind altering substances, see the deeply revealing reports from reliable major media sources available here.


How did Alexander Shulgin become known as the Godfather of Ecstasy?
2014-06-03, The Guardian (One of the UK's leading newspapers)
Posted: 2014-06-09 08:03:18
http://www.theguardian.com/science/shortcuts/2014/jun/03/alexander-shulgin-ma...

The explosion of dance music culture during the late '80s and early '90s conferred fame on some unlikely people, but few were quite as unlikely as Alexander Shulgin, who died on 2 June at his home in California at the age of 88. He was nearly 70 by the time he became known as the Godfather of Ecstasy, a title that made it sound like he had invented MDMA, which he hadn't: Shulgin had only introduced the drug to west coast psychotherapists in the late 70s. But, he had created more than 200 psychoactive compounds in his home laboratory, tested them all on himself and his wife and written about them in a 1991 book titled Phenethylamines I Have Known and Loved. The combination of the book, his association with ecstasy, and that drug's burgeoning popularity made him a hugely celebrated figure. Shulgin thought all drugs should be legalised, but he seemed about as far removed from the bug-eyed psychedelic proselyte of popular myth as it was possible to get. His writing was measured, calm and witty. He did not court the attention of the rave generation. If anything, he seemed faintly exasperated by the way MDMA was being used. "Go banging about with a psychedelic drug for a Saturday night turn-on, and you can get into a really bad place, psychologically," he had warned. Later he was to lament that MDMA had been "sidetracked into the Yahoo generation". None of the drugs Shulgin invented became as famous as the one he didn't. In the late '90s, there was talk that a compound called 2CB was "the new ecstasy" but it never attained the ubiquity of E. Nevertheless, Shulgin's legend was assured.

Note: To see Shulgin's fun and iconoclastic character, watch this fun four-minute video. Explore major media articles showing breakthroughs in therapy from an excellent compilation of news articles on mind altering drugs. And read the personal journey to healing of courageous CNN reporter Amber Lyon using these "medicines."


LSD, Reconsidered for Therapy
2014-03-04, New York Times
Posted: 2014-03-10 15:32:49
http://www.nytimes.com/2014/03/04/health/lsd-reconsidered-for-therapy.html

On [March 4], The Journal of Nervous and Mental Disease is posting online results from the first controlled trial of LSD in more than 40 years. The study, conducted in the office of a Swiss psychiatrist near Bern, tested the effects of the drug as a complement to talk therapy for 12 people nearing the end of life. Most of the subjects had terminal cancer, and several died within a year after the trial but not before having a mental adventure that appeared to have eased the existential gloom of their last days. Their anxiety went down and stayed down, said Dr. Peter Gasser, who conducted the therapy and followed up with his patients a year after the trial concluded. The new publication marks the latest in a series of baby steps by a loose coalition of researchers and fund-raisers who are working to bring hallucinogens back into the fold of mainstream psychiatry. Before research was effectively banned in 1966 in the United States, doctors tested LSDs effect for a variety of conditions, including end-of-life anxiety. But in the past few years, psychiatrists in the United States and abroad working with state regulators as well as ethics boards have tested Ecstasy-assisted therapy for post-traumatic stress; and other trials with hallucinogens are in the works. The effort is both political and scientific, said Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies, a foundation that has financed many of the studies. We want to break these substances out of the mold of the counterculture and bring them back to the lab.

Note: For more on mind altering drugs, see the deeply revealing reports from reliable major media sources available here.


Learning from a '50s Housewife on Acid
2011-01-18, ABC News
Posted: 2013-10-22 10:09:47
http://abcnews.go.com/Health/1950s-housewife-acid/story?id=12640926

A video [that went viral] featured footage of a mid-1950s housewife on an acid trip during an LSD experiment. In the film, a researcher, Dr. Sidney Cohen, is shown interviewing, and then dosing, a volunteer at the Veteran's Administration Hospital in Los Angeles. The woman, who is identified only as the wife of a hospital employee, is in her late 20s or early 30s and appears fairly typical of her time. LSD was a legal pharmaceutical drug until 1966. Journalist Don Lattin says he came across the video in the archives of philosopher Gerald Heard while researching a group biography on him, the British writer Aldous Huxley, and Bill Wilson, co-founder of Alcoholics Anonymous. In the video that Lattin posted online, [the housewife] is clearly under the influence and appears to be rather enjoying it. She says: "Everything is alive. This is reality. I wish you could see it. I wish I could talk in technicolor." "This shows that very early on in the 1950s, researchers were aware that there were possible beneficial uses, rather than military or more nefarious uses," he says. In the early 1950s and into the '60s the Army and CIA secretly funded a lot of research to see if LSD could be used as a chemical weapon or a truth serum, says Lattin. But Cohen and his ilk were pursuing a different line of study. They wanted to understand how it works, how the mind works and the connection between the psychotic state and a spiritually enlightened state." Indeed, Wilson, the AA co-founder, did a fair amount of LSD in the 50s , says Lattin. "This surprises people, but he wasn't doing it to get high," he adds. "It was to achieve that spiritual awakening."

Note: The video of this session is quite inspiring. See it at this link. For more on mind-altering drugs, see the deeply revealing reports from reliable major media sources available here.


Why I changed my mind on weed
2013-08-09, CNN
Posted: 2013-08-12 17:06:31
http://edition.cnn.com/2013/08/08/health/gupta-changed-mind-marijuana/index.html

Over the last year, I [CNN Chief Medical Correspondent Dr. Sanjay Gupta] have been working on a new documentary called "Weed." The title "Weed" may sound cavalier, but the content is not. I traveled around the world to interview medical leaders, experts, growers and patients. I spoke candidly to them, asking tough questions. What I found was stunning. Long before I began this project, I had steadily reviewed the scientific literature on medical marijuana from the United States and thought it was fairly unimpressive. Reading these papers five years ago, it was hard to make a case for medicinal marijuana. I even wrote about this in a TIME magazine article, back in 2009, titled "Why I would Vote No on Pot." Well, I am here to apologize. I apologize because I didn't look hard enough, until now. I didn't look far enough. I didn't review papers from smaller labs in other countries doing some remarkable research, and I was too dismissive of the loud chorus of legitimate patients whose symptoms improved on cannabis. I mistakenly believed the Drug Enforcement Agency listed marijuana as a schedule 1 substance because of sound scientific proof. Surely, they must have quality reasoning as to why marijuana is in the category of the most dangerous drugs that have "no accepted medicinal use and a high potential for abuse." They didn't have the science to support that claim, and I now know that when it comes to marijuana neither of those things are true. It doesn't have a high potential for abuse, and there are very legitimate medical applications. In fact, sometimes marijuana is the only thing that works.

Note: This article was authored by CNN's Chief Medical Correspondent, Dr. Sanjay Gupta. For more on the proven benefits from many mind-altering drugs, see the deeply revealing reports from reliable major media sources available here.


U.S. hemp crop zero despite strong sales
2013-02-08, San Francisco Chronicle (SF's leading newspaper)
Posted: 2013-02-19 09:44:58
http://www.sfgate.com/business/article/U-S-hemp-crop-zero-despite-strong-sale...

$452 million: That's the value of retail products containing imported hemp that were sold in the United States in 2011. While a cousin of marijuana, the plant can't get you high. Instead, it can be used to make clothes, horse bedding, auto parts, soap and even concrete. But thanks to it being classified like all cannabis plants as a Schedule I substance - the same as heroin - the U.S. hemp crop is precisely zero. If you want to grow hemp and avoid a jail sentence, you need a permit from the Drug Enforcement Administration.

Note: Many have suspected that hemp was outlawed along with marijuana to block competition with lumber and other industries. To see a 1938 Popular Mechanics article touting hemp as the "new billion dollar crop," click here.


Experimental treatment for PTSD: Ecstasy
2012-12-03, CNN
Posted: 2012-12-11 08:42:25
http://www.cnn.com/2012/12/01/health/ecstasy-ptsd-1/

More than 7 million Americans suffer from PTSD, and by most estimates, only half of them -- at best -- are ever cured. A decade ago, the widely acknowledged need for better treatments opened the door to [South Carolina psychiatrist Dr. Michael] Mithoefer and his unconventional approach. By ... February 2005, the soft-spoken, ponytailed Mithoefer had managed to convince the Drug Enforcement Administration to green-light a study of Ecstasy as an adjunct to psychotherapy. He'd gotten the 3,4-methylenedioxy-methylamphetamine (MDMA) -- the chemical name for pure Ecstasy -- from Rick Doblin, the founder of a MAPS, the Multidisciplinary Association for Psychedelic Studies. The group's stated purpose is to develop "medical, legal and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana." It wants to turn mind-altering drugs like Ecstasy into prescription medicine. To win broader acceptance for MDMA -- and for cousins like LSD and psilocybin, the mind-altering compound in so-called magic mushrooms -- "the medical route was the only route. Everything else was blocked." That meant a formal plan for drug development: study protocols, institutional review boards and the rest. Mithoefer, a University of Virginia-trained clinician who specializes in trauma and had a long-running interest in MDMA, was the perfect partner.

Note: To watch a CNN video clip on this showing remarkable success in treating PTSD, click here. For deeply revealing reports from reliable major media sources on beneficial mind-altering drugs, click here.


A Party Drug May Help the Brain Cope With Trauma
2012-11-20, New York Times
Posted: 2012-12-11 08:40:58
http://www.nytimes.com/2012/11/20/health/ecstasy-treatment-for-post-traumatic...

Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it. The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and 90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes. In a paper posted online ... by the Journal of Psychopharmacology, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment which combines psychotherapy with a dose of MDMA write that they found 15 of 21 people who recovered from severe post-traumatic stress in the therapy in the early 2000s reported minor to virtually no symptoms today. The Mithoefers he is a psychiatrist and she is a nurse collaborated on the study with researchers at the Medical University of South Carolina and the nonprofit Multidisciplinary Association for Psychedelic Studies. The patients in this group included mostly rape victims, and experts familiar with the work cautioned that it was preliminary, based on small numbers, and its applicability to war trauma entirely unknown.

Note: For the paper on this remarkable study published published online in the Journal of Psychopharmacology, click here. For deeply revealing reports from reliable major media sources on beneficial mind-altering drugs, click here.


Law, policy thwart research on marijuana
2012-10-19, Boston Globe
Posted: 2012-10-30 11:28:24
http://bostonglobe.com/lifestyle/health-wellness/2012/10/18/research-into-mar...

Massachusetts voters in 2 weeks will consider becoming the 18th state to legalize the use of marijuana for medical purposes. Individual doctors and patient advocacy groups, including the AIDS Action Committee of Massachusetts and the state chapter of the Leukemia and Lymphoma Society, have endorsed the ballot question, saying marijuana can help patients and is available now. To study marijuana, researchers must be licensed by the US Drug Enforcement Administration and get access to marijuana grown at the University of Mississippi, which contracts with the National Institute on Drug Abuse to produce the only federally sanctioned supply. That process can prove onerous, if not impossible, acting as a deterrent for those who might want to study marijuanas benefits, some researchers said. In 2000, the University of California created the Center for Medicinal Cannabis Research, with $9 million from the state. Dr. Igor Grant, the centers director, ... and colleagues have completed the most comprehensive research to date of the effects of marijuana in patients, including studies that were randomized and double-blind, gold standards in research. Four studies found the drug to be useful in treating pain. Three were in patients with HIV who had pain resulting from damage to their nervous system. Another study found that marijuana reduced muscle stiffness in patients with multiple sclerosis.

Note: For deeply revealing reports from reliable major media sources on mind-altering drugs, click here.


Can LSD cure depression?
2012-09-25, The Telegraph (One of the UK's leading newspapers)
Posted: 2012-10-30 11:25:09
http://www.telegraph.co.uk/science/9565026/Can-LSD-cure-depression.html

Until recently, prescribing Ecstasy, mescaline or magic mushrooms has been a guaranteed way for a psychiatrist to lose his research funding, his job or even his liberty. But now, scientists are beginning to suspect that such illegal drugs may be the key to treating a range of intractable illnesses, from post-traumatic stress disorder to depression. These chemicals [include] the psychedelic drugs psilocybin, derived from magic mushrooms, and LSD, as well as Ecstasy. A series of studies performed in Britain and the US is beginning to tease out their potential benefits. People become very emotionally tender on Ecstasy, which makes you more responsive to psychotherapy, explains Dr Robin Carhart-Harris. [In] volunteers given the ... drug, the area of their brain involved in positive memories became more active, while another processing negative memories was damped down. We think this would make it easier for patients to revisit a traumatic memory and overwrite or control it, says Carhart-Harris. Earlier studies have made surprising discoveries about what psilocybin, a class-A drug in Britain, was doing in the brain. These in turn could lead to new treatments for depression and agonising cluster headaches. This may all sound radical, or even dangerous yet half a century ago, research into the effects of psychedelic drugs was widespread and respectable. More than 1,000 papers were published looking at ways that psychiatrists could help patients with hallucinogenic chemicals.

Note: For deeply revealing reports from reliable major media sources on mind-altering drugs, click here.


Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find
2012-09-06, The Daily Beast/Newsweek
Posted: 2012-09-11 10:40:01
http://www.thedailybeast.com/articles/2012/09/06/marijuana-fights-cancer-and-...

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as cannabinoids, are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and significantly reduces the ability of the cancer to spread. Whats more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells. Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.

Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.


Scientists' agony over ecstasy
2012-07-18, The Guardian (One of the UK's leading newspapers)
Posted: 2012-08-14 09:06:18
http://www.guardian.co.uk/commentisfree/2012/jul/18/scientists-study-ecstasy-...

Research into ... Schedule I drugs like MDMA (ecstasy), LSD and magic mushrooms ... requires not only a high level of security, but also that the institutions involved buy a licence costing several thousand pounds not required for researching other drugs. Paradoxically, the other schedules include more harmful substances such as heroin. Funders often shy away from such research because of the red tape, associated higher costs, and the perception that it is possible to be stigmatised for supporting such work. Research into a Schedule I drug like MDMA has potential both to help our understanding of how drugs affect the brain, and provide those who take them with better harm-reduction information. It also helps us understand how we can make drugs work normally, advancing our treatment of brain disorders. Some Schedule I drugs have huge potential for serious conditions where treatment is currently inadequate, including addiction and depression. Frustratingly, almost no research has been carried out since current regulations came into force in 1971. And the situation is about to get worse; the government's new temporary drug control orders ... automatically puts new substances under Schedule I for the year that they are controlled. The likelihood of the drug then being downgraded is very remote, given that research will be practically impossible, especially within the year's timeframe.

Note: For deeply revealing reports from reliable major media sources on mind-altering drugs, click here.


A Judges Plea for Pot
2012-05-17, New York Times
Posted: 2012-05-22 11:47:59
http://www.nytimes.com/2012/05/17/opinion/a-judges-plea-for-medical-marijuana...

Three and a half years ago, on my 62nd birthday, doctors discovered a mass on my pancreas. It turned out to be Stage 3 pancreatic cancer. I was told I would be dead in four to six months. Today I am in that rare coterie of people who have survived this long with the disease. But I did not foresee that after having dedicated myself for 40 years to a life of the law, including more than two decades as a New York State judge, my quest for ameliorative and palliative care would lead me to marijuana. My survival has demanded an enormous price, including months of chemotherapy, radiation hell and brutal surgery. Inhaled marijuana is the only medicine that gives me some relief from nausea, stimulates my appetite, and makes it easier to fall asleep. The oral synthetic substitute, Marinol, prescribed by my doctors, was useless. Rather than watch the agony of my suffering, friends have chosen, at some personal risk, to provide the substance. I find a few puffs of marijuana before dinner gives me ammunition in the battle to eat. A few more puffs at bedtime permits desperately needed sleep. This is not a law-and-order issue; it is a medical and a human rights issue. Being treated at Memorial Sloan Kettering Cancer Center, I am receiving the absolute gold standard of medical care. But doctors cannot be expected to do what the law prohibits, even when they know it is in the best interests of their patients. When palliative care is understood as a fundamental human and medical right, marijuana for medical use should be beyond controversy.

Note: The author is Gustin L. Reichbach, who is a justice of the New York State Supreme Court in Brooklyn. For lots more from reliable sources on the benefits of many mind-altering drugs, click here.


Can a hallucinogen from Africa cure addiction?
2012-04-13, BBC News
Posted: 2012-05-15 15:52:52
http://www.bbc.co.uk/news/magazine-17666589

Since the 1960s a disparate group of scientists and former drug addicts have been advocating a radical treatment for addiction - a hallucinogen called ibogaine, derived from an African plant, that in some cases seems to obliterate withdrawal symptoms from heroin, cocaine and alcohol. So why isn't it widely used? The drug, derived from the root of a central African plant called iboga, had been used for centuries by the Bwiti people of Gabon and Cameroon, as part of a tribal initiation ceremony. But it wasn't until 1962, when a young heroin addict called Howard Lotsof stumbled upon ibogaine, that its value as an addiction treatment was uncovered. Lotsof took it to get high but when the hallucinogenic effects wore off, he realised he no longer had the compulsion to take heroin. He became convinced that he had found the solution to addiction and dedicated much of his life to promoting ibogaine as a treatment. Ibogaine affects the brain in two distinct ways. The first is metabolic. It creates a protein that blocks receptors in the brain that trigger cravings, stopping the symptoms of withdrawal. With normal detox this process can take months. Its second effect is much less understood. It seems to inspire a dream-like state that is intensely introspective, allowing addicts to address issues in their life that they use alcohol or drugs to suppress.

Note: For more news articles from reliable sources on mind-altering drugs, click here.


Doctors consider using street drugs to ease suffering of dying patients
2012-04-24, Fox News
Posted: 2012-05-15 15:49:26
http://www.foxnews.com/health/2012/04/24/doctors-consider-using-street-drugs-...

Recent studies at Harvard, U.C.L.A. [and] John Hopkins have now made it plain that doctors should [soon] be free to offer illicit drugs to patients who are terminally ill, in order to ease their emotional suffering. At Harvard, Dr. John Halpern ... tested MDMA (the street drug Ecstasy) to determine if it would ease the anxieties in two patients with terminal cancer. At U.C.L.A. and Hopkins, Drs. Charles Grob and Roland Griffiths used psilocybin (the active ingredient in hallucinogenic mushrooms) to help cancer patients past their paralyzing, debilitating fears. The results are reportedly consistently good. In many cases, patients are able to cope with their physical pain and psychological turmoil better than before. Some, no doubt, feel the drugs opened doors of perception previously closed to them, allowing them to make peace with their lives and the impending end of their lives. Recent data also show that low doses of the street drug Special K (ketamine), when slowly infused via IV, can instantly [relieve] major depression ... in many patients. And opiates like oxycodone ... are also extremely useful for those patients who ... suffer with unwieldy anxiety that cannot be addressed ... in any other way.

Note: For more news articles from reliable sources on mind-altering drugs, click here.


How Psychedelic Drugs Can Help Patients Face Death
2012-04-22, New York Times
Posted: 2012-05-01 09:02:51
http://www.nytimes.com/2012/04/22/magazine/how-psychedelic-drugs-can-help-pat...

Charles Grob [is] a psychiatrist and researcher at Harbor-U.C.L.A. Medical Center who [has administered] psilocybin an active component of magic mushrooms to end-stage cancer patients to see if it could reduce their fear of death. When the research was completed in 2008 ... the results showed that administering psilocybin to terminally ill subjects could be done safely while reducing the subjects anxiety and depression about their impending deaths. Grobs interest in the power of psychedelics to mitigate mortalitys sting is not just the obsession of one lone researcher. Dr. John Halpern, head of the Laboratory for Integrative Psychiatry at McLean Hospital in Belmont Mass., a psychiatric training hospital for Harvard Medical School, used MDMA also known as ecstasy in an effort to ease end-of-life anxieties in two patients with Stage 4 cancer. And there are two ongoing studies using psilocybin with terminal patients, one at New York Universitys medical school, led by Stephen Ross, and another at Johns Hopkins Bayview Medical Center, where Roland Griffiths has administered psilocybin to 22 cancer patients and is aiming for a sample size of 44. This research is in its very early stages, Grob told me earlier this month, but were getting consistently good results. Grob and his colleagues are part of a resurgence of scientific interest in the healing power of psychedelics.

Note: For fascinating reports from major media sources on the beneficial uses of psychedelics, click here.


Could A Club Drug Offer 'Almost Immediate' Relief From Depression?
2012-01-30, NPR blog
Posted: 2012-02-07 16:54:36
http://www.npr.org/blogs/health/2012/01/30/145992588/could-a-club-drug-offer-...

Traditional antidepressants like Prozac work on a group of chemical messengers in the brain called the serotonin system. Researchers once thought that a lack of serotonin was the cause of depression, and that these drugs worked simply by boosting serotonin levels. Recent research suggests a more complicated explanation. Serotonin drugs work by stimulating the birth of new neurons, which eventually form new connections in the brain. Ketamine, in contrast, activates a different chemical system in the brain the glutamate system. Researcher Ron Duman at Yale thinks ketamine rapidly increases the communication among existing neurons by creating new connections. This is a quicker process than waiting for new neurons to form and accomplishes the same goal of enhancing brain circuit activity. Ketamine has been used for decades as an anesthetic. It also has become a wildly popular but illegal club drug known as "Special K." Mental health researchers got interested in ketamine because of reports that it could make depression vanish almost instantly. Carlos Zarate ... does ketamine research at the NIH. Zarate says patients typically say, "'I feel that something's lifted or feel that I've never been depressed in my life. I feel I can work. I feel I can contribute to society.' And it was a different experience from feeling high. This was feeling that something has been removed."

Note: For many inspiring potential treatment breakthroughs in health issues, click here.


Magic Mushrooms Expand the Mind By Dampening Brain Activity
2012-01-24, Time Magazine
Posted: 2012-01-31 15:24:44
http://healthland.time.com/2012/01/24/magic-mushrooms-expand-the-mind-by-damp...

More than half a century ago, author Aldous Huxley titled his book on his experience with hallucinogens The Doors of Perception. Huxley posited that ordinary consciousness represents only a fraction of what the mind can take in. In order to keep us focused on survival, Huxley claimed, the brain must act as a reducing valve on the flood of potentially overwhelming sights, sounds and sensations. What remains, Huxley wrote, is a measly trickle of the kind of consciousness necessary to help us to stay alive. A new study by British researchers supports this theory. It shows for the first time how psilocybin the drug contained in magic mushrooms affects the connectivity of the brain. Researchers found that the psychedelic chemical ... does not work by ramping up the brains activity as theyd expected. Instead, it reduces it. Under the influence of mushrooms, overall brain activity drops, particularly in certain regions that are densely connected to sensory areas of the brain. When functioning normally, these connective hubs appear to help constrain the way we see, hear and experience the world, grounding us in reality. Psilocybin cuts activity in these nodes and severs their connection to other brain areas, allowing the senses to run free. Huxley ... had predicted what turns out to be a key finding of modern neuroscience: many of the human brains highest achievements involve preventing actions instead of initiating them, and sifting out useless information rather than collecting and presenting it for conscious consideration.

Note: There are several excellent links in the full article which show promising results of using these plants to improve mental health and more.


Magic Mushrooms Trigger Lasting Personality Change
2011-10-03, Time Magazine
Posted: 2012-01-31 15:21:29
http://healthland.time.com/2011/10/03/want-to-feel-younger-more-open-magic-mu...

The psychedelic drug psilocybin (the active ingredient in magic mushrooms) may produce lasting, positive changes in personality, new research finds. People who took the drug showed increases in the key personality dimension of openness being amenable to new ideas, experiences and perspectives more than a year later. Researchers led by Katherine MacLean, a postdoctoral student at Johns Hopkins University, analyzed personality data on 52 participants (average age 46) who had participated in the groups earlier research on the drug. These volunteers took psilocybin during two to five sessions, at various doses, under highly controlled conditions at the hospital. The earlier study had found positive psychological changes documented by both participants and their family members and other associates in calmness, happiness and kindness. The new research found that the drug takers also saw long-term changes to their underlying personality. The personality changes also ran counter to those expected as people age. Normally, as people grow older, they become increasingly less open to new ideas and new experiences. In contrast, in participants who experienced had what researchers call a full mystical experience, the scientists saw a shift toward increased openness, as though the volunteers had become decades younger. People became more curious and more interested in new ideas and experiences and in trying new things.


'Magic Mushrooms' Can Improve Psychological Health Long Term
2011-06-16, Time Magazine
Posted: 2011-10-18 17:08:00
http://healthland.time.com/2011/06/16/magic-mushrooms-can-improve-psychologic...

The psychedelic drug in magic mushrooms may have lasting medical and spiritual benefits, according to new research from Johns Hopkins School of Medicine. The mushroom-derived hallucinogen, called psilocybin, is known to trigger transformative spiritual states, but at high doses it can also result in "bad trips" marked by terror and panic. "The important point here is that we found the sweet spot where we can optimize the positive persistent effects and avoid some of the fear and anxiety that can occur and can be quite disruptive," says lead author Roland Griffiths, professor of behavioral biology at Hopkins. Giffiths' study involved 18 healthy adults, average age 46. Nearly all the volunteers were college graduates and 78% participated regularly in religious activities; all were interested in spiritual experience. Fourteen months after participating in the study, 94% of those who received the drug said the experiment was one of the top five most meaningful experiences of their lives; 39% said it was the single most meaningful experience. Their friends, family members and colleagues also reported that the psilocybin experience had made the participants calmer, happier and kinder.


Clearing the smoke: the science of cannabis
2011-03-03, The Guardian (One of the UK's leading newspapers)
Posted: 2011-04-05 20:35:50
http://www.guardian.co.uk/science/punctuated-equilibrium/2011/mar/03/1

A new documentary [has been] produced and aired by Montana PBS, a non-profit publicly-supported broadcasting television service in the United States. Their programme, "Clearing the Smoke", investigates the science of marijuana, [exploring] how cannabis acts on the brain and in the body in medically beneficial ways to treat nausea, pain, epilepsy and possibly even cancer. This programme includes extensive interviews with patients, doctors, [and] researchers, and skeptics detail the promises and the limitations of medicinal cannabis. Marijuana use is illegal throughout many countries of the world for reasons that are not clear. This video is important because it mainly investigates the scientific basis underlying the medical benefits of marijuana use instead of focusing on the social, political and legal hysteria that have been attached to it. The paper mentioned in this video, Marijuana Reconsidered, was published in book form and can be purchased from Amazon. The author, Dr Grinspoon, is the world's leading authority on marijuana. In this book, Dr Grinspoon examines -- and debunks -- many of the common misconceptions about marijuana.

Note: For an intriguing two-minute video clip of this program showing that cannabis has cured some forms of cancer in mice, click here. For the full, astonishing PBS documentary, click here.


MI6 ordered LSD tests on servicemen
2005-01-22, The Guardian (One of the UK's leading newspapers)
Posted: 2010-10-04 10:20:36
http://www.guardian.co.uk/science/2005/jan/22/uknews1

Fifty years ago, Eric Gow had a baffling and unexplained experience. As a 19-year-old sailor, he remembers going to a clandestine military establishment, where he was given something to drink in a sherry glass and experienced vivid hallucinations. Other servicemen also remember tripping: one thought he was seeing tigers jumping out of a wall, while another recalls faces "with eyes running down their cheeks, Salvador Dal-style". Mr Gow and another serviceman had volunteered to take part in what they thought was research to find a cure for the common cold. Mr Gow felt that the government had never explained what happened to him. But now he has received an official admission for the first time, confirmed last night, that the intelligence agency MI6 tested LSD on servicemen. One of the scientists involved at the time suggested that the experiments were stopped because it was feared that the acid could produce "suicidal tendencies". MI6, known formally as the Secret Intelligence Service (SIS) and responsible for spying operations abroad, carried out the tests in the cold war in an attempt to uncover a "truth drug" which would make prisoners talk against their will in interrogations. In parallel experiments, the CIA infamously tested LSD and other drugs on unwitting human subjects in a 20-year search to uncover mind-manipulation techniques. The trials were widely criticised when they came to light in the 1970s.

Note: For key reports from major media sources on CIA experimentation on unwitting subjects, click here.


'Magic mushrooms' ingredient beneficial to cancer patients, report says
2010-09-07, Los Angeles Times
Posted: 2010-09-13 11:08:48
http://www.latimes.com/news/science/la-sci-magic-mushrooms-20100907,0,4230087...

The psychedelic drug psilocybin, the active ingredient in "magic mushrooms," can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported [on September 6]. A single modest dose of the hallucinogen ... can improve patients' functioning for as long as six months, allowing them to spend their last days with more peace, researchers said. Dr. Charles Grob, a psychiatrist at Harbor- UCLA Medical Center and the Los Angeles Biomedical Research Institute ... and his colleagues studied 12 patients, ages 36 to 58, with advanced-stage cancer and anxiety resulting from their diagnoses. The patients were given a relatively low dose of psilocybin, 0.2 milligram per kilogram of body weight. Nonetheless, the team reported in the Archives of General Psychiatry, all patients reported a significant improvement in mood for at least two weeks after the psilocybin treatment and up to a six-month improvement on a scale that measures depression and anxiety. Most also reported a decreased need for narcotic pain relievers. No adverse reactions were observed. These types of patients normally do not respond well to psychological therapy, Grob said, but his study showed that the drug has "great promise for alleviating anxiety and other psychiatric symptoms."

Note: For many hope-inspiring reports from reliable sources on new cancer coping strategies and possible cures, click here.


Pont-Saint-Esprit poisoning: Did the CIA spread LSD?
2010-08-23, BBC News
Posted: 2010-08-31 10:04:49
http://www.bbc.co.uk/news/world-10996838

Nearly 60 years ago, a French town was hit by a sudden outbreak of hallucinations, which left five people dead and many seriously ill. On 16 August 1951, postman Leon Armunier was doing his rounds in the southern French town of Pont-Saint-Esprit when he was suddenly overwhelmed by nausea and wild hallucinations. "It was terrible. I had the sensation of shrinking and shrinking, and the fire and the serpents coiling around my arms," he remembers. Leon, now 87, fell off his bike and was taken to the hospital in Avignon. Over the coming days, dozens of other people in the town fell prey to similar symptoms. Doctors at the time concluded that bread at one of the town's bakeries had become contaminated by ergot, a poisonous fungus that occurs naturally on rye. That view remained largely unchallenged until 2009, when an American investigative journalist, Hank Albarelli, revealed a CIA document labelled: "Re: Pont-Saint-Esprit and F.Olson Files. SO Span/France Operation file, inclusive Olson. Intel files. Hand carry to Belin - tell him to see to it that these are buried." F. Olson is Frank Olson, a CIA scientist who, at the time of the Pont St Esprit incident, led research for the agency into the drug LSD. David Belin, meanwhile, was executive director of the Rockefeller Commission created by the White House in 1975 to investigate abuses carried out worldwide by the CIA. Albarelli believes the Pont-Saint-Esprit and F. Olson Files, mentioned in the document, would show - if they had not been "buried" - that the CIA was experimenting on the townspeople, by dosing them with LSD.

Note: Frank Olson later had his drink spiked with LSD and allegedly committed suicide shortly thereafter. Yet many believe he was "suicided" as he was having misgivings about his involvement in this program and considering spilling the beans, as reported in this news article. For an overview of CIA mind-control experimentation, click here.


Hallucinogens Have Doctors Tuning In Again
2010-04-11, New York Times
Posted: 2010-04-19 00:10:41
http://www.nytimes.com/2010/04/12/science/12psychedelics.html

Scientists are taking a new look at hallucinogens, which became taboo among regulators after enthusiasts like Timothy Leary promoted them in the 1960s with the slogan Turn on, tune in, drop out. Now, using rigorous protocols and safeguards, scientists have won permission to study once again the drugs potential for treating mental problems and illuminating the nature of consciousness. Researchers from around the world are gathering this week in San Jose, Calif., for the largest conference on psychedelic science held in the United States in four decades. They plan to discuss studies of psilocybin and other psychedelics for treating depression in cancer patients, obsessive-compulsive disorder, end-of-life anxiety, post-traumatic stress disorder and addiction to drugs or alcohol. Scientists are especially intrigued by the similarities between hallucinogenic experiences and the life-changing revelations reported throughout history by religious mystics and those who meditate. These similarities have been identified in neural imaging studies conducted by Swiss researchers and in experiments led by Roland Griffiths, a professor of behavioral biology at Johns Hopkins. In one of Dr. Griffithss first studies, involving 36 people with no serious physical or emotional problems, he and colleagues found that psilocybin could induce what the experimental subjects described as a profound spiritual experience with lasting positive effects for most of them.

Note: For key reports on health issues from reliable sources, click here.


French bread spiked with LSD in CIA experiment
2010-03-11, The Telegraph (One of the UK's leading newspapers)
Posted: 2010-03-25 15:37:29
http://www.telegraph.co.uk/news/worldnews/europe/france/7415082/French-bread-...

A 50-year mystery over the 'cursed bread' of Pont-Saint-Esprit, which left residents suffering hallucinations, has been solved after a writer discovered the US had spiked the bread with LSD as part of an experiment. In 1951, a quiet, picturesque village in southern France was suddenly and mysteriously struck down with mass insanity and hallucinations. At least five people died, dozens were interned in asylums and hundreds afflicted. For decades it was assumed that the local bread had been unwittingly poisoned with a psychedelic mould. Now, however, an American investigative journalist has uncovered evidence suggesting the CIA peppered local food with the hallucinogenic drug LSD as part of a mind control experiment at the height of the Cold War. One man tried to drown himself, screaming that his belly was being eaten by snakes. An 11-year-old tried to strangle his grandmother. Another man shouted: "I am a plane", before jumping out of a second-floor window, breaking his legs. He then got up and carried on for 50 yards. Many were taken to the local asylum in strait jackets.

Note: For lots more reliable information on CIA mind control experiments, click here and here.


LSD's long, strange trip back into the lab
2009-09-27, San Francisco Chronicle (San Francisco's leading newspaper)
Posted: 2009-10-12 14:05:12
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/09/27/MNEN19SNGD.DTL

LSD, the drug that launched the psychedelic era and became one of the resounding symbols of the counterculture movement of the '60s, is back in the labs. Nearly 40 years after widespread fear over recreational abuse of LSD and other hallucinogens forced dozens of scientists to abandon their work, researchers at a handful of major institutions - including UCSF and Harvard University - are reigniting studies. The study at UCSF ... is looking into the mechanisms of LSD and how it works in the brain. The hope is that such research might support further studies into medical applications of LSD - for chronic headaches, for example - or psychiatric uses. "Psychedelics are in labs all over the world and there's a lot of promise," said Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies in Santa Cruz. Stanislav Grof was one of the last scientists to abandon hallucinogenic research when he shut down several projects at the Maryland Psychiatric Research Center in 1973 after his funding dried up. He moved to California to work at a research institute in Big Sur, where he turned to studies about how to re-create the effects of those drugs through meditation and breathing techniques. He's pleased to see some of the stigma falling away from drugs like LSD, but it bothers him that the scientific community lost decades of research. "I thought psychiatry and psychology really lost a major opportunity because of the abuse that happened with unsupervised research," Grof said. "These are fascinating substances - and they're very, very powerful, so they should be used with great precaution."


Clinical trials test potential of hallucinogenic drugs to help patients with terminal illnesses
2008-08-12, The Guardian (One of the U.K.'s leading newspapers)
Posted: 2008-08-23 07:54:07
http://www.guardian.co.uk/science/2008/aug/12/medicalresearch.drugs

Scientists are exploring the use of psychedelic drugs such as LSD to treat a range of ailments from depression to cluster headaches and obsessive compulsive disorder. The first clinical trial using LSD since the 1970s began in Switzerland in June. It aims to use "psychedelic psychotherapy" to help patients with terminal illnesses come to terms with their imminent mortality and so improve their quality of life. Another psychedelic substance, psilocybin, has shown promising results in trials for treating symptoms of terminal cancer patients. In the Swiss trial eight subjects will receive a dose of 200 microgrammes of LSD. This is enough to induce a powerful psychedelic experience. A further four subjects will receive a dose of 20 microgrammes. Every participant will know they have received some LSD, but neither the subjects nor the researchers observing them will know for certain who received the full dose. During the course of therapy researchers will assess the patients' anxiety levels, quality of life and pain levels. Before hallucinogenic drugs became popular with the counter culture, they were at the forefront of brain science. They were used to help scientists understand the nature of consciousness and how the brain works and as treatments for a range of conditions. Dr Rick Doblin is president of the Multidisciplinary Association for Psychedelic Studies (MAPS) in California, a nonprofit organisation which funds clinical studies into psychedelic drugs, including the Swiss LSD trial. "These drugs, these experiences are not for the mystic who wants to sit on the mountain top and meditate. They are not for the counter-culture rebel. They are for everybody," he said.


Psychedelic Study Shows Positive Results
2008-07-01, CBS News/Associated Press
Posted: 2008-07-10 10:52:25
http://www.cbsnews.com/stories/2008/07/01/tech/main4221948.shtml

In 2002, at a Johns Hopkins University laboratory, a business consultant named Dede Osborn took a psychedelic drug as part of a research project. She felt like she was taking off. She saw colors. Then it felt like her heart was ripping open. But she called the experience joyful as well as painful, and says that it has helped her to this day. "I feel more centered in who I am and what I'm doing," said Osborn, now 66, of Providence, R.I. "I don't seem to have those self-doubts like I used to have. I feel much more grounded (and feel that) we are all connected." Scientists reported ... that when they surveyed volunteers 14 months after they took the drug, most said they were still feeling and behaving better because of the experience. Two-thirds of them also said the drug had produced one of the five most spiritually significant experiences they'd ever had. The drug, psilocybin, is found in so-called "magic mushrooms." It's illegal, but it has been used in religious ceremonies for centuries. The project made headlines in 2006 when researchers published their report on how the volunteers felt just two months after taking the drug. The new study followed them up [to] a year after that. Fourteen months after taking the drug, 64 percent of the volunteers said they still felt at least a moderate increase in well-being or life satisfaction, in terms of things like feeling more creative, self-confident, flexible and optimistic. The questionnaire answers indicated lasting gains in traits like being more sensitive, tolerant, loving and compassionate.

Note: For lots of exciting reports on new health research, click here.


Albert Hofmann, the Father of LSD, Dies at 102
2008-04-30, New York Times
Posted: 2008-05-08 11:20:13
http://www.nytimes.com/2008/04/30/world/europe/30hofmann.html?partner=rssuser...

Albert Hofmann, the mystical Swiss chemist who gave the world LSD, the most powerful psychotropic substance known, died ... at his hilltop home near Basel, Switzerland. He was 102. Dr. Hofmann first synthesized the compound lysergic acid diethylamide in 1938 but did not discover its psychopharmacological effects until five years later, when he accidentally ingested the substance that became known to the 1960s counterculture as acid. More important to him than the pleasures of the psychedelic experience was the drugs value as a revelatory aid for contemplating and understanding what he saw as humanitys oneness with nature. He earned his Ph.D. ... in 1929, when he was just 23. It was during his work on the ergot fungus, which grows in rye kernels, that he stumbled on LSD, accidentally ingesting a trace of the compound one ... afternoon in April 1943. Dr. Hofmanns work produced other important drugs, including methergine, used to treat postpartum hemorrhaging, the leading cause of death from childbirth. But it was LSD that shaped both his career and his spiritual quest. Through my LSD experience and my new picture of reality, I became aware of the wonder of creation, the magnificence of nature and of the animal and plant kingdom, Dr. Hofmann told the psychiatrist Stanislav Grof during an interview in 1984. I became very sensitive to what will happen to all this and all of us. Dr. Hofmann became an impassioned advocate for the environment and argued that LSD, besides being a valuable tool for psychiatry, could be used to awaken a deeper awareness of mankinds place in nature and help curb societys ultimately self-destructive degradation of the natural world.


Dr. Ecstasy
2005-01-30, New York Times
Posted: 2007-02-15 11:36:57
http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html?ex=1264914000&en=0b...

By [Alexander] Shulgin's own count, he has created nearly 200 psychedelic compounds, among them stimulants, depressants, aphrodisiacs, ''empathogens,'' [and] convulsants. And in 1976, Shulgin fished an obscure chemical called MDMA out of the depths of the chemical literature and introduced it to the wider world, where it came to be known as Ecstasy. Most of the scientific community considers Shulgin at best a curiosity and at worst a menace. Now, however, near the end of his career, his faith in the potential of psychedelics has at least a chance at vindication. A little more than a month ago, the [FDA] approved a Harvard Medical School study looking at whether MDMA can alleviate the fear and anxiety of terminal cancer patients. And next month will mark a year since [the start of a] study of Ecstasy-assisted therapy for post-traumatic stress disorder. Shulgin's knack for befriending the right people hasn't hurt. A week after I visited him, he was headed to Sonoma County for the annual ''summer encampment'' of the Bohemian Club, an exclusive, secretive San Francisco-based men's club that has counted every Republican president since Herbert Hoover among its members. For a long time, though, Shulgin's most helpful relationship was with the D.E.A. itself. The head of the D.E.A.'s Western Laboratory, Bob Sager, was one of his closest friends. In his office, Shulgin has several plaques awarded to him by the agency for his service. Shulgin has been credited with jump-starting today's therapeutic research.

Note: The sentence about the Bohemian Club is a very rare revelation in the major media on the influence of this secret society. For lots more reliable, verifiable information on secret societies, click here.


MI6 pays out over secret LSD mind control tests
2006-02-24, The Guardian (One of the U.K.'s leading newspapers)
Posted: 2006-11-11 00:00:00
http://politics.guardian.co.uk/homeaffairs/story/0,,1716708,00.html

The Secret Intelligence Service, MI6, has paid thousands of pounds in compensation to servicemen who were fed LSD without their consent in clandestine mind-control experiments in the 1950s. MI6 has agreed an out-of-court settlement with the men, who said they were duped into taking part in the experiments and had waited years to learn the truth. Don Webb, a former airman, said yesterday: "I feel vindicated; this has been a classic cover-up for years." MI6's counterparts at the CIA also did LSD experiments on men without their knowledge to try to control their minds. Mr Webb said scientists gave him LSD at least twice in a week. He remembers a nightmarish experience when he hallucinated for a long time. He saw "walls melting, cracks appearing in people's faces ... eyes would run down cheeks, Salvador Dali-type faces ... a flower would turn into a slug". He said he had first made inquiries about the experiments in the 1960s but was "blanked by the government, which quoted the Official Secrets Act". He said he experienced flashbacks for 10 years after the experiments. "They treated us just like guinea pigs."

Note: For lots more on the use of human guinea pigs by the government in attempts to master mind control, see http://www.WantToKnow.info/mindcontrol and http://www.WantToKnow.info/mindcontrol10pg#lsd


Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.